Rehabilitation programme
What studies of rehabilitation programme found
At a glance, by condition
Long COVID: C Might help, very uncertain
Based on the strongest evidence, the randomised trial and studies with no comparison group and compared with another group, not randomised and randomised trials (very low certainty): 21 of 29 findings are C.
14 outcomes rated · see each below
ME/CFS: C Might help, very uncertain
Based on the strongest evidence, studies with no comparison group (very low certainty): 2 findings, all C.
2 outcomes rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: For long COVID, rehabilitation programme might help some people, but research can’t show it yet. For ME/CFS, rehabilitation programme might help some people, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- Rehabilitation programme · Long COVID is hereRehabilitation programme · ME/CFS is hereCMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
Long COVID
Symptoms
Low mood or anxiety5 studies · 1,842 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (109 in all).
The randomised trial164 randomised · 116 started · 109 analysed · after eight weeks and when followed up after six months · two hours a day, three days a week over a period of eight weeks
Low mood or anxiety improved more than in the comparison group.
The evidence is very uncertain about the effect of rehabilitation programme on low mood or anxiety in long COVID. Improvement · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (109 in all)
Compared with another group, not randomised52 in the study · 8 weeks · two sessions per week, over an 8-week period
Low mood or anxiety improved more than in the comparison group.
The evidence is very uncertain about the effect of rehabilitation programme on low mood or anxiety in long COVID. Improvement · very low certainty C
- Serious risk of bias (ROBINS-I)
Studies with no comparison group3 studies · 1,750 people with results
Low mood or anxiety improved.
The evidence is very uncertain about the effect of rehabilitation programme on low mood or anxiety in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
See the 5 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- two hours a day, three days a week over a period of eight weeks
- Outcome
- risk of anxiety Hospital Anxiety and Depression Scale
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- High
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Low
-
- People in the study
- 52 in the study
- Dose
- two sessions per week, over an 8-week period
- Outcome
- HADS anxiety (HADS-A) Hospital Anxiety and Depression Scale
- Effect
- better
- Risk of bias
ROBINS-I: Serious
- Confounding
- Moderate. adjusted for: baseline values (including patients who were lost at follow-up); Bonferroni
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Selection of participants
- Moderate. comparison group: patients unable to participate due to logistical/transport issues
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Moderate. missing data: Rehab: 4 did not complete; UC: 4 failed re-evaluation; ANCOVA included patients lost at follow-up as covariate
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- Moderate. a pre-specified secondary outcome
-
- People in the study
- 601 in the study
- Dose
- 3 × 45-min exercise sessions per week, 12-week programme split into two 6-week phases
- Outcome
- WHO-5 score The World Health Organization- Five Well-Being Index (WHO-5)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 127 in the study · 121 with outcome data
- Dose
- —
- Outcome
- ITQ International Trauma Questionnaire
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
[Satisfaction of post-COVID patients with rehabilitation]. (2025)
- People in the study
- 1,028 in the study
- Dose
- —
- Outcome
- improvement in mental well-being
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Post-exertional malaise2 studies · 1,814 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); not all results were tested against chance; only people who finished were analysed.
Studies with no comparison group2 studies · 1,814 people with results
Post-exertional malaise improved.
The evidence is very uncertain about the effect of rehabilitation programme on post-exertional malaise in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
- Only people who finished were analysed
See the 2 studies
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Post-exertional malaise Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 1,549 in the study · 1,191 with outcome data
- Dose
- —
- Outcome
- Berücksichtigung von PEM im Zeitverlauf
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Depression2 studies · 1,651 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); only people who finished were analysed.
Studies with no comparison group2 studies · 1,651 people with results
Depression improved.
The evidence is very uncertain about the effect of rehabilitation programme on depression in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Only people who finished were analysed
See the 2 studies
-
[Satisfaction of post-COVID patients with rehabilitation]. (2025)
- People in the study
- 1,028 in the study
- Dose
- —
- Outcome
- improvement in depression had a significant influence on patient satisfaction and subjective treatment success
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Depression Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Breathlessness10 studies · 1,598 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (266 in all); the studies disagree.
Randomised trials3 studies · 266 people with results
Breathlessness improved more than in the comparison group.
The evidence is very uncertain about the effect of rehabilitation programme on breathlessness in long COVID. Improvement · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (266 in all)
- The studies disagree
Compared with another group, not randomised52 in the study · 8 weeks · two sessions per week, over an 8-week period
Breathlessness improved more than in the comparison group.
The evidence is very uncertain about the effect of rehabilitation programme on breathlessness in long COVID. Improvement · very low certainty C
- Serious risk of bias (ROBINS-I)
Studies with no comparison group6 studies · 1,432 people with results
Breathlessness improved.
The evidence is very uncertain about the effect of rehabilitation programme on breathlessness in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
- Only people who finished were analysed
See the 10 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- weekly six-hour telerehabilitation sessions (three days/week, two hours per session), 8-week
- Outcome
- breathing functions Functional Compass COVID-19 questionnaire
- Effect
- worse
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- High
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 36 randomised · 30 started · 30 analysed
- Dose
- 18 sessions over six weeks, three sessions/week for six weeks
- Outcome
- Borg scale
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
Tele-rehabilitation for individuals with long COVID: a randomised clinical trial. (2026)
- People in the study
- 132 randomised · 127 analysed
- Dose
- Supervised sessions lasted 40 min, held three times per week at times convenient for the participants
- Outcome
- TDI Functional score transition dyspnoea index
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Low
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 52 in the study
- Dose
- two sessions per week, over an 8-week period
- Outcome
- COPD Assessment Test (CAT) COPD Assessment Test
- Effect
- better
- Risk of bias
ROBINS-I: Serious
- Confounding
- Moderate. adjusted for: baseline values (including patients who were lost at follow-up); Bonferroni
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Selection of participants
- Moderate. comparison group: patients unable to participate due to logistical/transport issues
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Moderate. missing data: Rehab: 4 did not complete; UC: 4 failed re-evaluation; ANCOVA included patients lost at follow-up as covariate
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- Moderate. a pre-specified primary outcome
-
- People in the study
- 68 in the study
- Dose
- 14-day
- Outcome
- Breath-holding test
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Breathlessness Modified COVID-19 Yorkshire Rehabilitation Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 601 in the study
- Dose
- 3 × 45-min exercise sessions per week, 12-week programme split into two 6-week phases
- Outcome
- D-12 score Dyspnea-12 tool (D-12)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 43 in the study · 40 with outcome data
- Dose
- —
- Outcome
- respiratory muscle strength
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- breathlessness numeric rating scale
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- breathlessness COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Fatigue8 studies · 996 people took part in rehabilitation programme Mixed results C
Why this grade: Mixed results, very low certainty, from controlled studies: serious risk of bias (ROBINS-I); randomised trials found little or no difference.
Randomised trials2 studies · 253 people with results
No clear difference in fatigue.
The evidence is very uncertain about the effect of rehabilitation programme on fatigue in long COVID. Little or no difference · very low certainty D
- Some concerns about bias (RoB 2)
- 253 people in all; a small benefit can't be ruled out
- Effect size 0.32 (small)
How big was the difference?
0.32, small. The effect size compares rehabilitation programme with control group.
Compared with another group, not randomised52 in the study · 8 weeks · two sessions per week, over an 8-week period
Fatigue improved more than in the comparison group.
The evidence is very uncertain about the effect of rehabilitation programme on fatigue in long COVID. Improvement · very low certainty C
- Serious risk of bias (ROBINS-I)
Studies with no comparison group5 studies · 884 people with results
Fatigue improved.
The evidence is very uncertain about the effect of rehabilitation programme on fatigue in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
- Only people who finished were analysed
- The studies disagree
See the 8 studies
-
- People in the study
- 132 randomised · 104 analysed
- Dose
- 3-week, 5–6 days/week
- Outcome
- fatigue levels Fatigue Assessment Scale (FAS)
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- Low
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 181 randomised · 149 analysed
- Dose
- twice weekly face-to-face sessions (∼90–120 min per session)
- Outcome
- FACIT-FS Functional Assessment of Chronic Illness Therapy Fatigue Scale
- Effect
- no clear difference
- Risk of bias
RoB 2: Some concerns
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- Low
- Selection of the reported result
- Some concerns
-
- People in the study
- 52 in the study
- Dose
- two sessions per week, over an 8-week period
- Outcome
- Chalder Fatigue Scale—Likert score (CFQ-Lik) Chalder Fatigue Scale
- Effect
- better
- Risk of bias
ROBINS-I: Serious
- Confounding
- Moderate. adjusted for: baseline values (including patients who were lost at follow-up); Bonferroni
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Selection of participants
- Moderate. comparison group: patients unable to participate due to logistical/transport issues
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Moderate. missing data: Rehab: 4 did not complete; UC: 4 failed re-evaluation; ANCOVA included patients lost at follow-up as covariate
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- Moderate. a pre-specified primary outcome
-
- People in the study
- 43 in the study · 40 with outcome data
- Dose
- —
- Outcome
- impact of fatigue on daily activities
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Fatigue Modified COVID-19 Yorkshire Rehabilitation Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 127 in the study · 121 with outcome data
- Dose
- —
- Outcome
- BFI Brief Fatigue Inventory
- Effect
- worse
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- fatigue numeric rating scale
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- fatigue COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Smell and taste loss3 studies · 783 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (109 in all).
The randomised trial164 randomised · 116 started · 109 analysed · after eight weeks and at six months follow-up · weekly six-hour telerehabilitation sessions (three days/week, two hours per session), 8-week
Smell and taste loss improved more than in the comparison group.
The evidence is very uncertain about the effect of rehabilitation programme on smell and taste loss in long COVID. Improvement · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (109 in all)
Studies with no comparison group2 studies · 723 people with results
Smell and taste loss improved.
The evidence is very uncertain about the effect of rehabilitation programme on smell and taste loss in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Only people who finished were analysed
See the 3 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- weekly six-hour telerehabilitation sessions (three days/week, two hours per session), 8-week
- Outcome
- olfactory functions (b1562) Functional Compass COVID-19 questionnaire
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- High
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Smell/Taste Modified COVID-19 Yorkshire Rehabilitation Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 127 in the study · 100 with outcome data
- Dose
- mean duration of 28.84 ± 5.16 days
- Outcome
- chemosensory deficits
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Autonomic symptoms2 studies · 643 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (30 in all).
The randomised trial36 randomised · 30 started · 30 analysed · 18 sessions (i.e. three sessions/week for six weeks · 18 sessions over six weeks, three sessions/week for six weeks
Autonomic symptoms improved more than in the comparison group.
The evidence is very uncertain about the effect of rehabilitation programme on autonomic symptoms in long COVID. Improvement · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (30 in all)
Studies with no comparison group1,655 in the study · 1,276 started · 623 with outcome data · at baseline, immediately post-service, and three months post-service
Autonomic symptoms improved.
The evidence is very uncertain about the effect of rehabilitation programme on autonomic symptoms in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Only people who finished were analysed
See the 2 studies
-
- People in the study
- 36 randomised · 30 started · 30 analysed
- Dose
- 18 sessions over six weeks, three sessions/week for six weeks
- Outcome
- HR (bpm) Rest heart rate
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- Low
- Selection of the reported result
- Some concerns
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Palpitations/Dizziness Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Pain5 studies · 890 people took part in rehabilitation programme Little or no difference D
Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 109 people found no clear difference; a small benefit can't be ruled out.
The randomised trial164 randomised · 116 started · 109 analysed · after eight weeks and when followed up after six months · two hours a day, three days a week over a period of eight weeks
No clear difference in pain.
The evidence is very uncertain about the effect of rehabilitation programme on pain in long COVID. Little or no difference · very low certainty D
- High risk of bias (RoB 2) in the results that carry most of the weight
- One trial of 109 people found no clear difference; a small benefit can't be ruled out
Studies with no comparison group4 studies · 823 people with results
Pain improved.
The evidence is very uncertain about the effect of rehabilitation programme on pain in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
- Only people who finished were analysed
See the 5 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- two hours a day, three days a week over a period of eight weeks
- Outcome
- ICF pain-related b-categories between groups International Classification of Functioning, Disability and Health
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- High
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- High
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Pain/Discomfort Modified COVID-19 Yorkshire Rehabilitation Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 127 in the study · 100 with outcome data
- Dose
- mean duration of 28.84 ± 5.16 days
- Outcome
- chest pain
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- pain numeric rating scale
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- pain COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Cognition (brain fog)5 studies · 874 people took part in rehabilitation programme Little or no difference D
Why this grade: Little or no difference, very low certainty, from randomised trials: some concerns about bias (RoB 2); one trial of 149 people found no clear difference; a small benefit can't be ruled out; effect size 0.50 (small).
The randomised trial181 randomised · 149 analysed · 8 weeks · twice weekly face-to-face sessions (∼90–120 min per session)
No clear difference in cognition (brain fog).
The evidence is very uncertain about the effect of rehabilitation programme on cognition (brain fog) in long COVID. Little or no difference · very low certainty D
- Some concerns about bias (RoB 2)
- One trial of 149 people found no clear difference; a small benefit can't be ruled out
- Effect size 0.50 (small)
How big was the difference?
0.5, small. The effect size compares rehabilitation programme with remote.
Studies with no comparison group4 studies · 834 people with results
Cognition (brain fog) improved.
The evidence is very uncertain about the effect of rehabilitation programme on cognition (brain fog) in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
- Only people who finished were analysed
See the 5 studies
-
- People in the study
- 181 randomised · 149 analysed
- Dose
- twice weekly face-to-face sessions (∼90–120 min per session)
- Outcome
- MoCA Montreal Cognitive Assessment
- Effect
- no clear difference
- Risk of bias
RoB 2: Some concerns
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- Low
- Selection of the reported result
- Some concerns
-
- People in the study
- 43 in the study · 40 with outcome data
- Dose
- —
- Outcome
- cognitive performance
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Cognition Modified COVID-19 Yorkshire Rehabilitation Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 127 in the study · 121 with outcome data
- Dose
- —
- Outcome
- DSST1 Digit Symbol Substitution Test
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- impaired cognition COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Anxiety3 studies · 740 people took part in rehabilitation programme Little or no difference D
Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 109 people found no clear difference; a small benefit can't be ruled out.
The randomised trial164 randomised · 116 started · 109 analysed · after eight weeks and when followed up after six months · two hours a day, three days a week over a period of eight weeks
No clear difference in anxiety.
The evidence is very uncertain about the effect of rehabilitation programme on anxiety in long COVID. Little or no difference · very low certainty D
- High risk of bias (RoB 2) in the results that carry most of the weight
- One trial of 109 people found no clear difference; a small benefit can't be ruled out
Studies with no comparison group2 studies · 673 people with results
Anxiety improved.
The evidence is very uncertain about the effect of rehabilitation programme on anxiety in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
- Only people who finished were analysed
See the 3 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- two hours a day, three days a week over a period of eight weeks
- Outcome
- GAD-7 Generalised Anxiety Disorder-7 Scale
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- High
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- High
-
- People in the study
- 1,655 in the study · 1,276 started · 623 with outcome data
- Dose
- —
- Outcome
- Anxiety/Mood Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- anxiety COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Sleep1 study · 100 people took part in rehabilitation programme Little or no difference D
Why this grade: Little or no difference, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); the change wasn't shown to be more than chance.
Studies with no comparison group127 in the study · 100 with outcome data · mean duration of 28.84 ± 5.16 days · mean duration of 28.84 ± 5.16 days
No clear change in sleep.
The evidence is very uncertain about the effect of rehabilitation programme on sleep in long COVID. Little or no difference · very low certainty D
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- The change wasn't shown to be more than chance
See the 1 study
-
- People in the study
- 127 in the study · 100 with outcome data
- Dose
- mean duration of 28.84 ± 5.16 days
- Outcome
- Sleep Duration [h] ActiGraph GT9X Link
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Daily life and health overall
Daily functioning10 studies · 2,029 people took part in rehabilitation programme Mixed results C
Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (392 in all); the studies disagree; randomised trials found mixed results.
Randomised trials4 studies · 392 people with results
Studies disagree about daily functioning.
Studies disagree about whether rehabilitation programme helps daily functioning. Mixed results · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (392 in all)
- The studies disagree
Compared with another group, not randomised52 in the study · 8 weeks · two sessions per week, over an 8-week period
No clear difference in daily functioning.
The evidence is very uncertain about the effect of rehabilitation programme on daily functioning in long COVID. Little or no difference · very low certainty D
- Risk of bias couldn't be judged for most results (ROBINS-I: no information)
- The change wasn't shown to be more than chance
Studies with no comparison group5 studies · 1,837 people with results
Daily functioning improved.
The evidence is very uncertain about the effect of rehabilitation programme on daily functioning in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
- Only people who finished were analysed
- The studies disagree
See the 10 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- weekly six-hour telerehabilitation sessions (three days/week, two hours per session), 8-week
- Outcome
- ICF activities and participation between groups at six months follow-up Functional Compass COVID-19 questionnaire
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- High
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 181 randomised · 149 analysed
- Dose
- twice weekly face-to-face sessions (∼90–120 min per session)
- Outcome
- ISWT change, face-to-face rehabilitation versus usual care (adjusted) Incremental Shuttle Walking Test
- Effect
- better
- Risk of bias
RoB 2: Some concerns
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- Low
- Selection of the reported result
- Some concerns
-
- People in the study
- 36 randomised · 30 started · 30 analysed
- Dose
- 18 sessions over six weeks, three sessions/week for six weeks
- Outcome
- 6MWD 6-min walk distance
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- Low
- Selection of the reported result
- High
-
- People in the study
- 132 randomised · 104 analysed
- Dose
- 3-week, 5–6 days/week
- Outcome
- between-group difference in this change
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- Low
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 52 in the study
- Dose
- two sessions per week, over an 8-week period
- Outcome
- 6MWT (m) – between-groups significance at 8 weeks 6-min walking test
- Effect
- no clear difference
- Risk of bias
ROBINS-I: No information
- Confounding
- Moderate. adjusted for: baseline values (including patients who were lost at follow-up); Bonferroni
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Selection of participants
- Moderate. comparison group: patients unable to participate due to logistical/transport issues
patients who were unable to participate (due to logistical/transport issues) comprised the UC group (n=27)
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Moderate. missing data: Rehab: 4 did not complete; UC: 4 failed re-evaluation; ANCOVA included patients lost at follow-up as covariate
- Measurement of outcomes
- Moderate. administered or clinician-rated; assessors blinded: NI
- Selection of the reported result
- Moderate. a pre-specified secondary outcome
-
- People in the study
- 43 in the study · 40 with outcome data
- Dose
- —
- Outcome
- motor functional independence
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 127 in the study · 100 with outcome data
- Dose
- mean duration of 28.84 ± 5.16 days
- Outcome
- Inactivity [h] ActiGraph GT9X Link
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 601 in the study
- Dose
- 3 × 45-min exercise sessions per week, 12-week programme split into two 6-week phases
- Outcome
- DASI score Duke Activity Status Index (DASI)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 68 in the study
- Dose
- 14-day
- Outcome
- 6MWT (m) 6-minute walk test
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
[Satisfaction of post-COVID patients with rehabilitation]. (2025)
- People in the study
- 1,028 in the study
- Dose
- —
- Outcome
- performance
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Overall symptoms5 studies · 2,404 people took part in rehabilitation programme Little or no difference D
Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 109 people found no clear difference; a small benefit can't be ruled out.
The randomised trial164 randomised · 116 started · 109 analysed · after eight weeks and when followed up after six months · two hours a day, three days a week over a period of eight weeks
No clear difference in overall symptoms.
The evidence is very uncertain about the effect of rehabilitation programme on overall symptoms in long COVID. Little or no difference · very low certainty D
- High risk of bias (RoB 2) in the results that carry most of the weight
- One trial of 109 people found no clear difference; a small benefit can't be ruled out
Studies with no comparison group4 studies · 2,337 people with results
Overall symptoms improved.
The evidence is very uncertain about the effect of rehabilitation programme on overall symptoms in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
See the 5 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- two hours a day, three days a week over a period of eight weeks
- Outcome
- health- and pain-related parameters
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- High
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- High
-
- People in the study
- 68 in the study
- Dose
- 14-day
- Outcome
- symptoms
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 1,549 in the study · 1,191 with outcome data
- Dose
- —
- Outcome
- Allgemeinzustand infolge der Reha vier Wochen nach der Maßnahme
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
[Satisfaction of post-COVID patients with rehabilitation]. (2025)
- People in the study
- 1,028 in the study
- Dose
- —
- Outcome
- general State of health
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- overall health COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Quality of life6 studies · 866 people took part in rehabilitation programme Little or no difference D
Why this grade: Little or no difference, very low certainty, from randomised trials: some concerns about bias (RoB 2); 258 people in all; a small benefit can't be ruled out; effect size 0.37 (small).
Randomised trials2 studies · 258 people with results
No clear difference in quality of life.
The evidence is very uncertain about the effect of rehabilitation programme on quality of life in long COVID. Little or no difference · very low certainty D
- Some concerns about bias (RoB 2)
- 258 people in all; a small benefit can't be ruled out
- Effect size 0.37 (small)
How big was the difference?
0.37, small. The effect size compares rehabilitation programme with waiting list.
Studies with no comparison group4 studies · 759 people with results
Quality of life improved.
The evidence is very uncertain about the effect of rehabilitation programme on quality of life in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Only people who finished were analysed
See the 6 studies
-
- People in the study
- 164 randomised · 116 started · 109 analysed
- Dose
- two hours a day, three days a week over a period of eight weeks
- Outcome
- absolute values for SF-36 36-Item Short Form Health Survey
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- High
- Deviations from intended interventions
- High
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- High
-
- People in the study
- 181 randomised · 149 analysed
- Dose
- twice weekly face-to-face sessions (∼90–120 min per session)
- Outcome
- EQ-5D-5L utility index EuroQol five-dimension five-level questionnaire
- Effect
- no clear difference
- Risk of bias
RoB 2: Some concerns
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- Low
- Selection of the reported result
- Some concerns
-
- People in the study
- 601 in the study
- Dose
- 3 × 45-min exercise sessions per week, 12-week programme split into two 6-week phases
- Outcome
- EQ-5D-5L utility EuroQoL Five Dimension Five Level (EQ-5D-5L)
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 43 in the study · 40 with outcome data
- Dose
- —
- Outcome
- quality of life
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 68 in the study
- Dose
- 14-day
- Outcome
- EQ-VAS EuroQol Visual Analogue Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 50 in the study
- Dose
- —
- Outcome
- Euroqol-5D index Euroqol-5D
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
ME/CFS
Daily life and health overall
Daily functioning1 study · 27 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (27 in all); not all results were tested against chance.
Studies with no comparison group27 in the study · 10 months to 8 years; average 2.8 years; median 2.5 years · one day (day case) or 5-to-7-day admissions, approximately every four weeks
Daily functioning improved.
The evidence is very uncertain about the effect of rehabilitation programme on daily functioning in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (27 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 27 in the study
- Dose
- one day (day case) or 5-to-7-day admissions, approximately every four weeks
- Outcome
- improved their socialising or participation in recreational activities
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Overall symptoms1 study · 27 people took part in rehabilitation programme Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (27 in all); not all results were tested against chance.
Studies with no comparison group27 in the study · 10 months to 8 years; average 2.8 years; median 2.5 years · one day (day case) or 5-to-7-day admissions, approximately every four weeks
Overall symptoms improved.
The evidence is very uncertain about the effect of rehabilitation programme on overall symptoms in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (27 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 27 in the study
- Dose
- one day (day case) or 5-to-7-day admissions, approximately every four weeks
- Outcome
- improvement in one or more domains
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Side effects
Stopping because of side effects3 studies
Until T4 12 participants were classified as dropouts due to the following reasons: discontinuation of rehabilitation (n = 1), lack of interest in continuing the study (n = 6), health and time constraints as reasons for withdrawing from that specific assessment (n = 2), without providing reasons (n = 2), professional reasons (n = 1
Long-term course and factors influencing work ability and return to work in post-COVID patients 12 months after inpatient rehabilitation. (2024)Of the 25 patients in the Rehab group, 4 did not complete the programme due to professional commitments (n=3) and new-onset pulmonary embolism (n=1).
Additive benefit of rehabilitation on physical status, symptoms and mental health after hospitalisation for severe COVID-19 pneumonia. (2023)reasons for non-completion were not systematically recorded
A longitudinal evaluation of the community-based rehabilitation support programme for Post-COVID-19 condition in Hong Kong. (2026)
Side effects studies reported2 kinds
| Side effect | Studies that reported it |
|---|---|
| Worse symptoms or a flare | 4 studies |
| Fatigue | 3 studies |
All papers
- Increased physical performance after personalised physiotherapy and nutritional counselling in adults with post-COVID-19 condition: a feasibility randomised trial.2026 · randomised trial · 65 randomised
Summary
This pragmatic, single-centre pilot and feasibility randomised trial asked whether personalised multimodal therapy was feasible and explored preliminary clinical outcomes in 65 adults with Post-COVID-19 Condition. Participants were block-randomised to physiotherapy (n=33) or personalised multimodal therapy (n=32) for 12 weeks with 6-week follow-up. Personalised multimodal therapy combined online nutritional counselling with pacing-based physiotherapy; the control group received standard physiotherapy. The trial assessed feasibility and exploratory outcomes including the 1-min sit-to-stand test, 6-min walk test, and Multidimensional Fatigue Inventory. Between-group mean differences in 1-min sit-to-stand repetitions from baseline were 0.97 [−1.75, 3.70] at 12 weeks and 2.14 [−1.26, 5.54] at follow-up. For the 6-min walk test, between-group mean differences were 17.51 [−15.29, 50.31] at 12 weeks and 24.00 [−11.04, 59.03] at follow-up. On the Multidimensional Fatigue Inventory physical fatigue subscale, the between-group mean difference at follow-up was −2.21 [−4.29, −0.13]. Attrition was 18.5% at T1, 24.6% at T2 and 27.7% at T3. One medically significant event was reported (emergency care admission), with no causality between the study intervention suspected. The authors state limits including monocentre design and lack of systematic PEM collection.
- Symptom-based rehabilitation in people with post-COVID-19 condition (RELOAD study): a randomised controlled trial.2026 · randomised trial · 132 randomised · 104 analysed
Summary
Adults with post-COVID condition (PCC) were randomised in a two-arm trial: 132 were randomised, and 104 were included in the completer analysis (REHAB group n=47; control group n=57). Recruitment was at eight outpatient clinics specialised in pulmonology and post-COVID care, and the intervention was delivered at a single inpatient rehabilitation centre. The REHAB group received a 3-week symptom-based inpatient rehabilitation programme, 5–6 days/week, tailored to fatigue, cognitive problems or somatic symptoms; the control group received usual care. Outcomes included SF-12 physical component summary (PCS; primary), mental component summary (MCS), PHQ-9 depression, GAD-7 anxiety and Fatigue Assessment Scale. At 3 weeks post baseline, PCS favoured REHAB (mean difference 2.9 points, 95% CI 0.2 to 5.7, p=0.038); at the 3-month follow-up the difference was 4.2 points (95% CI 1.5 to 6.9, p=0.003). MCS differed at 3 weeks (5.7 points, 95% CI 2.0 to 9.4, p=0.003) but not at 3 months (4.0 points, 95% CI −0.6 to 8.5, p=0.088). PHQ-9 and GAD-7 differences were −2.7 and −2.4 points at 3 weeks (p<0.001), with PHQ-9 −2.0 points (p=0.02) and GAD-7 −1.3 points (p=0.11) at 3 months. Fatigue levels showed no significant between-group difference (p=0.24); fatigue improvements OR was 3.82 (95% CI 1.40 to 11.7, p=0.009) at 3 months. The proportion recorded as unable to work (PCC) changed from 40% to 31% in REHAB and 39% to 40% in control; the between-group difference was not significant (p=0.25). No adverse events were observed or reported. Withdrawals for harms were not reported.
- Effectiveness of tailored individual follow-up vs. standard one-day group course on health-related quality of life in patients with post COVID-19 condition: a randomized controlled trial.2026 · randomised trial · 60 randomised · 58 analysed
Summary
The study examined whether tailored individual follow-up improved health-related quality of life more than a standard one-day group course in post COVID-19 condition. This single-center, parallel-group randomized trial enrolled 60 outpatients at a regional clinic in Norway. Participants were randomized 1:1 to tailored individual follow-up (31 allocated) or a standard one-day multidisciplinary group course (29 allocated). The individual arm received four consultations of 1–1.5 h by a physiotherapist over 6–8 weeks; the standard arm received a one-day group course lasting 6 h. Both groups were introduced to graded activity based on CBT principles and offered the My COVID Rehabilitation app. The primary outcome was between-group difference in EQ-5D-5L-index score at 6 months. Primary outcome assessments were completed for 29 participants in each arm, and per-protocol analysis included 58. At 6 months, no significant between-group difference was found (score difference 0.07; 95% CI [−0.18, .04]; p = .11); adjusted analysis p = .48. The paper reported no persistent significant group differences for secondary outcomes. Both groups showed significant improvements in fatigue and EQ-VAS and reductions in number of symptoms; RAVLT improved in both groups, and CPT-3 omissions improved in the standard course group. Neuropsychological tests at 6 months were completed by 50 participants. No harms or unintended events were reported; one participant withdrew from the intervention group. Limitations stated include single-center design, lack of blinding, no untreated control group, small sample size and power, and 6-month follow-up.
- Effectiveness of adapted physical activity and therapeutic exercise programme in improving chronic fatigue syndrome in long COVID, delivered via hospital-based rehabilitation versus telerehabilitation.2026 · randomised trial · 145 randomised · 137 analysed
Summary
This assessor-blinded, three-armed randomised controlled trial enrolled 145 participants with chronic fatigue syndrome secondary to long COVID from a population-based cohort in eight administrative divisions in Bangladesh; 137 completed the study. Participants were allocated to hospital-based rehabilitation (48 enrolled; 46 analysed), telerehabilitation (48 enrolled; 45 analysed), or a home programme (49 enrolled; 46 analysed). Hospital-based rehabilitation and telerehabilitation received physiotherapist-supervised individualised exercise sessions lasting 45 min, twice weekly for 8 weeks; the home programme group exercised independently following structured instruction. Outcomes included the Chalder fatigue scale, physical functioning sub-domain of SF-36, DALYs, and cardiorespiratory parameters. After 8 weeks, Chalder fatigue scores decreased from 26.23 to 13.61 with hospital-based rehabilitation (p < 0.001) and from 26.11 to 16.64 with telerehabilitation (p < 0.001); the home programme changed from 26.11 to 25.35 (p = 0.057). Hospital-based rehabilitation versus telerehabilitation showed no statistically significant difference in fatigue (MD = −3.04; 95% CI −4.25, −1.82; p = 0.246). Physical functioning increased from 24.19 to 67.39 with hospital-based rehabilitation and from 24.89 to 30.79 with telerehabilitation (both p < 0.001); home programme changed from 24.80 to 25.17 (p = 0.321). DALYs decreased from 0.48 to 0.23 with hospital-based rehabilitation and from 0.47 to 0.39 with telerehabilitation; the home programme increased from 0.44 to 0.59 (p < 0.001), indicating worsening disability. Adverse events were documented, but counts were not reported. The authors state limitations including follow-up challenges, selection bias, and variable reliability and validity of digital meters.
- Does Fatigue in Patients with Post-COVID-19 Syndrome Improve with Rehabilitation?2026 · randomised trial · 33 randomised
Summary
This controlled and randomized clinical trial asked whether a six-week outpatient cardiopulmonary rehabilitation program improves submaximal exercise tolerance, dyspnea, fatigue, and body composition in adults over 18 years old with PCR-confirmed COVID-19 and post-COVID-19 syndrome. Thirty-three people were enrolled: 17 were allocated to cardiopulmonary rehabilitation with respiratory, aerobic, and resistance muscle training, and 16 to a control group receiving educational lectures. After 6 weeks, the rehabilitation group increased tolerance to submaximal exercise, with a difference of 100.46 m. The rehabilitation group showed reduced fatigue (-11.88 [-23 .12 to -0.64]), whereas the control group showed no difference (5.18 [-16.77-6.29]). No inter-group difference was observed after rehabilitation (2.31 [-15.52-10.90]). The rehabilitation group also improved functional capacity by increasing distance walked on the 6MWT, reduced dyspnea and fatigue, and increased muscle mass in the upper limbs. The authors state that the CPRG improved functional capacity, reduced dyspnea and fatigue, and increased muscle mass in the upper limbs. Harms, people who worsened, and withdrawals were not reported. Limitations were not reported.
- Tele-rehabilitation for individuals with long COVID: a randomised clinical trial.2026 · randomised trial · 132 randomised · 127 analysed
- Cost-effectiveness of a brief cognitive-behavioral outpatient rehabilitation program for patients with post-COVID-19 condition within a pragmatic randomized controlled trial.2026 · randomised trial · 314 randomised · 310 started · 204 analysed
Summary
This economic evaluation was conducted alongside a two-arm, single-center, pragmatic randomized controlled trial in Norway. It included 314 participants with post-COVID-19 condition; 310 started treatment (154 in the intervention group and 156 in the care-as-usual group). Participants were non-hospitalized patients. The intervention was a brief outpatient rehabilitation program based on a cognitive-behavioral approach, with minimum 2 and maximum 8 outpatient encounters with a medical doctor and physiotherapists; each encounter lasted one hour, with approximately two to six weeks between encounters. It was compared with care as usual. Costs and quality-adjusted life-years (QALYs) were summarized over 12 months, with EQ-5D-5L and health care utilization questionnaires. At T1, SF-36-PFS was higher in the intervention group (mean difference 9.2; 95% CI 4.3–14.2), and the effect was sustained at 12 months. QALYs were 0.765 in the intervention group and 0.708 in the CAU group, with an incremental QALY gain of 0.056 (95% CI: 0.024 to 0.077). Costs were NOK 45,176 per patient for CAU and NOK 24,494 for the intervention group, an overall cost reduction of NOK −20,682 (95% CI -47230 to -1614). The authors reported 100% of simulations at the NOK 275 000 threshold and lower adverse-event frequencies, without counts. Numbers who worsened or stopped due to side effects were not reported.
- A First Randomized Eight-Week Multidisciplinary Telerehabilitation Study for the Post-COVID-19 Condition: Improvements in Health- and Pain-Related Parameters.2025 · randomised trial · 164 randomised · 116 started · 109 analysed
- Balance rehabilitation and Long Covid syndrome: effectiveness of thermal water treatment vs. home-based program.2025 · randomised trial · 60 randomised · 44 analysed
Summary
This randomized trial examined balance in 60 adults with Long Covid syndrome at a rehabilitation unit in Padova, Italy. Participants were randomly assigned on a 1:1 ratio to a spa resort rehabilitation program (Group A; 30) or a home-based program (Group B; 30). Group A received a 5-week program with two sessions per week, totaling 10 sessions; Group B received a similar 5-week program twice weekly. Balance and proprioception were assessed from center of pressure during standing with eyes open and closed before treatment, right after treatment, and at approximately 3 months and 6 months after treatment. 44 were considered for further analysis (21 Group A and 23 Group B). Only eyes-closed SD OAP and ST showed significant effects or interactions. For Group B, SD OAP decreased from T0 to T1 (time effect −2.977, p < 0.05) and ST increased (0.109, p < 0.05). ST showed a time:Group interaction (β = −0.119, p < 0.05), and SD OAP from T1 to T2 showed a time:Group interaction (β = −1.826, p < 0.05). No significant Group or time:Group effects occurred in the OC condition. More significant improvements right after rehabilitation in mean stay time and SD OAP were reported for home-based than spa-resort, and improvements in SD OAP at 3 months for spa-resort. Five Group B participants were dropouts after one session; technical issues prevented use of data from five Group A and two Group B participants, and data from four Group A participants were discarded for poor compliance. Side effects were not reported.
- A tablet-based intervention study to alleviate cognitive and psychological symptoms in patients with post-Covid-19 condition.2025 · randomised trial · 40 randomised · 34 analysed
- Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitation.2025 · randomised trial · 181 randomised · 149 analysed
Summary
PHOSP-R was a single-blind, three-arm randomised controlled trial of exercise-based rehabilitation for adults with post-COVID syndrome after hospitalisation with acute COVID-19. 181 participants were randomised; 149 completed the trial and provided primary outcome data at follow-up. The interventions were an 8-week face-to-face programme or an 8-week remote programme, each added to usual care, compared with usual care alone. The primary outcome was change in Incremental Shuttle Walking Test (ISWT) distance. The adjusted analysis showed a difference in ISWT favouring face-to-face rehabilitation versus usual care (mean 52 m, 95% CI 19–85 m; p=0.002) and favouring remote rehabilitation versus usual care (mean 34 m, 95% CI 1–66 m; p=0.047). The paper reports no differences between groups for HRQoL or self-reported symptoms. Two serious adverse events were reported, one a death; all were adjudged unrelated to the intervention. No per-arm withdrawal counts due to harms are reported. The authors state limitations: the trial included only hospitalised patients; participants were randomised based on their ability to access each intervention; some differences between groups were present, with those unable to attend remote programmes being older; these variables were controlled in the predefined analysis plan; and this was not considered a fault of the randomisation.
- Cardiopulmonary rehabilitation's influence on cognitive functions, psychological state, and sleep quality in long COVID-19 patients: A randomized controlled trial.2025 · randomised trial · 40 randomised · 32 analysed
Summary
This randomized controlled trial asked whether an eight-week cardiopulmonary rehabilitation programme affects cognition, psychological state, and sleep in people with long COVID. Forty participants were randomly assigned to rehabilitation or control; 32 finished and completed measurements (15 rehabilitation, 17 control). The rehabilitation programme was individualized, supervised, and scheduled three times per week for eight weeks, with aerobic exercise, resistance training, and respiratory exercises; the control group maintained their usual habits. Neuropsychological tests and questionnaires were administered at baseline and study completion. The paper reports no significant group difference for pre–post changes on cognitive performances. For questionnaires, a significant group difference was observed for the Geriatric Depression Scale (p = 0.015) and the Perceived-Stress Scale (p = 0.002); depression scores were +2.68 in the control group and −2.39 in the rehabilitation group, and perceived stress scores were +3.26 in the control group and −2.46 in the rehabilitation group. No significant differences were found regarding anxiety or sleep quality. The paper did not report withdrawals related to harms or side effects. The authors state the sample was small and the programme relatively short.
- Improved Functioning and Activity According to the International Classification of Functioning and Disability after Multidisciplinary Telerehabilitation for Post-COVID-19 Condition-A Randomized Control Study.2024 · randomised trial · 164 randomised · 116 started · 109 analysed
Summary
This randomized control study included 164 people who registered for a study of multidisciplinary group telerehabilitation for a post-COVID-19 condition; recruitment was through the COVID-19 patient organization in Sweden. After randomization, 116 continued, and 109 completed questionnaires after eight weeks. The rehabilitation group (67 participants) received an eight-week multidisciplinary telerehabilitation programme over Microsoft Teams with weekly six-hour sessions, breathing exercises, mindfulness, an ACT approach, relaxation and muscle strength training such as yoga and Qigong, tailored exercises via ExorLive Go, psychoeducation, and six individual sessions. The waiting list controls (42 participants) were offered telerehabilitation in the next round. Outcomes included the Functional Compass COVID-19 questionnaire (ICF categories), mMRC, and CCQ. At eight weeks, the telerehabilitation group had additional improvements in several ICF body functions and activity/participation categories; no significant between-group difference was found for ICF d-categories at the start or after eight weeks. Breathing functions improved in both groups, but the waiting list scored more improvement (p = 0.034). At six months, 60 telerehabilitation and 21 waiting-list participants completed data; activities and participation showed no significant between-group difference, and olfactory functions were more impaired in the waiting list (p = 0.021). mMRC and CCQ showed no between-group differences. Some participants reported worsening of symptoms; no persistent negative effects were reported, and no one withdrew due to temporary worsening. Four participants (7%) from the telerehabilitation group withdrew and one was excluded.
- Effects of a cardiopulmonary rehabilitation programme on submaximal exercise in Tunisian patients with long-COVID19: A randomized clinical trial.2024 · randomised trial · 36 randomised · 30 started · 30 analysed
Summary
This single-blinded randomised trial asked whether an ambulatory cardiopulmonary rehabilitation programme (CPRP) changes submaximal exercise in Tunisian long-COVID patients with persistent dyspnoea at least three months after diagnosis. Of 36 who agreed to participate, 30 completed the protocol: 20 in the intervention group (IG) and 10 in the control group (CG). The IG received 18 CPRP sessions over six weeks (three sessions/week), including warm-up, aerobic training, resistance training, respiratory exercises and therapeutic education; the CG was asked to maintain usual sedentary activities. Evaluations included the 6-min walk test (main outcome 6MWD), Borg and mMRC dyspnoea, resting and end-of-walk heart rate, SpO2 and desaturation. The IG showed larger changes than the CG in 6MWD (168 ± 99 vs. 5 ± 45 m; 28 ± 8 vs. 1 ± 8% predicted), Borg (-3.5 ± 2.0 vs. -1.3 ± 1.5), mMRC (-1.5 ± 0.8 vs. -0.1 ± 0.3), resting HR (-9 ± 9 vs. 1 ± 7 bpm; -5 ± 6 vs. 0 ± 4%). Desaturation changed from 6 (30) to 2 (10) in the IG and from 1 (10) to 2 (20) in the CG. The authors report no influence of the CPRP on SpO2, weight or BMI. No patient stopped during the 6MWT, and no side effects were noted.
- Virtual rehabilitation for individuals with Long COVID: a randomized controlled trial2024 · randomised trial · 132 randomised · 127 analysed · preprint
Summary
This randomized controlled trial evaluated whether an 8-week virtual rehabilitation program added to usual outpatient care improved functional mobility in individuals with long COVID compared with usual outpatient care alone. It enrolled 132 individuals with long COVID (mean age 48 ± 11.8; 75% female); 65 were allocated to the intervention and 67 to the control group. The intervention consisted of an 8-week virtual home-based rehabilitation program with supervised and independent sessions, personalized symptom-titrated aerobic and resistance exercises, and long COVID educational sessions. Outcomes included AM-PAC mobility (primary), 1-minute sit-to-stand, TUG, BDI/TDI, Fatigue Visual Analog Scale, SF-12, EQ-5D-5L, DSQ-PEM, HADS, IES-R, healthcare utilization, acceptability, and adverse events. One hundred twenty-seven completed the post-assessment and were included in the analysis (5 dropouts). No between-group difference was found for change in AM-PAC mobility (95% CI -0.91 to 2.13). The proportion achieving the minimal detectable change in AM-PAC mobility was higher in the intervention group (35.8% (SE 6.0%) vs. 17.0% (SE 4.7%)) (95% CI 3.9 to 33.8). Greater improvements were reported for EQ-5D-5L pain/discomfort, EQ-5D-5L VAS, VAS fatigue, and TDI functional, effort, and total scores; there were no between-group differences in other outcomes and no serious adverse events. Forty-five adverse events definitely or possibly related to the intervention were reported by 30 participants (13 Grade 1, 32 Grade 2); 28 were PEM-related (11 definitely, 17 possibly related), all mild or moderate. The paper reports that 25 participants (39%) could only perform simple range of motion and flexibility exercises or were unable to progress through the FITT principle; symptoms are listed. Four intervention participants discontinued (time commitment n=1, concerned about PEM n=1, exercise evoked symptoms n=1, no longer interested n=1); one control participant discontinued (no longer internet access n=1). Eight individuals (14%) commented negatively on how the program affected their symptoms.
- Effects of a respiratory and neurological rehabilitation treatment plan in post Covid-19 affected university students. Randomized clinical study.2024 · randomised trial · 220 randomised · 200 started · 200 analysed
Summary
This randomized controlled experimental study enrolled 220 patients with medically diagnosed COVID-19 and more than 5 months of evolution, dyspnoea or perceived fatigue, and olfactory and gustatory perception problems, recruited at the Catholic University of Avila, Spain. Two hundred patients were divided into an intervention group (n = 100) and a control group (n = 100); 200 finished the study. The intervention group received a 31-day plan: inspiratory training with Powerbreathe Plus® (30 breaths once daily for seven consecutive days followed by a rest day, day 1 to day 30), aerobic walking for 40 min (day 2 to day 30, once daily for five consecutive days followed by a rest day), and olfactory and gustatory training once daily. The control group received no treatment for 31 days. Outcomes included FVC, FEV1, FEV1/FVC, MIP, modified Borg scale, modified Medical Research Council scale, and the Singapore Smell and Taste Questionnaire. The paper reports significant group-by-time differences for FVC, FEV1/FVC, MIP, modified Borg, modified Medical Research Council, and smell and taste questions, with no statistical improvement in FEV1. The paper reports the 100 randomised to the intervention group followed the treatment plan in its entirety. Side effects were not reported; 200 of 220 enrolled completed the study, with loss reasons in the flow chart.
- CORRECTION OF SARCOPENIA IN ELDERLY PATIENTS WITH POST-COVID-19 SYNDROME USING PHYSICAL THERAPY2024 · randomised trial · 108 randomised
Summary
Elderly people with post-COVID syndrome and sarcopenia were examined (108 elderly people). A control group of 33 people who did not have coronavirus disease was compared with 75 people who had coronavirus pneumonia and post-COVID syndrome; the main group was divided by a blinded randomised method into main group 1 (34 people), who had rehabilitation in polyclinic conditions according to the general principles of the Protocol, and main group 2 (41 people), who followed a developed rehabilitation programme for 3 months. The programme included therapeutic exercises of various orientations, functional training, independent Otago exercise programme, a course of general massage (10 sessions), ergotherapeutic methods, nutritional recommendations and patient education. Hand dynamometry, Short Physical Performance Battery and Edmonton Frail Scale were measured before and after. Both main groups improved versus baseline on hand strength, SPPB balance, walking speed, chair standing and total SPPB, and main group 2 had statistically significantly better values than main group 1 (p<0.05). Hand dynamometry improved but did not reach values showing absence of sarcopenia. Edmonton Frail Scale total improvement was 23% in main group 1 and 46% in main group 2, reported with p>0.05, while the abstract says p<0.05 for all studied parameters. Social support scores were higher after than before in both groups. Side effects and withdrawals were not reported. No limitations are reported.
- Effects of a cardiopulmonary rehabilitation protocol on functional capacity, dyspnea, fatigue, and body composition in individuals with post-COVID-19 syndrome: A randomized controlled trial.2024 · randomised trial · 34 randomised · 33 analysed
Summary
This randomized controlled trial examined a six-week cardiopulmonary rehabilitation protocol in individuals with post-COVID-19 syndrome (PCS). Individuals were recruited through social media and the waiting list of the physical therapy and outpatient clinic of a University Hospital and randomized between May 2021 and January 2022. The text reports 34 individuals allocated to the cardiopulmonary rehabilitation group (CPRG; n = 18) or control group (CG; n = 16); one in the CPRG dropped out, totaling 33 individuals. The CPRG performed lung expansion therapy, inspiratory muscle training, upper-limb strengthening exercises, and aerobic treadmill exercises for 6 weeks. The CG received biweekly remote educational lectures for 6 weeks. Outcomes assessed at baseline and after 6 weeks included the six-minute walk test (6MWT), dyspnea on the modified Medical Research Council scale, fatigue on the Modified Fatigue Impact Scale, and body composition. After six weeks, the CPRG increased 6MWT distance by 199.29 m, while the CG increased by 61.62 m; the inter-group difference was 100.46 m (7.40-193 m). Dyspnea was reduced in the CPRG (-2.11) and CG (-0.32), with an inter-group difference of -1.45 (-1.98 to -0.92). The CPRG showed reduced fatigue (-11.88), whereas the CG showed no difference (5.18); no inter-group difference was observed (2.31 [-15.52-10.90]). Upper-limb muscle mass increased in the CPRG (0.23 kg), with an inter-group difference of 0.63 kg (0.09-1.18 kg). Lower-limb muscle mass was not different in the CPRG (0.02 kg) and CG (0.02 kg). Adverse events were reported daily during the 6 weeks, and individual data were analyzed; event counts are not reported. One CPRG participant dropped out, with reasons not reported. The authors state limitations due to the nature of the randomized controlled trial, rehabilitation environment, and assessments.
- Effectiveness of an online multimodal rehabilitation program in long COVID patients: a randomized clinical trial.2024 · randomised trial · 134 randomised · 124 analysed
Summary
This randomized trial assessed an online multimodal rehabilitation program for Long COVID. A total of 134 patients from different Spanish Long-COVID associations were recruited and randomized: 67 to the control group and 67 to the intervention group. The intervention group received usual treatment from their general practitioner plus the online program, which included eight videoconference sessions (one per week), each approximately 1.5 hours, and a Moodle platform; the control group received usual treatment. Measurements were carried out three months apart. The primary outcome was quality of life measured with the SF-36. At three months, 124 participants completed the evaluation, 62 in each group. For SF-36 Mental Health, the T1-T0 change was 1.98 (8.87) in the intervention group and -1.26 (8.99) in the control group, p=0.046. For SF-36 Physical Health, the change was 1.97 (8.77) versus 1.38 (6.83), p=0.678. The paper reports no significant differences in any secondary variable. In linear regression, group (b=3.193; p=0.044) and self-efficacy improvement (b=0.298; p=0.009) were predictors of greater improvement in mental health-related quality of life. A total of 10 participants did not complete the three-month analysis: 3 preferred other studies, 1 had personal and work-related reasons, 1 had a serious state of health incompatible with continuity, and 5 did not attend the evaluation session. For harms, the text states: 'Any recommendations or exercises that caused any harm or discomfort to patients had to be suspended immediately.' The authors note possible residual confounding from initial differences in number of persistent symptoms and Sit-to-Stand test score, and difficulty measuring adherence.
- Educational, Exercise, and Occupational Therapy-Based Telerehabilitation Program Versus "Wait-and-See" for Improving Self-perceived Exertion in Patients With Post-COVID Fatigue and Dyspnea: A Randomized Clinical Trial.2024 · randomised trial · 64 randomised
Summary
This randomized clinical trial compared a 7-week telerehabilitation program with a 'wait-and-see' control in 64 patients with post-COVID fatigue and dyspnea recruited from four primary health care centers in Madrid; the mean duration of long-COVID symptoms was 14.8 ± 1.7 months. The experimental group (n=32) received 18 videoconference sessions of 40 minutes on alternate days, including sanitary education, respiratory therapy, physical conditioning with aerobic exercise, active mobilizations and motor control exercises, and exercises for daily living activities; the control group (n=32) received no intervention. Outcomes were assessed at baseline, after the program and at 1- and 3-months follow-up. Post-intervention, the experimental group had lower Modified Borg Dyspnea Scale scores during daily activities (0.3 ± 0.5 vs 8.2 ± 0.7), lower mMRC dyspnea severity (0.2 ± 0.4 vs 2.3 ± 0.5) and lower SGRQ scores (11.7 ± 4.8 vs 69.8 ± 9.6). At 3 months, distance walked in the 6MWT was 710.1 ± 135.6 m in the experimental group versus 518.3 ± 87.2 m in controls. The control group also improved significantly in perceived exertion after one month, dyspnea after one month and quality of life after 3 months. No adverse events were reported, and none of the participants withdrew.
- Long-term outcomes of different rehabilitation programs in patients with long COVID syndrome: a cohort prospective study.2023 · randomised trial · 120 randomised · 113 analysed
Summary
This prospective cohort study, conducted in four medical centers, evaluated long-term outcomes of rehabilitation programs in patients with long COVID syndrome. A total of 120 patients were included, and 113 patients (aged between 21 and 85, mean age 58.4 years) completed the study; 7 patients (5.83%) dropped out. The experimental group (n=25) received a tailored multidisciplinary program of 7-8 sessions including aquatic exercises, respiratory and motor exercises, social integration training, neuropsychologic sessions, LASER therapy and magnetotherapy. Comparison group 1 (n=25) received 7-8 sessions of eastern medicine techniques; comparison group 2 (n=29) received respiratory and motor exercise therapy physiotherapy, inhalation of mineral water, balneotherapy with dry carbon dioxide baths and magnetotherapy for 10-15 sessions; comparison group 3 (n=34) performed self-training and home-based physical exercise. A structured telephone contact after 6 months ± 7 days from the end of rehabilitation recorded hospital admissions, deaths, disability, specialist consultations and ambulance calls. The patients in the comparison groups were more likely to request therapeutic care (χ2=6.635, p=0.001; χ2=13.463, p=0.001; χ2=10.949, p=0.001) and more likely to be hospitalized (χ2=5.357, p=0.021; χ2=0.125, p=0.724; χ2=0.856, p=0.355) than the EG. Hospital admissions were 1 (4.00%) in the EG, 7 (28.00%) in CG1, 2 (6.90%) in CG2 and 4 (11.76%) in CG3. The RR of hospital admissions was 0.143 (CI: 0.019; 1.078) versus CG1, 0.580 (CI: 0.056; 6.022) versus CG2 and 0.340 (CI: 0.040; 2.860) versus CG3; the RR was reduced by 85.7%, 42.0% and 66.0%, respectively. General practitioner consultations were 4 (16.00%) in the EG versus 17 (68.00%), 19 (65.52%) and 20 (58.82%) in the comparison groups. There were no patient deaths or new onset of disability in any analyzed group. The authors state future studies will need to further investigate these aspects.
- [Natural therapeutic factors in medical rehabilitation of patients with post-COVID syndrome].2022 · randomised trial · 168 randomised
Summary
This randomised controlled study included 168 patients with post-COVID syndrome and allocated them to four groups: control (n=40) received pharmacotherapy and physical therapy (ЛФК) in the gym; comparison group 1 (n=43) additionally received drinking mineral waters; comparison group 2 (n=43) additionally received ЛФК on the Nalchik resort health path route; main group (n=42) additionally received group psychotherapy on the health path route. The abstract does not report treatment duration. Outcomes named in the abstract were overall rehabilitation effectiveness, external respiration function, cognitive status, exercise tolerance, physical health and mental health. The abstract states that overall rehabilitation effectiveness increased by 10—15% compared with the other observation groups; it lists improvement in external respiration function (p<0,05), cognitive status (p<0,01), exercise tolerance (p<0,01), and restoration of physical (p<0,01) and mental health (p<0,01). No per-group numbers for these outcomes, no adverse events and no withdrawals are reported in the abstract. The authors conclude that summation and integration of sanogenetic effects of physical factors, psychocorrection methods and pharmacotherapy provide significant improvement of physical and mental status of patients with post-COVID syndrome. Limitations are not reported.
- Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trial.2017 · randomised trial · 122 randomised · 109 analysed
Summary
This multi-centre, two-arm RCT took place at four rehabilitation centres in the Netherlands, inviting patients between December 2008 and January 2011. It included 122 patients with chronic fatigue syndrome; 62 were randomised to multidisciplinary rehabilitation treatment (MRT) and 60 to cognitive behavioural therapy (CBT). MRT was given for 6 months with 44.5 face-to-face contact hours; CBT was given for 6 months with 16 face-to-face contact hours. Outcomes were assessed at baseline, 4, 14, 26 and 52 weeks. Data from 109 patients (57 MRT and 52 CBT) were analysed; 13 patients (5 MRT and 8 CBT) were excluded because less than 75% of TiC-P questionnaires were available, and 17 questionnaires were imputed. At 52 weeks, fatigue on the CIS was significantly lower with MRT (estimated effect -6.48, 95% CI -11.54 to -1.42). The QALY difference was not significant (0.09, 95% CI -0.02 to 0.19). SF-36 estimates were 3.53 (95% CI -0.67 to 7.74) for PCS and 1.36 (95% CI -2.28 to 5.00) for MCS. Healthcare costs were significantly higher with MRT (difference €5,681, 95% CI €4,632 to €6,793), as were societal costs (difference €5,389, 95% CI €2,488 to €8,091); patient and family costs and productivity costs were not significantly different. The ICER was €856 per unit on the CIS fatigue subscale and €11,8074 per QALY. MRT had a 94–99% likelihood of being more cost-effective using fatigue/quality of life, and a 5% and 29% likelihood using QALY at thresholds of €27,000 and €60,000. No harms, side effects, or adverse events were reported.
- Multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: a randomized controlled trial.2016 · randomised trial · 122 randomised · 104 started · 112 analysed
- Treatment expectations influence the outcome of multidisciplinary rehabilitation treatment in patients with CFS.2016 · randomised trial · 122 randomised
- Multidisciplinary rehabilitation treatment or cognitive behavioural therapy for patients with chronic fatigue syndrome2016 · randomised trial · 122 randomised · 112 analysed
Summary
This two-arm, pragmatic, multi-centre randomised controlled trial compared multidisciplinary rehabilitation treatment (MRT) with cognitive behavioural therapy (CBT) in 122 patients with chronic fatigue syndrome at four rehabilitation centres in the Netherlands. Participants were randomly assigned to CBT (N = 60) or MRT (N = 62); both treatments took 6 months to complete. Outcomes were assessed before treatment and at 26 and 52 weeks after treatment initiation. Primary outcomes were fatigue on the Checklist Individual Strength fatigue subscale and health-related quality of life on the Short-Form 36. At 26 weeks, 114 participants completed assessment (55 CBT, 59 MRT); at 52 weeks, 112 completed assessment (55 CBT, 57 MRT). MRT was significantly more effective than CBT in reducing fatigue at 52 weeks: the estimated difference was -5.69 (95% CI -10.62 to -0.76; P = 0.02). At 26 weeks the difference was -3.02 (95% CI -8.07 to 2.03; P = 0.24). Patients showed an improvement in quality of life over time, but between-group differences were not significant. Self-efficacy and achievement of personal goals increased more in the MRT group; at 52 weeks differences were 1.89 (0.40 to 3.38; P = 0.01) and -17.28 (-26.95 to -7.62; P = 0.001). At 52 weeks, 37 MRT participants (66.1%) were satisfied versus 22 CBT participants (40.0%; P = 0.006). In total, 18 participants (12 CBT, six MRT) withdrew from treatment; two (one CBT, one MRT) reported an increase in complaints and three did not experience improvement.
- Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow-up.2011 · randomised trial · 120 randomised · 115 analysed
- Quality of life and symptom severity for individuals with chronic fatigue syndrome: findings from a randomized clinical trial.2004 · randomised trial · 47 randomised
Summary
This randomized clinical trial examined an integrative, consumer-driven rehabilitation program for individuals with chronic fatigue syndrome. Forty-seven participants were randomly assigned to an immediate program group (n = 23) or a delayed program control group (n = 24). The program was compared with the delayed program control condition. The text does not report the program duration. Assessments used the Chronic Fatigue Syndrome Symptom Rating Scale and the Quality of Life Index before the program, after program participants completed the group phase, and after program participants completed the one-on-one phase. Linear growth models compared program and control conditions over time using random-effects regression analyses. The paper reports significant condition by time interactions for the main outcomes of symptom severity and overall quality of life. Effect sizes for these interactions were Cohen's d = 0.71 for symptom severity and Cohen's d = .66 for overall quality of life, described as moderate. The text does not report the number analysed, withdrawals, or harms. The authors state that findings indicate consumer driven programs such as this one can have a positive impact on symptom severity and quality of life over time for individuals with chronic fatigue syndrome. The text does not state limitations.
- Addressing persistent symptoms in post-COVID condition: Through a multimodal intervention delivered in two technology-based formats.2026 · compared with another group
- Effectiveness of multidisciplinary rehabilitation on functional recovery in post-COVID-19 patients: a multicentric study across Ecuadorian healthcare centers.2026 · compared with another group · 477 in the study · 250 with outcome data
Summary
This prospective longitudinal cohort study asked whether a multidisciplinary rehabilitation programme was associated with functional and perceived-health changes in adults with confirmed prior SARS-CoV-2 infection in Ecuador. A total of 477 patients were enrolled; 354 (74.2%) met post-COVID-19 condition (PCC) criteria at baseline and 123 (25.8%) were classified as non-PCC. All received multidisciplinary rehabilitation three times per week for 8 weeks, with follow-up over 12 weeks. Outcomes were the post-COVID-19 functional status scale (PCFS) and a 5-point Likert perceived health improvement item (AVS). At Week 12, 250 (52.4%) completed evaluations. Mean PCFS decreased by 0.48 points (95% CI –0.65 to −0.31, p < 0.0001), and mean AVS increased by 0.68 points (95% CI 0.56 to 0.80, p < 0.0001). In adjusted models, baseline PCC was associated with lower odds of PCFS improvement (aOR 0.27, 95% CI 0.13–0.56, p < 0.001). AVS improvement did not differ by baseline PCC status (p = 0.062). The paper did not report side effects, and it did not report withdrawals from harms.
- FEATURES OF EARLY DETECTION AND MULTIDISCIPLINARY REHABILITATION OF POST-COVID-19 COMPLICATIONS2026 · compared with another group · 184 in the study
Summary
This clinical cohort study enrolled 184 adults recovering from PCR-confirmed moderate-to-severe SARS-CoV-2 infection at the Andijan State Medical Institute Clinic and Simulation Centre, to evaluate early detection and multidisciplinary rehabilitation for Long COVID / post-COVID condition. Patients were divided into two parallel, demographically matched cohorts: Group 1 (Early Multidisciplinary Rehabilitation, n = 92) received daily supervised diaphragmatic breathing exercises, heart-rate guided pacing, neurocognitive training, and gradual mobility restoration over 12 weeks; Group 2 (Standard/Delayed Care, n = 92) received standard ambulatory care without structured pacing. Outcomes at 3 months included DLCO, 6-Minute Walk Distance, Fatigue Severity Scale, MoCA, PEM relapse rates and functional recovery. The paper reports DLCO 84.5 ± 6.2% in Group 1 versus 71.3 ± 7.4% in Group 2, 6MWT 485 ± 36 m versus 395 ± 42 m (reported increases of +143 meters versus +53 meters), FSS 2.1 ± 0.5 versus 3.6 ± 0.6, and MoCA 27.1 ± 1.2 versus 24.2 ± 1.5, each with p < 0.001. It states early heart-rate guided pacing significantly reduced PEM relapse rates (p < 0.001), and reports a 34.8% accelerated functional recovery rate compared with delayed/standard care and a 34.8% net superiority in complete functional recovery rate. Group 1 was reported "without inducing autonomic crashes"; withdrawals and other side effects were not reported. Limitations were not reported.
- Health Resort Treatment Mitigates Neuropsychiatric Symptoms in Long COVID Patients: A Retrospective Study.2025 · compared with another group · 239 in the study · 120 with outcome data
Summary
This retrospective study reviewed medical records of 239 people with long COVID who underwent health resort treatment at the Gwarek Rehabilitation Hospital and Sanatorium in Goczałkowice-Zdrój (Poland) in 2021; 120 records were analyzed after 30 were excluded for incomplete data. Treatment lasted 2 to 6 weeks and included balneological factors (mud therapy, water therapies), exercises, physical medicine modalities, health education and psychological support. Group I (n = 70) received balneological factors; Group II (n = 50) did not. Patients rated neuropsychiatric symptom severity on a 0–10 numeric rating scale before and after treatment. In the whole group, sleep disorders changed from 2.47 ± 2.23 to 0.86 ± 1.25 points (p < 0.00001), dizziness from 1.39 ± 1.94 to 0.34 ± 0.76 points (p < 0.00001), and memory disorders from 2.68 ± 2.5 to 1 ± 1.4 points (p < 0.00001). The authors report a significant reduction in all persistent COVID-19 symptoms. Changes were approximately 41% greater for concentration disorders, 36% for memory disorders, 44% for paresthesia and 34% for anxiety in Group I than Group II; headache change did not differ. After treatment, symptom severity did not differ between groups or genders. Side effects were checked at a routine control examination after seven days; no harms events or withdrawals due to harms were reported.
- Efficacy of structured exercise & relaxation techniques in managing post-COVID paraspinal myalgia in manual labourers of Belagavi, Karnataka: A quasi-experimental study.2025 · compared with another group
Summary
Male manual labourers aged 40–50 yr from Belagavi, Karnataka, with post-acute COVID-19 syndrome-associated paraspinal myalgia were enrolled from a neurosurgery outpatient department. Sixty participants were enrolled, with 30 in each group. The experimental group received progressive muscle relaxation technique plus spinal muscle training; the control group received standard neurosurgical care. Both were delivered by telerehabilitation over 12 wk, with three sessions weekly, each lasting 60 min. The study measured serum interleukin-17 and Katz index of activities of daily living scores before and after the intervention. In the experimental group, IL-17 fell from 31.13±3.68 pg/mL to 18.96±2.56 pg/mL and ADL scores rose from 2.93±0.94 to 5.03±0.85. In the control group, IL-17 fell from 31.05±4.24 pg/mL to 28.89±4.58 pg/mL and ADL scores rose from 2.50±1.13 to 3.53±1.04. Within-group changes were reported as P<0.001 in both groups, and between-group P values were <0.001 for both outcomes. Cohen's d was 3.84 for IL-17 and 2.33 for ADL in the experimental group, and 0.49 and 0.95 in the control group. No loss to attrition was reported over the 12-wk intervention; harms were not reported. The authors stated limitations including a modest sample size, restriction to male participants aged 40–50 yr, lack of an in-person rehabilitation comparison group, the non-randomized quasi-experimental design, and the need for long-term follow up.
- Post-COVID Rehabilitation Outcomes: A Comparative Cohort Study.2025 · compared with another group · 1,346 in the study · 597 with outcome data
- Quality of Life and Functional Status in Individuals with Persistent Post-COVID Symptoms: A Cross-Sectional Comparison by Reported Rehabilitation.2025 · compared with another group · 406 in the study
Summary
Researchers ran a cross-sectional online survey between 15 April and 15 May 2024 of 406 adults (308 women; mean age 36.0 ± 12.1 years) with persistent symptoms after COVID-19, recruited from two private, moderator-supervised Facebook support communities for people with ongoing post-COVID-19 symptoms. Participants completed the SF-36 and the Post-COVID-19 Functional Status (PCFS) scale and reported whether they had completed any form of rehabilitation for post-COVID problems; 182 (44.8%) reported rehabilitation and 224 (55.2%) did not, and outcomes were compared between these two groups. All SF-36 indicators except Physical Functioning differed significantly between groups, favouring the rehabilitation group; the largest differences were for Vitality (r = 0.743) and Mental Health (r = 0.572), whereas Physical Functioning showed only a borderline difference (p = 0.052). In multivariable models, rehabilitation was positively associated with Vitality (β = 0.645) and inversely associated with PCFS scores (β = −0.246). No harms or side effects were reported for either group. The authors state that the cross-sectional design with self-reported exposure and outcomes precludes causal inference about the impact of rehabilitation.
- Optimizing cardiopulmonary rehabilitation duration for long COVID patients: an exercise physiology monitoring approach.2024 · compared with another group · 200 in the study
Summary
This observational quasi-experimental study enrolled 200 adults with long COVID syndrome at the Department of Pulmonology, Semmelweis University outpatient clinic. According to performance, 100 age-matched patients received a one-time checkup with a draft of a home-based program without supervision (outpatient clinic group), and 100 were involved in a 2-week pulmonary rehabilitation program. Rehabilitation included group breathing exercise sessions and individualized low-intensity continuous exercise training, plus dietary and social counselling; high-intensity interval training was used in severe cases. The paper compared the outpatient group with the rehabilitation group and followed the rehabilitation group with cardiopulmonary exercise testing at 2- and 3-month follow-up. Of the 100 rehabilitation participants, 73 returned for the 2-month follow-up and 38 attended the 3-month assessment, a dropout rate of 27% at 2 months and 62% at 3 months in the follow-up phase. No adverse event was recorded related to the rehabilitation program. Between the 2-month and 3-month CPET, significant differences were reported for VO2max (ml/min) p=0.033 and VO2/kg (ml/min/kg) p=0.021. No significant differences were reported for peak work rate p=0.084, HR p=0.948, HRR p=0.918, VCO2max p=0.129, VE max p=0.052, VE/VO2max p=0.531, and VE/VCO2max p=0.291.
- Impact of Multi-Professional Intervention on Health-Related Physical Fitness and Biomarkers in Overweight COVID-19 Survivors for 8 and 16 Weeks: A Non-Randomized Clinical Trial.2024 · compared with another group · 146 in the study · 75 started · 59 with outcome data
Summary
Why: to investigate a multi-professional intervention on health-related physical fitness and biochemical parameters in overweight COVID-19 survivors with mild, moderate, or severe/critical symptoms. Who: non-randomized clinical trial; 146 volunteers were invited, 75 were accepted, and 59 were analysed (mild n = 31, moderate n = 13, severe/critical n = 15); recruitment was through Maringá, Paraná, Brazil, health services and media. What was given: physical exercises twice weekly for 60 min, food re-education once weekly for approximately 45 min, and psychoeducation once weekly for approximately 45 min, over 16 weeks; groups were defined by symptom severity, with no separate control group described. Measured: anthropometric and body composition outcomes (primary), and physical fitness and biochemical markers (secondary) before, after 8 weeks, and after 16 weeks. Found: time effects after 8 weeks for abdominal circumference, MIHS right and left, MILTS, push-up, abdominal strength–endurance, sit-stand, VO2peak, distance covered, total cholesterol, LDL-c, HbA1c, and urea; flexibility increased after 8 and 16 weeks; pre-test and final DBP fell after 16 weeks; GGT, lipase, and magnesium fell after 16 weeks. No time effects were observed for weight, BMI, fat-free mass, musculoskeletal mass, fat mass, or body fat percentage. Between groups, fat mass and body fat percentage were higher in severe/critical than mild; no between-group differences were reported for physical fitness tests or cardiorespiratory parameters. The text reports 16 dropouts over 16 weeks, including 9 dropouts related to health problems, low %SpO2 during physical exercise and at rest, and medical advice for suspending practical activities.
- Rehabilitation Is Associated With Improvements in Post-COVID-19 Sequelae.2024 · compared with another group · 134 in the study · 119 with outcome data
Summary
This non-randomized case-control study enrolled people with persistent symptoms after COVID-19 at a hospital Long COVID day clinic. One hundred thirty-four subjects were initially recruited; 47 participated in the rehabilitation program and 72 composed the control group, and one subject withdrew consent and was excluded, reducing the study population to 119 subjects. The rehabilitation group attended an 8-week supervised program twice a week that included supervised interval aerobic and resistance training, education, physiotherapy, dietary advice, and psychological support; the control group received usual care. Measurements were collected at baseline and 8 weeks thereafter. Adjusted odds ratios for clinically important improvement with rehabilitation versus control were 4.56 (95% CI 1.95–10.66) for 6MWT distance, 7.93 (2.82–22.26) for SPPB, 4.64 (1.88-11.48) for 1-min sit-to-stand, 3.63 (1.53–8.59) for IPAQ, 7.40 (2.92–18.75) for CAT, 4.43 (1.83–10.74) for mMRC, 4.07 (1.51–10.98) for FSS, 3.33 (1.45–7.67) for Chalder, 3.46 (1.51–7.95) for PCFS, 6.25 (2.16–18.04) for MoCA, and 3.12 (1.37–7.08) for EQ-VAS. Mean baseline 6MWT distance was 490 m and increased by 62 m in rehab versus 11.5 m in controls (P < .001); 53% of rehab subjects had mMRC score 0 or 1 after 8 weeks. No adverse effects were reported during rehabilitation. 9 control subjects were lost at follow-up and 5 rehab subjects could not complete the program due to transportation and logistics reasons.
- Sex-specific differences of cardiopulmonary fitness and pulmonary function in exercise-based rehabilitation of patients with long-term post-COVID-19 syndrome.2024 · compared with another group · 145 in the study
- Focus on post-exertional malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deterioration.2023 · compared with another group
Summary
This was a non-prespecified secondary analysis of two online surveys by the Norwegian ME Association. In the hospital survey, 82 respondents were included and 86 consultations and 89 interventions were evaluated; in the rehabilitation survey, 788 respondents were included. Respondents had ME/CFS or long COVID with PEM; only two long COVID patients with PEM were in the study population. The analysis compared care where PEM was addressed (PEM+) with care where it was not (no-PEM), across hospital consultations, hospital interventions, and rehabilitation stays. Reported outcomes included satisfaction or benefit, changes in health or disease severity, function, completion, and care-quality ratings. After hospital intervention, health deterioration on at least one time point was 22.4% in PEM+ vs. 45.2% in no-PEM (p = 0.026); after rehabilitation it was 40.1% vs. 63.2% (P = <0.001). Function worsening after hospital intervention was 19.0% vs. 61.3% (p < 0.001). Worsening disease severity after hospital intervention was not significant at 1–2 weeks (OR 0.37, 95% CI 0.14–1.04, p = 0.058) or 3–6 months (OR 0.38, 95% CI 0.14–1.08, p = 0.07). Satisfaction was higher with PEM-focus in consultations (OR 11.57, 95% CI 3.72–35.96, p < 0.001), interventions (benefit OR 9.74, 95% CI 1,21–78.57, p = 0.033), and rehabilitation (OR 5.75, 95% CI 4.14–7.98, p < 0.001). Completion after rehabilitation did not differ significantly (p = 0.12). The authors state that the low sample size of the hospital survey may have reduced statistical power.
- Physical Activity in Long COVID: A Comparative Study of Exercise Rehabilitation Benefits in Patients with Long COVID, Coronary Artery Disease and Fibromyalgia.2023 · compared with another group
Summary
This prospective comparative study examined a 4-week exercise rehabilitation program in long COVID patients (n = 38) from COVIMOUV, compared with coronary artery disease patients (n = 38) from CITIUS and fibromyalgia patients (n = 38) from FIMOUV. Long COVID patients received a multidisciplinary physical rehabilitation protocol over four weeks at three 2 h sessions per week, including two exercise sessions (90 min aerobic exercise and 30 min resistance exercise) and one therapeutic education session. Coronary patients received five sessions of 2 h of cardiac rehabilitation for four weeks; fibromyalgia patients received two exercise sessions of 90 min and one therapeutic education workshop per week over four weeks. Outcomes were assessed at baseline and at the end of the 4-week intervention by cardiopulmonary exercise test, handgrip test, and supine heart rate variability. Cardiorespiratory and muscular parameters were enhanced after exercise rehabilitation in the three groups (p < 0.001). VO2 at VT1, MAP and handgrip strength significantly increased for the three groups (p < 0.001), without significant time-by-group interaction. VO2 peak improved (p < 0.001) with an interaction effect (p = 0.019); the post hoc test found a significant difference between COVID and coronary groups (p = 0.046), with gains of +18 ± 19% vs. +10 ± 16%. Handgrip strength in long COVID improved by +17%. No significant difference was observed for autonomic variables. Harms, side effects and withdrawals were not reported.
- Additive benefit of rehabilitation on physical status, symptoms and mental health after hospitalisation for severe COVID-19 pneumonia.2023 · compared with another group · 52 in the study
Summary
This prospective, interventional, non-randomised parallel assignment two-arm study enrolled 52 patients with COVID-19 pneumonia 6–8 weeks post-hospital discharge; 25 were able to participate in an 8-week rehabilitation programme added to usual care and 27 were unable to participate and received usual care. The programme included supervised exercise, education, breathing control, dietary advice and psychological support, with two sessions per week over an 8-week period. Outcomes were assessed at baseline and following 8 weeks from baseline, including fatigue and respiratory symptoms, functional capacity, mental health and health-related quality of life. At 8 weeks, the rehabilitation group showed greater improvement in CAT by 7.07 (4.29–9.84), p<0.001; Chalder-Likert by 5.65 (3.04–8.25), p<0.001; Chalder bimodal by 3.04 (1.28–4.79), p=0.001; FACIT by 6.37 (2.08–10.65), p=0.005; and FSS by 1.36 (0.47–2.25), p=0.004. Greater improvements were also reported for SPPB by 1.13 (0.46–1.79), p=0.002; HADS anxiety by 2.93 (0.67–5.18), p=0.013; BDI by 7.81 (1.52–14.09), p=0.017; MoCA by 2.83 (1.5–4.14), p<0.001; EQ-5D-5L UI by 0.21 (0.1–0.32), p=0.001; and VAS by 6.57 (0.2–13.16), p=0.043. Both groups improved 6MWT by approximately 60 m, with no between-group difference (p=0.501). HADS-Depression (p=0.627) and IES-R (p=0.135) were not significantly different between groups at 8 weeks. In the Rehab group, 4 did not complete the programme due to professional commitments (n=3) and new-onset pulmonary embolism (n=1); in the UC group, four patients failed to attend the re-evaluation visit at 8 weeks. No adverse effects were reported during exercise training, and no adverse effects were found or reported in the UC group.
- Effects of an inpatient rehabilitation programme on functional capacity, quality of life and psychological distress in patients with post covid-19 condition: an observational study.2023 · compared with another group · 779 in the study
- The effect of comprehensive rehabilitation on post-COVID-19 syndrome2023 · compared with another group · 39 in the study
- First results from post-COVID inpatient rehabilitation.2022 · compared with another group · 458 in the study · 150 with outcome data
Summary
This observational study with control groups asked whether post-COVID rehabilitation patients differ from psychosomatic and psychocardiological rehabilitation patients and whether they improve during rehabilitation. During September 2021 to March 2022, 458 patients were included; after case-control matching for gender, 150 patients were analysed: post-COVID n = 51 (34.0%), psychosomatic n = 49 (32.7%), psychocardiological n = 50 (33.3%). Post-COVID patients received a multimodal rehabilitation concept including individual and group psychotherapy (CBT), individualised aerobic exercise training, body awareness training, breathing therapy, relaxation techniques, cognitive training and social counselling, over five weeks; comparators received psychosomatic or psychocardiological rehabilitation. Measures at admission and discharge included BDI-II, HEALTH-49 and 6MWT. At admission, post-COVID patients were as burdened as the two other patient groups in activity and participation. In all complaint domains and sub-groups, symptom severity was significantly reduced (effect sizes ranging from d = .34 to d = 1.22). Post-COVID BDI-II changed from 19.29 (9.03) to 13.83 (8.95). In the 6-MWT, walking distance improved by an average of 76.43 ± 63.58 meters (d = 1.22); comparable data were used in 39 cases (76%), and not a single patient deteriorated in walking distance. For activity and participation, 56.52% of post-COVID patients improved and 0.00% worsened. There were no indications of post-exercise malaise in the course of rehabilitation. The text does not report withdrawals for harms. Limitations: not randomised controlled design; no control group without intervention; small sample sizes with 51 post-COVID patients.
- Management of Long COVID-The CoviMouv' Pilot Study: Importance of Adapted Physical Activity for Prolonged Symptoms Following SARS-CoV2 Infection.2022 · compared with another group · 17 in the study
Summary
This nonrandomized controlled pilot study enrolled 17 patients (nine men and eight women) with post-COVID-19 fatigue for <3 months after hospitalization in a COVID-19 unit at Saint-Etienne Hospital, recruited from March to July 2021. Patients were assigned to tele-R (n = 9) or trad-R (n = 8). Tele-R was 12 supervised personalized exercise sessions and three therapeutic education workshops over a 4-week training program; trad-R was three physiotherapy sessions per week for 4 weeks. Outcomes were assessed at baseline (M0) and at 1 month (M1). The primary outcome was CFS-11. Data were collected on nine tele-R and six trad-R patients; two trad-R patients did not return for post-testing. CFS-11 was reduced in both groups (tele-R 25.2 ± 5.3 vs. 21.1 ± 5.1; trad-R 27.6 ± 4.2 vs. 26.2 ± 5.2), with a significant time effect (p = 0.010) and no difference between groups. VO2max improved by 3.8 points (+18 ± 15%) in tele-R and 4.1 points (+17 ± 19%) in trad-R (p = 0.005); ΔVO2, ΔMAP, ΔVT1, and Δ6-WMT were not significantly different between groups. Handgrip was not improved (9 ± 16 vs. 2 ± 16%, p = 0.400). No adverse events were declared. The authors state the sample was reduced, there was no control group without rehabilitation and no randomization, and a larger study would be necessary.
- Rehabilitation Programs Effectiveness Model: a Retrospective Comparative Study of Patients with Post-Acute COVID-19 Syndrome2022 · compared with another group
Summary
This retrospective comparative study evaluated post-COVID rehabilitation strategies in patients with post-acute COVID-19 syndrome (U 09.9). Patients were enrolled at the republican and federal rehabilitation centers: Krasnodar Territory (n=25), the Republic of Buryatia (n=25), and Moscow (n=25). The study reports a rehabilitation programme at each center; treatment duration and follow-up are not reported. A prognostic model was built with nonlinear maximum likelihood logit regression to estimate expected rehabilitation effectiveness, measured by a reduction in the severity of dyspnea. The best expected rehabilitation effectiveness was reported for the National Medical Research Center (Moscow) (β=-1.788685, p=0.009964604). A slightly lower expected rehabilitation effectiveness was observed in the resort with a curative climate (Krasnodar Territory) (β=0.9913501, p=0.182944), and the lowest expected effectiveness was registered in the regional rehabilitation center (the Republic of Buryatia) (β=1.054594 p=0.2642723). Harms and withdrawals were not reported. The authors describe the choice and content of treatment strategies as debatable and the study as a preliminary answer.
- Outpatient rehabilitative treatment of chronic fatigue syndrome (CFS/ME).2004 · compared with another group · 78 in the study · 56 with outcome data
Summary
This non-randomised study assessed outpatient multidisciplinary rehabilitative treatment compared with supportive care alone for children and adolescents with CFS/ME. Fifty six young people aged 9–17 years, drawn from southeast England, were followed for 3–24 months. All received supportive care; families opted for the rehabilitation programme (supportive care plus graded activities/exercise programme and family sessions) or no additional treatment. Twenty two (39%) had supportive care alone and 26 (46%) entered the programme. Family sessions lasted an hour, fortnightly to every few months (median 6 sessions, range 3–15). Outcomes were self rated Global Wellness score and school attendance, plus a combined severity category. At end of follow up, median Wellness was 85 in the programme group and 67 with supportive care alone (p=0.002); mean percentage change in Wellness was 71 (19) and 31 (11) (p=0.05). Median school attendance was 90 and 40 (p=0.02); mean percentage change was 182 (49) and 25 (17) (p=0.01). The programme group had less severe CFS/ME at end of follow up (x2=16.3, p<0.01), with 43% in the resolved category compared with 4.5% of those having supportive treatment alone. Of 17 subjects in the severe category who entered the programme, six (35%) were in the resolved category at end of follow up, three (18%) minimal, three (18%) moderate, and 23.8% continued to have severe CFS/ME. Depressed mood and family beliefs about aetiology were not significantly associated with outcomes. Harms and withdrawals were not reported.
- The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome.2002 · compared with another group · 18 in the study
Summary
Eighteen patients who consulted the medical or psychosomatic clinic of Kagoshima University Hospital and met CDC criteria for chronic fatigue syndrome were treated as inpatients. Nine had postinfectious CFS and nine noninfectious CFS; a healthy control group had 20 people. All received a three-stage multidisciplinary program, each stage requiring 3 weeks, including Chinese (herbal) medicine, vitamin C, sedatives, antianxiety drugs, low dose antidepressants, rehabilitation such as massage and thermotherapy, counseling, cognitive–behavioral therapy, family therapy, exercise therapy, and biofeedback therapy. Psychobehavioral tests were done at first consultation and 3 months after treatment; prognosis was investigated 2 years after treatment. In the postinfectious group, physical complaint fell from 43.6 to 25.1 (p < 0.05) and SDS from 48.4 to 38.9 (p < 0.01). In the noninfectious group, the paper reports no significant improvement in either physical or mental symptoms; fatigue score was 4.3 before and 4.4 after treatment. At 2 years, 8 postinfectious patients returned to work versus 3 noninfectious patients (p < 0.05); 1 versus 6 were treated as outpatients. Harms, side effects, and withdrawals were not reported.
- An evaluation of multidisciplinary intervention for chronic fatigue syndrome with long-term follow-up, and a comparison with untreated controls.1998 · compared with another group · 71 in the study · 51 started · 51 with outcome data
Summary
This study assessed 71 patients meeting Fukuda criteria for chronic fatigue syndrome at a multidisciplinary clinic; 51 proceeded to treatment and 20 were assessed but not treated. Treatment lasted an average of 6 months (range 2–12 months) and included optimal medical management, antidepressant medication for ongoing affective or anxiety disorder, a comprehensive cognitive–behavioral program, structured physical exercise and activation, sleep and activity management, and vocational goals. At the end of treatment among the 51 treated patients, 31 returned to work, 14 were work equivalent, and 6 were disabled on benefits. At follow-up (average 33 months for treated patients who returned to work), 13 of these 31 were contacted: 10 continued working and 3 were work equivalent. Of 14 work-equivalent patients, 2 were contacted: 1 returned to work and 1 remained work equivalent. Of 6 disabled patients, 2 were contacted and both continued totally disabled. None of 15 treated patients reported a major relapse. Among 5 untreated patients followed for an average of 50 months, 3 remained as symptomatic and disabled, 1 improved and returned to employment, and 1 had worsening symptoms with benefits terminated. Withdrawals for harms or side effects were not reported. The authors state patients were not randomly selected for assessment or intervention.
- Depression, but Not Fatigue, Improves as Part of Multimodal Post-COVID Rehabilitation.2026 · no comparison group · 1,176 in the study · 1,028 started · 1,028 with outcome data
- Serum extracellular vesicle RNA profiles in long COVID: insights from exercise-induced gene modulation.2026 · no comparison group · 21 in the study · 14 with outcome data
Summary
This single-center pilot clinical trial asked whether long COVID is associated with persistent viral or immune-related extracellular vesicle (EV) RNA signals and whether exercise training changes EV RNA profiles. Fourteen adults with long COVID completed the study out of 21 subjects; participants were recruited at the Lundquist Institute, Harbor–UCLA Medical Center, California, USA. They received a 10-week, twice-weekly on-site aerobic training program with sessions lasting 60 to 90 min, plus instruction in breathing techniques and gentle yoga, stretching, balance exercises, and relaxation techniques. There was no control group; comparisons were before versus after training and rest versus peak exercise. Assessments included cardiopulmonary exercise testing, white blood cell counts, serum EV RNA sequencing, and pathway analysis. Peak oxygen uptake increased after training by 7.4%, from 1.880 ± 0.69 to 2.03 ± 0.07 L/min; VO2 ml/kg/min rose from 19.3 ± 5.1 to 20.9 ± 5.1*, and peak work rate from 139 ± 49 to 155 ± 55* (16%). RNA sequencing found no significant differentially expressed genes (DEGs) at rest between pre- and post-training and no significant DEGs at peak exercise before training; after training, DEGs were identified at peak exercise versus rest. Post-exertional malaise was assessed within 48 h after each session; if PEM symptoms appeared or worsened, exercise time and intensity were reduced by 50%; counts of PEM and withdrawal counts were not reported. The authors state the intervention was well tolerated; 14 out of 21 subjects completed all exercise trials and the study.
- Factors associated with post-COVID-19 health conditions at a rehabilitation center: a cross-sectional study, Paraíba, Brazil, 2024.2026 · no comparison group · 398 in the study
Summary
This cross-sectional study characterized 398 medical records of people with post-COVID-19 conditions treated at the SuperAR Post-COVID Rehabilitation Center in Campina Grande, Brazil, with treatment between January 2021 and December 2023 and data collection from September to December 2023. Records included people who received respiratory physiotherapy, motor therapy, acupuncture or neurology; treatment duration was not reported. There was no comparison group and no randomisation. The outcome was treatment result, categorized as hospital discharge or dropout. Of 398 medical records analyzed, 282 service users (78.1%) were discharged and 79 (21.9%) dropped out. For oxygen inhalation therapy during hospitalization, dropout was 18 (14.6) among those who received it versus 49 (29.2) among those who did not; the reported prevalence ratio was 0.50 (95%CI 0.31; 0.82; p-value 0.004). Side effects were not reported. The authors state limits: the study analyzed only the SuperAR Program and did not include other health services in Campina Grande, and medical records had insufficient information.
- Real-world outcomes of a multidisciplinary rehabilitation programme for adults with long COVID: a retrospective cohort study.2026 · no comparison group · 170 in the study
Summary
This retrospective cohort study described 170 adults with Long COVID referred from eight Primary Care Networks and healthcare service clusters in the London Borough of Croydon who completed a structured multidisciplinary rehabilitation programme at a university hospital in South London. The programme typically spanned 12 weeks and integrated fatigue management education, psychological support, and, where appropriate, group-based graded exercise or movement therapy. There was no comparison group; outcomes were measured with seven validated instruments at baseline and discharge. Statistically significant improvements were reported for STS-1 (r = 0.590, adjusted p < 0.001), MRC dyspnoea (r = 0.491, adjusted p < 0.001), FSS (r = 0.382, adjusted p < 0.001), WSAS (d = −0.323, adjusted p < 0.001), PHQ-2 (r = 0.321, adjusted p < 0.001), and GAD-2 (r = 0.314, adjusted p < 0.001). EQ-5D usual activities, anxiety/depression, mobility, and VAS health score also improved; pain/discomfort (r = 0.154, adjusted p = 0.057) and self-care (r = 0.106, adjusted p = 0.116) did not reach significance. MCID was achieved by 63.5% on STS-1 (n = 108), 48.8% for MRC (n = 83), 45.9% for PHQ-2 (n = 78), 43.5% for WSAS (n = 74), 41.8% for GAD-2 (n = 71), and 22.4% for self-care (n = 38). No significant linear association was found between referral-to-assessment time and outcome change (p > 0.05 for all); exploratory non-linear modelling suggested greatest WSAS/PHQ-2 improvement at 100–150 days. Side effects were not reported. Exclusions included death (n = 1), failure to complete the programme (n = 20), declined participation (n = 39), and non-attendance at assessment (n = 7).
- The role of rehabilitation in Post-COVID-19 syndrome (PCS) recovery: An effectiveness study.2026 · no comparison group · 48 in the study · 36 with outcome data
Summary
This prospective cohort study asked whether a virtual group rehabilitation program for adults with Post-COVID-19 syndrome (PCS), referred to a COVID clinic over 6 months, changed symptoms. Participants (n = 48) were assessed at three timepoints and served as their own control; after excluding incomplete data, 36 participants were included in the analysis. The program was led by occupational therapy and physiotherapy and ran for a 6-week rehabilitation period, with follow-up printed as week 12. The paper reports C19-YRSm at 29 ± 1.7 at baseline, 28.3 ± 1.7 at week 6 (p = 0.34), and 18.3 ± 1.9 at week 12 (p < 0.001). MFIS was 54.1 ± 2.8 at baseline, 54.2 ± 2.6 at week 6 (p = 0.18), and 36.8 ± 3.2 at week 12 (p < 0.001). Harms and withdrawals were not reported. The recorded data do not include a limitations statement. The authors conclude: 'A virtual MDT-led rehabilitation program significantly reduced PCS symptoms, supporting the value of structured rehabilitation in PCS recovery.'
- A longitudinal evaluation of the community-based rehabilitation support programme for Post-COVID-19 condition in Hong Kong.2026 · no comparison group · 1,655 in the study · 1,276 started · 623 with outcome data
- Safety and Physical Outcomes of a Novel Australian Multidisciplinary Long COVID Clinic That Incorporates Exercise: A Prospective Observational Study.2025 · no comparison group · 119 in the study · 72 with outcome data
Summary
Researchers studied adults aged 18 or over with Long COVID symptoms for more than 12 weeks that impaired activities of daily living, referred to a single Long COVID Recovery Clinic in the Australian Capital Territory. Of 119 people who enrolled and commenced the program, 72 completed it; median participation duration was 112 days (range 5–384). The program combined personalised exercise prescription, peripheral and inspiratory strength training, whole-body cardiovascular training, pacing and education. There was no comparison group; outcomes were compared with baseline. Measured outcomes included the Modified COVID-19 Yorkshire Rehabilitation Scale, maximum inspiratory pressure, Timed-Up-and-Go, ten-metre-walk-test comfortable and fast speeds, and 6-minute-walk-test distance. Among completers, improvements were reported for Other Symptoms (MD −1.5, p=0.003), Overall Health Score (MD 1.3, p<0.001), Total Score (MD −6.5, p=0.02), maximum inspiratory pressure (MD 11.7 cmH2O, p=0.002), Timed-Up-and-Go (MD −1.0 sec, p<0.001), comfortable speed (MD 0.7 m/sec, p=0.006), fast speed (MD 0.2 m/sec, p<0.001) and 6-minute-walk-test distance (MD 63.0 m, p<0.001). No significant changes were reported for symptom severity (p=0.08), functional disability (p=0.32) or physical score (p=0.06). There were no adverse events as a result of participation in exercise. One person died from a pre-existing non-COVID medical condition before starting interventions, and 8 participants were hospitalised for non-COVID pre-existing conditions during the study timeframe.
- [Rehabilitation of Health Care and Social Workers after COVID-19 Infection: Results of a Retrospective Cross-sectional Study].2025 · no comparison group · 211 in the study
Summary
This German survey asked health care and social workers with post-COVID syndrome how they experienced the rehabilitation paid for by their occupational insurer. Of 394 people contacted, 211 answered a questionnaire; all had moderate or severe post-COVID syndrome. 194 reported rehabilitation, given as outpatient care, inpatient care or both. 114 people said they had the impression that their symptoms improved with rehabilitation; this impression did not differ significantly between the settings. There was no comparison group of people without rehabilitation, and the abstract does not report side effects.
- Cognitive and Affective Performance of Brazilian Long COVID Patients: An In-Depth Analysis Before and After Psychoeducational Rehabilitation.2025 · no comparison group
Summary
The supplied text is a monthly long COVID bulletin entry that lists an article by Souza and colleagues. The entry gives the article title and the journal name but provides no account of the study itself. It does not state how many people took part, which condition group was included beyond the title's reference to Brazilian long COVID patients, where the study was carried out, what the psychoeducational rehabilitation consisted of, how long it lasted, or what it was compared with. It reports no measured outcomes, no findings, no side effects, no people who worsened or stopped, and no withdrawals. The bulletin describes itself as a current awareness bulletin that is not comprehensive, has not been critically appraised, and is not a substitute for clinical or professional judgement. Because the text contains only a citation listing and no study data, no results, harms, authors' conclusions, or limitations can be recorded from this text.
- Perspectives of Individuals With Long COVID on Virtual Physical Rehabilitation: A Qualitative Study.2025 · no comparison group · 13 in the study
Summary
This qualitative descriptive study interviewed 13 people with long COVID who completed the intervention arm of a randomized controlled trial (132 people were included in the trial; intervention group n=65). Participants were recruited in Quebec or Ontario, Canada. The program was 8 weeks of one-on-one, personalized, symptom-titrated functional aerobic and strengthening exercises delivered 3 times per week (14 supervised and 10 independent sessions, each lasting 45-50 minutes), weekly educational sessions, and usual care. Control group participants (n=67) received usual care and were not interviewed. Semistructured videoconference interviews were conducted at (mean ± SD) 32.3±20.6 days after the intervention and analyzed thematically. Participants' age (mean ± SD) was 48.3±15.6 years; 6 of 13 had been hospitalized during their COVID-19 infection; 12 reported PEM at study entry. Four themes were generated: motivation and confidence, program features, health effects, and post-program suggestions. Most expressed confidence in joining and praised the format and kinesiologist supervision; some found independent sessions harder. Participants reported a wide range of improvements attributed to the program, including increased energy, mobility, cough, fatigue, shortness of breath, muscle pain, anxiety and depression, while a few reported no change and one reported deterioration upon returning to work. Fatigue immediately after exercise, typically lasting <3 hours, was reported; 2 participants reported cognitive fatigue from virtual sessions. Table 1 reports adverse events during the program: 3 participants none, 7 one, 2 two, 1 three. 3 participants suggested reducing session frequency to twice weekly, and most recommended extending the program by 4 weeks.
- Course of neuropsychological health in post-COVID patients differs 6 and 12 months after inpatient rehabilitation.2025 · no comparison group · 127 in the study · 121 with outcome data
- How a long COVID rehabilitation intervention works: refining its programme theory through a realist-informed qualitative study.2025 · no comparison group · 12 with outcome data
Summary
This qualitative realist study asked how, why, for whom and under what circumstances a structured outpatient long COVID rehabilitation intervention worked in a Danish municipality. Twelve patients with long COVID (10 females, 2 men; aged 20–80 years) completed interviews after participating in the intervention, which had a minimum duration of three months and included energy-management strategies, advice and strategies for balancing daily activities, peer support, breathing techniques, and physical exercises. There was no comparison group; the study used interviews with patients, health professionals and the manager, not quantitative outcome comparisons. Patients reported that the intervention enabled them to perform more activities at home, work and leisure with fewer symptom relapses, increased self-efficacy for previously challenging activities, feeling less alone, a sense of belonging and reduced stigma, feeling seen, acknowledged, helped and supported, feeling heard and included, a more coherent rehabilitation course, and strengthened commitment and engagement. The authors describe acceptance as an overarching mechanism and identity transformation as central, supported by person-centred rehabilitation, patient education and peer support. Harms and withdrawals were not reported. No difference, worsening or stopping data were reported.
- [Satisfaction of post-COVID patients with rehabilitation].2025 · no comparison group · 1,028 in the study
Summary
This prospective multicentre cohort study examined subjective treatment success and satisfaction among inpatients with PCS (post-COVID per the title) undergoing rehabilitation across dual rehabilitation, psychosomatics, neurology and pneumology indications. The study enrolled n=1028; the number started and analysed, treatment duration, and harms were not reported. There was no comparison group. Patients received a multimodal rehabilitation programme, and outcomes were examined at the end of PCS rehabilitation. Subjective success of treatment was rated as good to very good across all PCS rehabilitation indications. Approximately 62% experienced improvement in physical symptoms and about 58% improvement in mental well-being; general state of health improved in 62% and performance in 47%. Considering all categories together, at least one area improved in 87.5%. Around 90% would recommend rehabilitation to others or return for treatment, and comparable results showed the treatment met patients' needs. Global patient satisfaction correlated with subjectively experienced psychological relief (r=-0.727, p<0.001) but not with the 6-minute walking test. Regression analyses showed only improvement in depression had a significant influence on patient satisfaction and subjective treatment success, not improvement in walking distance or the socio-medical assessment. The authors conclude that PCS rehabilitants were satisfied and experienced successful treatment. Limitations were not reported in the abstract.
- [Importance of avoidance and endurance in post-COVID syndrome : Can dysfunctional patterns be changed?].2025 · no comparison group · 478 in the study · 383 with outcome data
Summary
This prospective cohort study (PoCoRe) examined illness behaviour according to the avoidance-endurance model (AEM) in people with post-COVID syndrome (PCS) during inpatient rehabilitation in four German rehabilitation indications (dual rehabilitation, psychosomatic, neurological and pneumological medicine); rehabilitation lasted 5 weeks on average. Of 478 enrolled patients, 383 had AEM data at discharge. Behaviour was assessed with the Avoidance-Endurance Questionnaire at rehabilitation start and end. At start, 67.7 % showed an endurance pattern: 57.7 % distress-endurance and 10.0 % eustress-endurance; 24.1 % had fear-avoidance and 8.2 % an adaptive response. At discharge the adaptive response was 17.0 % and eustress-endurance 22.7 %; changes from start to discharge were −4.8 for fear-avoidance, −6.7 for distress-endurance, +12.7 for eustress-endurance and +8.83 for adaptive response. The authors report that about 10–15 % of patients developed in an unfavourable direction, and 21.2 % of patients who had been adaptive switched to dysfunctional behaviour such as fear-avoidance (9.1 %) and distress-endurance (12.1 %). No comparison group was studied. The authors state the sample was highly chronified and that switches between patterns may reflect test-retest reliability.
- Acceptability and feasibility of a group intervention for long COVID in Johannesburg, South Africa: a mixed-method study.2025 · no comparison group · 67 in the study · 59 with outcome data
Summary
This mixed-methods study assessed acceptability and feasibility of an 8-week group intervention for long COVID at Tembisa Provincial Tertiary Hospital in Johannesburg, South Africa. A total of 67 participants were initially recruited; 59 completed the sessions and both pre- and post-intervention evaluation. The intervention consisted of weekly in-person group sessions complemented by home-tasks and self-management exercises, with rehabilitation specialists at selected sessions. There was no comparison group. Acceptability and feasibility were assessed with a 20-item questionnaire at the end of the intervention and semi-structured interviews with nine participants. Nearly 98.3% stated group sessions were supportive and helpful. Of 59 participants, 58 attended more than half of planned sessions, and almost 80% attended all eight sessions. A total of 34 (57.6%) felt the 8-week duration was too short; 59.3% found the session duration satisfactory. For materials, 93.2% (55/59) found them interesting and 52.5% (31/59) personally relevant; none mentioned confusing or too long. Perceived benefits: 27.1% (16/59) positive experience, 16.9% (10/59) guidance and education, 59.3% (35/59) components contributed to well-being. Five left after baseline, one missed endline due to work, one attended only one week and dropped out, one missed endline due to illness. Side effects were not reported.
- Consumer Experience of an Australian Multidisciplinary Long COVID Clinic That Incorporates Personalised Exercise Prescription: A Qualitative Analysis.2025 · no comparison group · 15 in the study
- Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey.2024 · no comparison group · 852 in the study · 536 with outcome data
Summary
This cross-sectional follow-up survey asked patients with long COVID seen at a post-COVID clinic (PCoCC) about symptoms and treatments. A total of 852 patients were identified; 536 completed the survey. The mean time from COVID-19 infection to survey completion was 23.2 ± 6.4 months. There was no comparison group; patients rated symptoms at the initial clinic visit (baseline, by recall) and at follow-up on a 1-10 scale, and rated whether treatments were helpful. Surveyed treatments included low-dose naltrexone, vagal nerve stimulator, midodrine, fludrocortisone, pyridostigmine, aripiprazole, plasmapheresis, reishi mushroom and nattokinase/serrapeptase; treatment duration was not reported. Overall functioning median improved from 8 (6, 9) at baseline to 5 (3, 8) at follow-up (P < .001); fatigue improved from 8 (7,10) to 6 (3, 8) and brain fog from 8 (6, 9) to 5 (3, 8) (P < .001 for both). All individual symptoms assessed were significantly improved (P < .001). Only 4.5% (24/536) had recovered completely. Helpful ratings included low-dose naltrexone 45/77 (58%), vagal nerve stimulator 18/34 (53%), plasmapheresis 9/9 (100%), midodrine 7/17 (41%), fludrocortisone 8/17 (47%), pyridostigmine 2/3 (67%), aripiprazole 8/17 (47%), reishi mushroom 8/19 (42%) and nattokinase/serrapeptase 5/9 (56%). A minority worsened in overall function and in fatigue, myalgia and orthostasis; counts, side-effect counts, and withdrawals due to harms were not reported.
- ["The idea of rehabilitation will have to be completely rethought for this illness" - Qualitative results of an online survey on patients' experiences with inpatient rehabilitation for post COVID-19 condition (long COVID)].2024 · no comparison group · 1,549 in the study · 1,191 with outcome data
- Neuropsychological outcome of indoor rehabilitation in post-COVID-19 condition-results of the PoCoRe study.2024 · no comparison group · 1,086 in the study · 701 with outcome data
Summary
PoCoRe was a prospective, non-randomized, controlled longitudinal study in six German indoor rehabilitation centers. It included 1,086 recruited participants with post-COVID-19 condition; 701 were included in the main data analysis. Patients with ME/CFS were not excluded, but ME/CFS symptoms were not assessed systematically. Treatment was multidisciplinary indoor rehabilitation with psychoeducation, exercise, psychotherapy, pacing, breathing and relaxation therapy, and cognitive training, adapted to individual needs; duration was not reported. Outcomes were assessed on admission and discharge, with no control group. Measures were the FSMC fatigue scale, TAP attention subtests and MoCA. Fatigue prevalence was 84.6% at admission and 77.4% at discharge; FSMC total mean was 76.86 at admission and 73.56 at discharge (p < 0.001). Abnormal alertness reaction times were 70% at admission and 50% at discharge. Sustained attention abnormalities were 55% and 43% (significant, mild effect); working memory 26% and 20%; divided attention 33% and 26% (significant, small effect). MoCA scores were suspicious in 177 of 657 (27%) at admission; 72 of 115 (63%) normalized at discharge. Some worsened: 10 participants (1.5%) in working memory, 32 (4.9%) in divided attention, 52 (7.8%) in sustained attention, and 3 of 115 (3%) on MoCA. Withdrawals due to harms were not reported.
- Long-term course and factors influencing work ability and return to work in post-COVID patients 12 months after inpatient rehabilitation.2024 · no comparison group · 127 in the study · 114 with outcome data
Summary
This prospective, longitudinal observational study had no control group. It enrolled 127 post-COVID patients with work-related SARS-CoV-2 infection at the German BG Hospital Bad Reichenhall; paired sample analyses were conducted for 114 participants. All received a multidisciplinary post-COVID rehabilitation program with an average duration of 28.80 days (SD: 5.23 days). Work ability (WAI), subjective prognosis of employment (SPE), and return to work (RTW) were assessed at the beginning of rehabilitation (T1) and 12 months after the beginning of rehabilitation (T4). The WAI total decreased from a median of 24.50 (IQR 20.00–28.00) at T1 to 21.00 (IQR 17.00–27.00) at T4 (p < 0.001). The SPE scale increased from a median of 2.00 (IQR 1.00–3.00) at T1 to 2.00 (IQR 1.00–3.00) at T4 (p = 0.022). At T4, 54 (47%) patients had returned to work and 57 (50%) had not. Among patients unable to work, 6 (5%) were in the process of reintegration, 8 (7%) were receiving disability pension, and 3 (3%) old-age pension. A significant difference in WAI Dimension 5 was reported for psychological treatment (yes vs. no) (p = 0.027). By T4, 12 participants were classified as dropouts. The paper reports no side effects and no method for collecting adverse events. The authors state limitations including no control group, a relatively small sample, and one hospital specializing in occupational diseases.
- How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany.2024 · no comparison group · 48 in the study
Summary
This qualitative study explored how people with long COVID in Germany used and experienced COVID-19 vaccination and outpatient or inpatient rehabilitation. Forty-eight adults with long COVID participated: 25 in one-on-one interviews and 23 in four focus groups. Participants were recruited through university hospital websites, social media, and respondents’ networks. No treatment duration and no comparison group were reported; the study analysed interview and focus-group accounts. Thirty-five participants reported receiving a COVID-19 vaccination, and 16 reported using rehabilitation. Nine participants stated they developed long COVID despite vaccination before COVID-19. Ten participants reported vaccination reactions, and two reported severe side effects. Three participants experienced symptoms comparable to the acute phase of COVID-19; two reported externally visible symptoms; two reported very poor health and heart problems; one reported extrasystoles; and one interviewee was hospitalized with myocarditis. Two participants reported persistent deterioration of their long COVID symptoms after vaccination. Among rehabilitation users, four reported rehabilitation helped to improve their health situation and alleviate long COVID complaints, while four experienced rehabilitation as unhelpful or counterproductive. Two persons found the combination of inpatient rehabilitation and rehabilitation sport helpful, and two participants reported inpatient psychosomatic rehabilitation in which long COVID was not considered. The authors note heterogeneous experiences and high willingness to be vaccinated and to participate in rehabilitation.
- Monitoring of Long COVID Symptoms Using Digitalised COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) in Patients Attending Long COVID Rehabilitation Clinic2024 · no comparison group · 50 in the study
Summary
This retrospective service-improvement analysis used the digitalised COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) via the ELAROS application in patients attending a long COVID rehabilitation clinic. A total of 50 patients submitted 186 assessments during attendance, and 100 eligible initial and final assessments were analysed. Patients had undergone LC rehabilitation during the period between assessments; follow-up was at least 6 weeks after the initial assessment. There was no comparison group and the study was not randomised. The paper reports within-patient symptom change rather than a controlled treatment effect. On the second assessment after completing LC rehabilitation, 46% of patients had seen improvement in overall health and 28% had no change in symptoms. Many common symptoms, including pain, anxiety, breathlessness, fatigue and impaired cognition, responded well to rehabilitation, with more than 50% of people reporting improvement. Difficulty in swallowing responded least, with only 22% of patients affected by this reporting improvement post rehabilitation. Some symptoms worsened despite rehabilitation; this was highest for issues of caring for family/social life, where 44% of sufferers reported worsening at final assessment. The authors note the observational design lacked a control arm and state that further research with a larger population and ethnic variety is warranted.
- Motor and Respiratory Tele-Rehabilitation in Patients with Long COVID-19 after Hospital Discharge: An Interventional Study.2024 · no comparison group · 28 started · 23 with outcome data
Summary
Twenty-eight adults with long COVID started a home-based motor and respiratory tele-rehabilitation program after discharge from inpatient rehabilitation at two centres in Italy and Switzerland; 23 completed and were included in the analysis. The program lasted three weeks, following a four-week multidisciplinary inpatient rehabilitation course. It used a respiratory muscle training device (SpiroTiger) for breathing exercises up to five times per week and a motor rehabilitation device (Euleria home) for free-body exercises three to five times per week. There was no control group; outcomes were measured before inpatient rehabilitation (T0), at discharge (T1), and after tele-rehabilitation (T2). Motor function was assessed with the instrumented Six-Minutes Walking Test; respiratory function with FVC and MVV; handgrip strength and a satisfaction questionnaire were also recorded. Walked distance increased by 18.3% from baseline and by approximately 73 m between baseline and final assessment; the paper reports >50 m change from baseline to hospital-based rehabilitation and <25 m during tele-rehabilitation. Significant improvements (p < 0.05) in motor and respiratory function were reported, while maximum isometric force showed no significant variation and stride length did not reach significance. Mean SUS scores were 85.5/100 for the respiratory device and 84.1/100 for the motor device. Five participants withdrew; no adverse events occurred during the home-based program. The authors note a small sample, no control group, and preliminary outcomes.
- Device-assessed physical activity and sleep quality of post-COVID patients undergoing a rehabilitation program.2024 · no comparison group · 127 in the study · 100 with outcome data
Summary
This longitudinal observational study examined 100 post-COVID patients (73 females/27 males; age M = 51.13 ± 10.82 years) recruited at the BG Hospital Bad Reichenhall after their accident insurance providers registered them for rehabilitation. Out of 127 recruited patients, 119 were sent an accelerometer. All included patients underwent an inpatient multidisciplinary post-COVID rehabilitation program with a mean duration of 28.84 ± 5.16 days; there was no control group, and outcomes were compared before (T1) and after (T2) rehabilitation. Physical activity and sleep were device-assessed with an ActiGraph GT9X Link worn in the domestic environment for at least seven days, two weeks before and two weeks after rehabilitation. The paired sample reported was PA N = 98 and sleep quality N = 98. No significant changes were found for inactivity, light, moderate, or vigorous physical activity, or for time in bed, sleep duration, WASO, sleep regularity, sleep efficiency, or sleep latency. At T1, 92 (93.9%) patients reached the WHO activity goal and at T2, 94 (95.9%) did, with no significant difference between timepoints. Five symptom prevalences decreased significantly: chest pain from 85 to 72%, cardiac ailments from 66 to 51%, ENT ailments from 57 to 33%, chemosensory deficits from 56 to 43%, and coughing and wheezing from 43 to 27%; none of the observed symptoms increased. Three patients dropped out at T2 (one reinfected with SARS-CoV-2, two no longer interested), one discontinued the study, two did not want to wear the accelerometer, and one was sick at the measurement period. Treatment side effects were not reported in the text.
- Multidisciplinary rehabilitation with a focus on physiotherapy in patients with Post Covid19 condition: an observational pilot study.2024 · no comparison group · 37 in the study · 33 with outcome data
Summary
This pilot observational study asked whether a 3-week day-clinic multidisciplinary bio-psycho-social rehabilitation program with a focus on physiotherapy was feasible and explored effects on physical functioning in patients with Post-Covid-19 Condition, fatigue and reduced physical capacity. It took place at the day care clinic, PRM section of the Musculoskeletal University Center Munich (MUM), LMU University Hospital. Of 37 patients who agreed to participate, 33 completed the program and were analysed; there was no comparison group. Treatment consisted of nine treatment days over three weeks, including gym training, pulmonary physiotherapy, group physiotherapy, pool exercises, occupational training, cognitive training, self-help techniques, psychological lessons, individual appointments, patient education and group discussions. The 6MWT changed from 500.6 ± 97.4 m to 512.0 ± 87.4 m, which was not statistically significant. According to the minimal important difference, the 6MWT improved in 13 patients, remained stable in 14 and worsened in 6. PRE was almost unchanged (4.35 ± 2.17 to 4.53 ± 2.11), and 5STS changes were not significant (14.0 ± 6.3 s to 13.1 ± 4.0 s). Four patients discontinued; two reported deterioration of PCC symptoms and one worsening fatigue. Two discontinuations were probably associated with the program. One patient had an acute respiratory infection and another an acute ankle injury outside the program; one was excluded from analysis after missing two days due to severe fatigue.
- Telerehabilitation for patients who have been hospitalised with covid-19: a qualitative study.2024 · no comparison group · 10 in the study
Summary
This qualitative study explored the views of people who had been hospitalised with Covid-19 and then took part in a supervised, group-based telerehabilitation programme after discharge. All 40 participants who completed the programme were invited; 10 consented and were interviewed between one and six months after programme completion. The programme used 12 sessions of group exercise delivered twice a week for six weeks by video conferencing, with once-weekly educational sessions. There was no comparison group; the study reports participants' experiences from semi-structured interviews analysed thematically. Participants described the programme as a positive experience and reported perceived improvements including building up stamina for walking, improved muscle strength and tone, managing breathlessness and breathing control, weight loss, improved sleep quality, and fatigue management. They also described broader wellbeing gains, a sense of fun and enjoyment, reduced social isolation, and the instructors as central to the positive experience. Views on maintaining exercises after the programme were mixed, and some participants said they would have liked to keep exercising online as a group beyond the six weeks. Most found the WebEx platform relatively easy to use, though some initially found being online daunting. Harms were not reported. The authors state limitations: a limited number of participants, one acute hospital trust in one geographical location, and self-selected participants who had all completed the programme.
- Changes in fatigue symptoms following an exercise-based rehabilitation programme for patients with long COVID.2024 · no comparison group · 170 in the study · 148 with outcome data
Summary
This prospective observational cohort study enrolled individuals with persistent COVID-19 symptoms beyond 12 weeks at a specialist COVID-19 rehabilitation service. The 6-week programme comprised two supervised sessions per week of symptom-titrated exercise (60 min, with rest periods) followed by 30 min of education; there was no comparison group. The programme was completed by 170 individuals, and discharge assessment data were available for 148. Fatigue (FACIT) changed pre- to post-programme by a mean (CI) of 5 (4–7) points in the results table (p<0.01); the abstract reports a change of −5 (−7– −4). 89 (60%) patients improved by the minimal important difference. Exercise capacity increased by 82 (65–99) m on the ISWT and 398 (333–462) s on the ESWT. DSQ frequency and severity composite scores improved by 20 (13–28) and 19 (13–26) points in 44 patients. Among those with severe versus not severe fatigue, FACIT improved by 7 versus 2 points (p=0.03); ISWT, ESWT and CAT changes did not differ between these groups (p>0.05). FACIT did not improve by ≥1 point in 30 (20%) individuals. The authors state participants did not demonstrate severe symptom exacerbation during the programme.
- Gender-Related Effectiveness of Personalized Post-COVID-19 Rehabilitation.2024 · no comparison group · 97 started · 90 with outcome data
Summary
This paper reports a prospective PCR-SIRIO 8 study of a six-week personalized post-COVID-19 rehabilitation program in adults with confirmed COVID-19 and general practitioner referral for post-COVID-19 syndrome (PCS). It had no comparison group and was not randomised. Of 97 people who started rehabilitation, 90 were included in the final analysis (49 women, 41 men); only patients who underwent the complete program were analysed. The outpatient program included high-intensity interval training, resistance, aerobic, balance and respiratory exercises plus therapeutic education. Before and after the six-week program, the study measured body composition, grip strength, fatigue, functioning, dyspnea, 30 CST, 6MWT and SPPB. The paper reports increases in skeletal muscle mass (24.11 kg vs. 24.37 kg, p = 0.001) and phase angle (4.89° vs. 5.01°, p = 0.001), and reductions in abdominal fat tissue volume (3.03 L vs. 2.85 L, p = 0.01), waist circumference (0.96 m vs. 0.95 m, p = 0.001) and hydration level (83.54% vs. 82.72%, p = 0.001). Decreased fat tissue volume and increased skeletal muscle mass were observed only in females; increased grip strength only in males. Fatigue, physical capacity, balance, dyspnea and functioning were reported as significantly improved regardless of gender. Deltas did not differ between genders (p > 0.05). Harms and withdrawals were not reported.
- Physical Health in Patients with Post-COVID-19 6 and 12 Months after an Inpatient Rehabilitation: An Observational Study.2024 · no comparison group · 127 in the study · 121 with outcome data
- Improved clinical outcomes in response to a 12-week blended digital and community-based long-COVID-19 rehabilitation programme.2023 · no comparison group · 601 in the study
Summary
This service evaluation enrolled 601 adults with long COVID who completed the Nuffield Health COVID-19 Rehabilitation Programme. The 12-week, group-based programme had two 6-week phases with 3 × 45-min exercise sessions per week and a weekly telephone call with a rehabilitation specialist lasting up to 45 min; the first 6 weeks were remote and the last 6 weeks included face-to-face sessions. No control group was included. Outcomes were measured at baseline and Week 12. The programme reported improvements in D-12 score (mean change -3.4 [95% CI -3.9 to -2.9]), DASI (9.2 [8.2 to 10.1]), WHO-5 (20.3 [18.6 to 22.0]), EQ-5D-5L utility (0.11 [0.10 to 0.13]), EQ-5D VAS (14.7 [12.6 to 16.9]) and sit-to-stand results (4.1 [3.5 to 4.6]). Participants reported fewer GP consultations (p < 0.001), sick days (p = 0.003) and outpatient visits (p = 0.007) during the previous 3 months compared with baseline; inpatient episodes did not change (p = 0.235). A subgroup with Week 0, 6 and 12 measures showed improvements from Week 0 to 6 and further improvements from Week 6 to 12 (all p < 0.001). Harms and withdrawals for harms were not reported. The authors state a control group was not included, the follow-up was relatively short at 12 weeks, and people with chronic fatigue syndrome before COVID-19 were excluded.
- Attention deficits and depressive symptoms improve differentially after rehabilitation of post-COVID condition - A prospective cohort study.2023 · no comparison group · 80 in the study
Summary
This prospective single-arm cohort study examined 80 inpatients with post-COVID condition at a German rehabilitation clinic. Patients received five weeks of multimodal inpatient rehabilitation including individual and group psychotherapy (CBT), cognitive training in a group setting (2 × 50 min per week) and in an individual setting as needed, individualised aerobic exercise training, body awareness training, breathing therapy, relaxation techniques and social counselling. There was no comparison group. Depression was measured with the PHQ-9 and attention with the TAP at admission and discharge. PHQ-9 total decreased from 15.15 (SD 5.11) at admission to 8.80 (SD 4.61) at discharge (Cohen's d 1.57, p < 0.001). In the TAP sub-tests working memory, sustained attention and divided attention, there was no statistically significant change in performance from admission to discharge. On discharge, alertness 1 had worsened, but patients were still in the average range (PR = 38); the effect was small (d = 0.32), and for alertness patients tended to deteriorate in individual cognitive sub-components during rehabilitation. The authors state limitations including retrospective data evaluation, a single-centre design and allocation bias.
- Impact of Rehabilitation on Physical and Neuropsychological Health of Patients Who Acquired COVID-19 in the Workplace.2023 · no comparison group · 127 in the study · 124 with outcome data
Summary
This longitudinal observational study examined changes after inpatient multidisciplinary post-COVID rehabilitation in 127 patients (97 females/30 males) who acquired COVID-19 in the workplace and were recruited at the German BG Hospital Bad Reichenhall. All participants received the rehabilitation program, with a mean duration of 28.77 (9–42) days, including medical treatment and care and comprehensive physical and psychological treatments; there was no control group. Due to drop-out of 3 participants, 124 paired samples were analyzed. Measures included PCFS, 6MWD, 1MSTST, quadriceps and handgrip strength, MoCA, DSST, HADS-D, BFI, FIS and WAI. Except for fatigue, prevalence of all post-COVID symptoms decreased. PCFS scores decreased (p = 0.017). 6MWD increased by 64 m (p < 0.001); 90 patients improved by 30 m or more, 19 below 30 m, and 10 did not improve. 1MSTST increased from 20 to 22 (p = 0.001), 70 achieved MCID; quadriceps strength improved by 12.80 kg (p < 0.001); handgrip change was not significant. MoCA was 27 at T1 and 27 at T2 (p = 0.015), mild cognitive impairment 24.8% to 21.3%; DSST improved (p < 0.001). HADSdepression 7 to 6, HADSanxiety 7 to 5 (both p < 0.001), BFI 5.6 to 5.3 (p = 0.004), FIS 97 to 85.5 (p = 0.001). WAI did not increase (p = 0.408); 90 out of 124 were still unable to work, and 72.5% were still unable to work after discharge. One participant was re-infected with SARS-CoV-2 during rehabilitation.
- Cardiopulmonary rehabilitation programme improves physical health and quality of life in post-COVID syndrome.2023 · no comparison group · 68 in the study
Summary
This observational quasi-experimental study enrolled 68 patients with post-COVID syndrome at the Department of Pulmonology, Semmelweis University, invited through their pulmonologists. Participants received a 14-day comprehensive cardiopulmonary rehabilitation programme including a 30-minute group exercise session two or three times daily, low-intensity individual training, and respiratory muscle strengthening twice daily (inhaling 30 times at 40% of maximum inspiratory pressure). There was no comparison group. Outcomes were recorded before rehabilitation and after 2 weeks and 2 months. Significant improvements were reported for 6MWT (p=0.031 after 2 weeks; p=0.019 after 2 months), mMRC (p=0.003; p=0.001), EQ-VAS (p=0.015; p=0.011), PCFS (p=0.032; p=0.030), and breath-holding test (p=0.041 at both times). PEmax changed after 2 weeks (p=0.032) but not after 2 months (p=0.632). FEV1, FEV1/FVC, PImax, CK, TLCO, and KLCO were not significant. EQ-5D showed a positive change in all five dimensions, with significant P<0.05 for pain/discomfort and anxiety/depression. After the 2-week rehabilitation, symptoms became less severe. No adverse events were observed, and all patients completed at least 90% of the programme. Authors state limitations including no randomisation or RCT.
- Post-COVID-19 Ongoing Symptoms and Health-Related Quality of Life: Does Rehabilitation Matter?: Preliminary Evidence.2023 · no comparison group · 50 in the study
Summary
This retrospective observational study explored outcomes in 50 subjects with post-COVID-19 ongoing symptoms, including long COVID (symptoms lasting over 3 months). The setting was not reported. Participants received a rehabilitation program focused on three symptoms: fatigue, breathlessness, and pain; the duration was not reported. There was no comparison group, and participants were not randomised. Outcomes were observed before and after treatment. Symptoms intensity was measured with a numeric rating scale and quality of life with Euroqol-5D. The abstract reports that symptoms intensity decreased and quality of life improved. Mean differences were breathlessness -2.91, fatigue -2.05, and pain -2.41 (P > 0.001 as printed). Quality of life mean differences were Euroqol-5D index 0.104 and Euroqol-5D visual analog scale 19.21 (P < 0.001). Harms, side effects, and withdrawals were not reported. The authors state the aims included assessing feasibility and observing possible change in symptoms and quality of life.
- Whole-Body Cryostimulation in Post-COVID Rehabilitation for Patients with Obesity: A Multidisciplinary Feasibility Study.2023 · no comparison group · 16 in the study
Summary
This single-arm longitudinal study asked whether a four-week multidisciplinary rehabilitation programme including whole-body cryostimulation (WBC) was feasible in adults with obesity and post-COVID condition. Sixteen patients (three males; mean age 55.9 ± 7.51 years) admitted to a rehabilitation and pneumology unit in Piancavallo, Italy, were enrolled and started treatment; all 16 were analysed. The programme combined individualized nutritional intervention, psychological support, supervised physical activity (two 60-min physiotherapy sessions daily), and ten WBC sessions over 2 weeks (1 per day, Monday to Friday, −110 °C for 2 min). There was no comparison group. Outcomes were measured at baseline and at the end of the four-week protocol. All patients completed the protocol, and all 16 attended all four weekly sessions. No adverse events occurred during the intervention period. The authors report statistically significant changes in weight, waist circumference and BMI, which were lower at discharge; significant reductions in SBP and HR but not DBP; significant improvement in TUG and 6MWT distance; significant reduction in VAS pain; and an improvement in psychological well-being on the PGWBI scale. Patients hospitalized in the Pneumology Department showed significant improvements in basal Sp02. Participants reported positive physical and mental changes and were generally satisfied with the programme setting; motivation was very high. The authors state limitations include lack of a control group and a small number of participants.
- Effects of Multidisciplinary Rehabilitation Program in Patients with Long COVID-19: Post-COVID-19 Rehabilitation (PCR SIRIO 8) Study.2023 · no comparison group · 97 in the study
Summary
Authors conducted a prospective, observational, single-center study with no comparison group in patients with post-COVID-19 syndrome recruited from a post-COVID-19 rehabilitation outpatient clinic. A total of 97 patients were enrolled. The program consisted of physical training (90 min, 3 times a week), education (30 min, 3 times a week), and group psychotherapy (30 min, once a week) for six consecutive weeks. Outcomes included body composition, CPET, dyspnea, fatigue, exercise tolerance, and physical fitness. After six weeks, abdominal fatty tissue mass decreased from 2.8 kg to 2.5 kg (p = 0.0086) and skeletal muscle mass increased from 23.2 kg to 24.2 kg (p = 0.0104). CPET was not performed in 57 patients; in 40 patients (41.2%), VO2peak was 18 mL/kg/min (p = 0.74), predicted peak VO2 79.5% to 81.0% (p = 0.86), VE/VCO2 slope 29.4 to 29.2 (p = 0.81), and predicted anaerobic threshold 50% (p = 0.99). Borg score changed from 3 to 2 (p < 0.0001), mMRC from 2 to 1 (p < 0.0001), MFIS from 37 to 27 (p < 0.0001), 6MWT from 320 to 382.5 m (p < 0.0001), 30CST from 13 to 16 (p < 0.0001), and SPPB from 14 to 16 (p < 0.0001); almost 80% reported dyspnea improvement. Harms and withdrawals due to harms were not reported. Authors state limitations: less than a half had CPET before and after; individualized exercise intensity limits generalization; patients enrolled at different time points post infection.
- Effects of continuous aerobic training associated with resistance training on maximal and submaximal exercise tolerance, fatigue, and quality of life of patients post-COVID-19.2023 · no comparison group · 41 started · 26 with outcome data
Summary
This quasi-experimental single-group before–after study asked whether a 12-session outpatient cardiopulmonary rehabilitation program, with continuous aerobic training plus resistance training twice a week, changed exercise tolerance, fatigue and quality of life in adults over 18 years with post-COVID-19. Assessments were at the Laboratory of Cardiopulmonary Physiotherapy of the Federal University of Pernambuco and interventions at the Physical Therapy Outpatient Clinic (Post-ICU Rehabilitation) of Hospital das Clínicas in Pernambuco. There was no comparison group. A total of 41 patients started the intervention protocol and 26 completed the program. Outcomes included lung function, respiratory muscle strength, cardiopulmonary exercise test variables, six-minute walk test, Fatigue Pictogram, Short-form–36 and Patient Global Impression of Change. The paper reports a significant increase of 18.62% in VO2peak and 29.05% in TVO2peak, a 5.21% reduction in VE/VCO2 slope, and an increase of 70.57 m in the six-minute walk test (p = 0.001). Total SF-36 score increased 49.53%. After rehabilitation, 36% reported being “Not at all tired” and 28% reported “I can do everything I normally do”; 65.4% reported “Better, and a definitive improvement that has made a real and worthwhile difference”. Several measures were not significant, including FVC p = 0.249, FEV1/FVC p = 0.090, MIP p = 0.111, VO2AT p = 0.850, VE/VCO2 p = 0.650, TVO2 AT p = 0.061 and T1/2 p = 0.626. Harms and side effects were not reported. The authors state that limited randomization and recruitment of a control group affected the study.
- [Rehabilitation for Post-COVID Syndrome covered by the German Pension Insurance in 2021].2023 · no comparison group · 9,666 with outcome data
Summary
This cross-sectional analysis examined medical rehabilitation completed in 2021 and covered by the German Pension Insurance for patients with post-COVID-19 condition, identified in first or second place in the uniform discharge report. Children’s rehabilitation and oncological rehabilitation for pensioners and their relatives were excluded. The study analysed 9,666 rehabilitations; a comparison group was not reported, and the design was not randomised. The treatment recorded was medical rehabilitation, mapped as OTHER; duration and follow-up were not reported. Outcomes were proportions from the discharge data. Treating physicians considered post-COVID-19 condition-associated symptoms improved through rehabilitation in 80.7% of those affected. With regard to performance in the last job or on the general job market, over 90.0% received a prognosis for 6 hours and more. Only 6.5% were assessed as having a reduced capacity to earn of less than 3 hours on the general labor market. Of those affected, 63.8% were on sick leave when admitted and 63.0% when discharged. The paper did not report side effects, harms, or withdrawals for harms. Worsening and stopping were not reported. The authors stated that the importance of post-COVID-19 condition in medical rehabilitation increased significantly over the course of 2021 and reported long periods of disability; study limitations were not reported.
- Multidisciplinary outpatient rehabilitation of physical and neurological sequelae and persistent symptoms of covid-19: a prospective, observational cohort study.2022 · no comparison group · 43 in the study · 40 with outcome data
Summary
This prospective, observational cohort study investigated multidisciplinary rehabilitation for post Covid-19 sequelae and persistent symptoms. From 58 patients referred for neurorehabilitation, 43 were eligible for and participated; 40 of 43 individuals (52 ± 11.4 years, 24 male) completed the rehabilitation program. Participants received multidisciplinary rehabilitation for 8 weeks. There was no comparison group. Before and after 8 weeks of rehabilitation, patients underwent physical, neuropsychological and respiratory evaluations and assessment of functional independence, impact of fatigue and quality of life. After 8 weeks of rehabilitation, patients reported significant improvements in motor functional independence, upper and lower limb functionality, impact of fatigue on daily activities, respiratory muscle strength, cognitive performance, and quality of life. Harms and side effects were not reported. The authors conclude that post Covid-19 patients present with heterogeneous neurological, physical, and respiratory impairments requiring a multidisciplinary rehabilitation approach to reduce disability and improve functionality and quality of life. Limitations of the study were not reported in the supplied text.
- A service evaluation of a community project combining psychoeducation and mind-body complementary approaches to support those with long covid in the UK.2022 · no comparison group · 46 in the study · 25 started · 16 with outcome data
Summary
This service evaluation examined a community Long Covid support project in the UK. People with long Covid self-referred: N = 46 self-referred, and n = 25 engaged in some level of support. The service offered group sessions combining psychoeducation and mind-body complementary approaches and optional 1:2:1 physiotherapy or craniosacral therapy (CST), as 4- or 6-week programmes. There was no comparison group. Outcomes included the Warwick Holistic Health Questionnaire (WHHQ-18) and service evaluation feedback. For the WHHQ-18, n = 16 had data: mean group score was 33.7 (SD=12.5) at the start and 39.5 (SD=10.8) at follow up; n = 12 showed an improved score, n = 1 showed a decline and n = 3 did not complete. In the 4-week programme, N = 10 registered and n = 8 attended the initial and final week; N = 7 gave feedback, scoring the programme 12/16 or 74%. In the 6-week programme, N = 10 registered, n = 8 attended and n = 5 completed; N = 5 gave feedback, scoring delivery 11/16 or 69%. N = 6 participants were offered CST, with 16 1-hour sessions delivered; n = 2 attended all sessions available. Two participants chose face-to-face physiotherapy. Reported events included one CST participant who did not attend the remainder due to illness and not feeling well enough, and one who did not continue beyond the initial session as they did not feel the sessions were of benefit; feedback included the comment that breathing exercises make me anxious. The authors state all data were self-reported and that small numbers mean the WHHQ-18 results cannot be generalised.
- The Recovery Journey and the Rehabilitation Boat - A qualitative study to explore experiences of COVID-19 rehabilitation.2022 · no comparison group · 36 in the study · 13 started · 13 with outcome data
- Providing prevention, diagnosis, and treatment of patients after COVID-19 using artificial intelligence.2022 · no comparison group
Summary
This abstract reports an investigation of prevention, diagnosis and treatment for patients after COVID-19 using artificial intelligence and virtual reality combined with traditional rehabilitation. The patients were people with post-COVID syndrome who met criteria for a combined rehabilitation program using virtual reality; the abstract does not report how many patients were included, where they were treated, or how long the program lasted. The combined rehabilitation method consisted of breathing exercises, upper and lower limb rehabilitation, cognitive tasks and virtual reality. The abstract reports no comparison group. Outcomes described were the ability to improve breathing, limb motor skills and cognitive function. The authors state that in patients who underwent the combined rehabilitation method they observed progress in these three areas; no numerical results, p-values or significance statements are given for them. Harms, side effects and withdrawals are not reported. The authors state no limitations in the abstract. In their conclusion, the authors write: “We showed that artificial intelligence and virtual reality methods have the potential to accelerate rehabilitation and increase motivation in patients with post-COVID syndrome.”
- A tele-health primary care rehabilitation program improves self-perceived exertion in COVID-19 survivors experiencing Post-COVID fatigue and dyspnea: A quasi-experimental study.2022 · no comparison group · 68 in the study · 71 started
Summary
This prospective, multicenter, single-group, quasi-experimental study enrolled 68 COVID-19 survivors with post-COVID fatigue and dyspnea from four primary care centers in Madrid; 71 were initially included and 68 were finally analyzed. Participants received a tele-health rehabilitation program by videoconference: 18 sessions of 40 minutes, three times a week, planned for up to 7 weeks, combining sanitary education, respiratory/breathing exercises, airway clearing, and physical conditioning. There was no comparison group. Outcomes assessed at baseline, after the program, and at 1- and 3-month follow-up included self-perceived exertion during daily living (Modified Borg Dyspnea Scale), dyspnea severity (mMRC), health-related quality of life (SGRQ), and the 6-Minute Walking Test (heart rate, oxygen saturation, perceived exertion, distance walked). The paper reports significant improvements in daily living activities, dyspnea severity, and quality of life at all follow-ups (p<0.001), significant increases in oxygen saturation before and after the 6-Minute Walking Test versus baseline (P<0.001), heart-rate adaptations at rest during follow-up (P = 0.012), and lower perceived exertion before and after the 6-Minute Walking Test despite larger distance walked (P<0.001). No adverse events were reported; 3 participants withdrew during follow-up for unknown reasons. The authors state limits: no control group, inability to control some intervention aspects such as aerobic exercise intensity, and a small sample.
- Physical and psychological reconditioning in long COVID syndrome: Results of an out-of-hospital exercise and psychological - based rehabilitation program.2022 · no comparison group · 30 in the study
Summary
This single-group study enrolled 30 consecutive patients with Long Covid Syndrome (LCS) at the Pneumology Service of Dolo – Venice, Italy; 18 were males, and mean age was 58 years. Patients received an out-of-hospital multidisciplinary rehabilitation (MDR) program combining physical training and psychological treatment. Physical training was scheduled as 3 training sessions per week of 90 min duration; during the MDR program each patient underwent 4 psychological interviews and 13 physical training sessions on average (range 8–20). There was no control group. Outcomes included COVID-19 residual symptoms, body composition, handgrip and leg press strength, cardiopulmonary exercise test parameters, SF-36 quality of life, and Zung depression and anxiety scales, assessed before and after the program. After the MDR program, all symptoms decreased significantly, with 50% of patients reporting no symptoms; dyspnea and fatigue significantly decreased. Body composition improvements did not reach statistical significance. Handgrip strength changed from 39.04 ± 11.1 to 45.12 ± 11.3, leg press from 198.38 ± 50.4 to 225.81 ± 51.9, VO2 peak from 17.53 ± 5.2 to 20 ± 4.4, and peak work rate from 113.17 ± 41 to 133.91 ± 43.3. Zung depression changed from 40.45 (±8.6) to 36.27 (±8.5), and anxiety from 39.59 (±8.9) to 34.22 (±8.5). No adverse events nor dropouts were observed during the training period. The authors state limitations including no control group, a sample size of 30 patients, and no long-term follow-up data.
- Key Features of a Multi-Disciplinary Hospital-Based Rehabilitation Program for Children and Adolescents with Moderate to Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ME/CFS.2022 · no comparison group · 27 in the study
Summary
This retrospective review of medical records described outcomes of 27 children and young people (CYP) with moderate to severe ME/CFS treated in a tertiary adolescent service in the UK, who received ward-based treatment in 2015 (day-case or 5-to-7-day admissions, approximately every four weeks). Length of time in the service ranged from 10 months to 8 years, with an average of 2.8 years and median of 2.5 years. There was no comparison group. Four markers of wellbeing were reviewed: mobility, education, sleep and social/recreational involvement. On discharge, 23/27 (85%) showed improvement in one or more domains; 19/27 (70%) improved physical ability/mobility, 15/23 (65%) improved in attending education/employment, 12/24 (50%) improved sleep, and 16/27 (59.2%) improved socialising. 8/27 (30%) improved in all four areas. Out of 27 CYP, 6 achieved low-level dependence after treatment and 9 were able to walk as normal; 5 showed no change and 3 decreased in their level of ability. Reported events included 3 patients whose physical ability regressed and 2 who went from part time formal education to out of education; some patients were discharged after being unable to engage with the service. Authors state limitations: no control group, an outcome framework that has not been validated, and small numbers with clinical heterogeneity preventing further statistical analysis.
- A Feasibility Study Combining Psycho-Education and Mind-Body Complementary Approaches to Support Those with Post COVID-19 Syndrome ‘Long COVID’ in a UK Based Community Setting2022 · no comparison group · 46 in the study · 25 started · 16 with outcome data
Summary
This mixed-methods feasibility study evaluated a community long COVID support package combining psycho-education and mind-body complementary approaches, including Qigong, seated yoga, breathing techniques and mindfulness, physiotherapy with advice on graded exercise and pacing, and craniosacral therapy (CST). N=46 participants were referred into the service and N=25 participants engaged with the service. For the WHHQ-18, n=16 showed a positive group change: mean score was 33.7 (SD=12.5) at the start and 39.5 (SD=10.8) at follow-up. Individually, n=12 improved, n=1 declined and n=3 did not complete. In the 4-week programme, N=10 registered and n=8 attended the initial and final week; N=7 gave feedback and scored the programme as 12/16 or 74%, with Qigong most enjoyed (n=5) and memory least enjoyed (n=2). In the 6-week programme, N=10 registered, n=8 attended and n=5 completed; N=5 gave feedback and scored delivery as 11/16 or 69%. CST: N=6 participants were offered 4 x 1:2:1 sessions (a potential 24 1-hour sessions), and 16 1-hour sessions were delivered; n=1 did not continue beyond the initial session, and n=1 attended two out of four but did not attend the remainder, due to illness and not feeling well enough. Two participants chose physiotherapy and each had two sessions before attending the group. The authors report no comparison group.
- A Mixed-Methods Evaluation of a Virtual Rehabilitation Program for Self-Management in Post-COVID-19 Syndrome (Long COVID).2022 · no comparison group · 38 in the study
Summary
This mixed-methods service evaluation examined a 10-week Long COVID Virtual Rehabilitation Program (VRP) delivered online on Microsoft Teams to people with Long COVID (PwLC) at a community healthcare NHS Trust in the North of England, UK. Thirty-eight PwLC responded to the telephone questionnaire after the VRP; there was no comparison group. The VRP consisted of weekly hour-long sessions over 10 weeks, each with a pre-recorded video of approximately 20 min and peer discussion. Questionnaires used open and closed questions and were completed within two to three weeks of finishing the VRP; attendance and demographics were also collected. Thirty-six respondents felt able to put the knowledge and skills into practice, one did not, and one did not answer. Twenty-four found the current session times and days acceptable. Sixteen reported issues with Microsoft Teams. Ten attended less than 50% of sessions; barriers to implementing skills were work (n = 3) and home (n = 1). Three said group size was “too big” and no-one said “too small.” Content was perceived as “Just right,” though some elements were repetitive. Respondents described digital delivery enabling self-management, better energy management, returning to work, and that the course helped. Harms comments included repeated information “making me tired” and exercise/activity “made me feel bad about myself—muscle loss made me panic about that.” Withdrawals due to harms were not reported.
- Post-Covid-19 Syndrome: Improvements in Health-Related Quality of Life Following Psychology-Led Interdisciplinary Virtual Rehabilitation.2021 · no comparison group · 219 in the study · 149 started · 76 with outcome data
Summary
This service evaluation described a 7-week virtual “Recovering from COVID” course for social, health, and care staff in Bradford, Airedale, and Craven with post-COVID-19 syndrome. Two hundred and nineteen participants registered; one hundreds and forty nine provided demographic information and completed baseline and pre-course assessments; 76 responded to post-course assessments. The course included activity management, pacing, energy conservation, nutrition/diet, stress management, sleep optimization, and breathing optimization. There was no comparison group. Health-related quality of life was measured with the EuroQol EQ-5D-5L, including visual analog scale (VAS) and UK Index scores, before COVID-19, before the course, and between session 6 and 7. VAS scores showed a significant decrease of 33% from pre-COVID to pre-course and a significant improvement of 10% at post-course; UK Index scores showed a significant decrease of 34% and a significant improvement of 7%. At post-course, 3% reported full health; 53.9% reported an improved overall health state, and 10.5% a worse overall health state. Worse dimension percentages included mobility 9.2, self-care 11.8, usual activities 9.2, pain/discomfort 11.8, and anxiety/depression 13.2. Feedback among n = 76: 96% felt more knowledgeable, 100% found exercises helpful, 91% felt confident implementing strategies, and 99% would recommend the course. The authors state no comparison group, low response with only half completing post-course assessments, no long-term evaluation, and retrospective pre-COVID self-reports.
- Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition - A cohort study.2021 · no comparison group · 32 in the study · 30 with outcome data
Summary
Researchers reported early experiences of a 6-week rehabilitation programme for people with lasting symptoms after COVID-19. The study was an observational cohort without a comparator group. The first 32 individuals referred through a discharge follow-up pathway, COVID-19 medical follow-up or GP referral and who self-identified rehabilitation needs were reported; 30 completed the programme. The programme had two supervised sessions per week and included aerobic exercise, strength training, educational discussions and pacing advice. Outcomes included shuttle walking tests, the CAT, FACIT, HADS, EQ5D and MoCA, measured before and after rehabilitation. Among completers, the ISWT improved by 112[105] m (p < 0.01), the ESWT by 544[377] seconds (p < 0.01), FACIT by 5[7] points (p < 0.01), EQ5D thermometer by 8[19] (p = 0.05), MoCA by 2[2] points (p < 0.01), and CAT by 3[6] (p < 0.05). HADS anxiety and depression changes were 0[4] and 1[4], reported as not statistically significant. There were no serious adverse events recorded and no dropouts related to symptom worsening. 4 people reported an increase in fatigue and recorded meaningful improvements in their exercise capacity; one patient did not improve either fatigue or exercise capacity. Two dropouts were due to social circumstances. The authors stated this sample size is small and there is no comparator group.
- Symptoms of chronic fatigue syndrome/myalgic encephalopathy are not determined by activity pacing when measured by the chronic pain coping inventory.2018 · no comparison group · 114 in the study
- Outcomes and predictors of response from an optimised, multidisciplinary intervention for chronic fatigue states.2016 · no comparison group · 264 in the study
Summary
This study evaluated a manualised, 12-week, multi-disciplinary outpatient treatment program for adults with a chronic fatigue state, either chronic fatigue syndrome (CFS) or post-cancer fatigue (PCF), referred by general practitioners to an academic Fatigue Clinic. Of 389 patients who attended the Clinic, 264 (68%) met eligibility criteria; the complete-data analysis group comprised 168 patients (64%). The program combined cognitive behavioural therapy (CBT), graded exercise therapy (GET) and activity pacing, with follow-up at 24 weeks. There was no randomly allocated control group. Outcomes included self-reported fatigue (SOMA), physical function and social functioning (SF-36), mood disturbance (PSYCH), and interviewer-designated outcomes via the SCIN in a subgroup of 44 patients. Fatigue improved from baseline to end-treatment (Mdiff = -1.82, p<0.001) and to follow-up (Mdiff = -1.42, p<0.001). Physical function improved from baseline to end-treatment (Mdiff = 2.35, p<0.05). At end-treatment, 91 patients (34.5%) had a 1 SD improvement in fatigue and 7 (2.7%) had a 1 SD deterioration; at follow-up, 78 (29.5%) had a 1 SD improvement and 13 (4.9%) a 1 SD deterioration. Seven patients (3%) met the criterion for a significant adverse outcome, of whom only one did not complete treatment; six had emergent psychiatric or medical comorbidities, notably depression and pain. No additional improvement between end-treatment and follow-up was seen for mood disturbance (Mdiff = -0.13, p=1.00) or social functioning (Mdiff = -0.67, p=1.00).
- Cognitive behavioural treatment for chronic fatigue syndrome in a rehabilitation setting: effectiveness and predictors of outcome.2011 · no comparison group · 160 in the study
Summary
This uncontrolled implementation study took place in a large tertiary rehabilitation centre in the Netherlands. It examined cognitive behavioural therapy combined with graded exercise therapy in daily practice for patients with chronic fatigue syndrome (CFS) according to CDC criteria. A total of 160 consecutive CFS patients started an inpatient multicomponent rehabilitation program; treatment took about 25 weeks and was delivered in a group format with CBT, GET and occupational therapy. There was no comparison group. Subjective fatigue and individual strength (CIS-20) and physical impairment (SF-36) were measured at baseline, post-treatment and six months after the end of the program. From baseline to post-treatment, mean subjective fatigue, individual strength and physical impairment scores improved with 23%, 21.0% and 29.9% respectively; these changes were statistically significant (p < 0.001) and indicated large treatment effects. From post-treatment to 6-month follow-up these scores did not significantly change. Clinically significant improvement was found in 33.8% (n = 54) at post-treatment and 30.6% (n = 49) at follow-up. Out of 160 patients, 149 completed the program (7% dropped out of treatment) and 116 finished the follow-up measurement. Harms were not reported beyond dropout. The authors noted the absence of a control group and selection bias from a tertiary rehabilitation centre.
- Predictors of outcome in a multi-component treatment program for chronic fatigue syndrome.2010 · no comparison group · 212 in the study · 192 started · 178 with outcome data
Summary
This study examined predictors of outcome in a six-month outpatient group rehabilitation program for chronic fatigue syndrome at a tertiary care centre in Belgium. Participants were 212 consecutive patients meeting CDC criteria for CFS; 192 had complete data at the start, 14 were lost to follow-up, and the completer sample was 178. The program mainly included group cognitive–behavioral therapy (CBT), flexible graded exercise therapy (GET) and progressive relaxation therapy (PRT). About half (N = 91) followed monthly sessions with 7 sessions each of CBT, GET and PRT; the other half (N = 101) followed a more intensive weekly program with 13 sessions each of CBT, GET and PRT plus 6 information/education sessions and 7 experiential group meetings. The paper states there was no control group. Patients completed self-report questionnaires before the first treatment session and after the last session. Measures included fatigue, attributions, sense of control, physical activity, functional impairment, somatic focus and depression. Only pre-treatment severity of depression was associated with post-treatment fatigue and improvement in fatigue. In total, 39.3% (n = 70) showed substantial improvement, defined as a reduction of more than 10% in fatigue scores, whereas 60.7% (n = 108) showed less or no improvement. Side effects were not reported, and withdrawals in relation to side effects were not reported. Limitations stated were a tertiary care sample, no control group and no long-term follow-up.
- [Favourable results of a rehabilitation programme with cognitive behavioural therapy and graded physical activity in patients with the chronic-fatigue syndrome].2006 · no comparison group · 127 in the study · 99 started · 74 with outcome data
Summary
This prospective, uncontrolled study was carried out at a rehabilitation centre in Enschede, the Netherlands, and concerned patients with chronic-fatigue syndrome. The stated aim was to examine clinically significant changes in fatigue, experienced disability and physical function after a specific interdisciplinary rehabilitation course. The programme combined cognitive behavioural principles with graded activity; the duration of the programme was not reported. Of 127 successive people who enrolled, 99 fulfilled the inclusion criteria, and measured data were complete in 74 patients. There was no comparison group. After treatment, the paper reported significant improvement in fatigue, experienced disability and physical function; it described the magnitude as generally 'average'. At the end of treatment, 70% of patients were clinically less fatigued, 68% experienced less disability, and 55% functioned better physically. In 34% the level of fatigue was normalised after treatment, while 9.5% of patients had more fatigue. The abstract reported more fatigue in 9.5% and did not report other harms. Withdrawals for harms were not reported. The abstract does not state limitations.
- Long-term outcomes of an integrative rehabilitation program on quality of life: a follow-up study.2006 · no comparison group · 23 in the study
Summary
This follow-up study examined 23 people diagnosed with chronic fatigue syndrome (CFS) who had received an integrative rehabilitation program. Participants were recruited from local CFS self-help organizations (62%), physician referral (25%), and advertisements (13%). The program consisted of eight illness-management group sessions, biweekly over a period of 4 months, followed by 7 months of individualized peer counseling once weekly for 30 min per session, for a program duration of 12 months. This follow-up used a within-subjects, repeated measures cohort design; there was no comparison group with follow-up data. Quality of life was measured with the Quality of Life Index at baseline, after the group phase, after the one-on-one phase, and 4 and 12 months following program completion. A within-subjects repeated measures ANOVA found significant increases in overall quality of life for up to 1 year following program completion [F(4, 21)=23.5, Pb.001]. The total increase over the project period was from a baseline score of 13 to a final score of 16, a 23% change over time. The reported pattern was stable quality of life from baseline to the post-group phase, an increase from the post-group phase to the post-one-on-one phase, then a relative plateau to the 4- and 12-month follow-up periods. There were no dropouts among participants; missing data existed for one subject at the third and fourth assessment time points. The authors state that small sample size and lack of follow-up data on control subjects limit conclusions.
- How relevant are exercise capacity measures for evaluating treatment effects in chronic fatigue syndrome? Results from a prospective, multidisciplinary outcome study.2006 · no comparison group · 135 in the study · 116 with outcome data
Summary
In this six-month prospective outcome study, 135 patients (116 female and 19 male) with chronic fatigue syndrome attended a multidisciplinary outpatient treatment programme at a university outpatient rehabilitation clinic in a group setting. The analysis was confined to 116 women. Treatment combined cognitive behavioural therapy group sessions and graded exercise training group sessions, with psycho-educational and supportive group discussions, relaxation and breathing exercises, and on-demand psychiatric and/or medical consultations. There was no comparison group. Outcomes included SF-36, SCL-90 total score, Causal Attribution List, Self-Efficacy Scale, a maximum progressive bicycle ergometer test and an isokinetic leg strength test, before and after treatment. The total group significantly improved on nearly all reported HRQoL/psychosocial variables. Most SF-36 subscales improved significantly except role limitations attributed to emotional problems; the SCL-90 total score decrease was not statistically significant; non-physical causal attributions and self-efficacy improved significantly. Exercise duration, peak workload, peak respiratory gas exchange ratio and hamstring strength improved significantly, while changes in peak Vo₂ were not significant. Less fit patients improved significantly more on exercise capacity measures than their more fit counterparts, while both subgroups showed generally similar post-treatment changes on HRQoL/psychosocial variables. Three out of 119 patients were excluded from analysis because they withdrew prematurely from therapy; for one patient the physical demand of the training programme was too high. Side-effect counts were not reported.
- In search of a new balance. Can high "action-proneness" in patients with chronic fatigue syndrome be changed by a multidisciplinary group treatment?2006 · no comparison group · 62 in the study · 56 with outcome data
Summary
This was a naturalistic pre/post study without a comparison group. Sixty-two consecutively admitted patients with CFS (55 female, 7 male) were referred by general practitioners to the CFS Reference Centre, University Hospitals Leuven; significant others (n=62) also participated. The intervention was a multidisciplinary group treatment including cognitive behaviour therapy (CBT) and graded exercise therapy (GET) and lasted 6 months. GET consisted of 1-h sessions with an initial training intensity corresponding to the work load at 60% of the heart rate reserve; from Week 3 participants were asked to exercise three times a week, including at home. Action-proneness was measured with the Dutch Questionnaire for Habitual Action-proneness retrospectively for before illness onset, before treatment and after treatment. Pretreatment action-proneness (M=17.75, S.D.=6.21, n=58) was reported as significantly lower than premorbid levels (M=38.27, S.D.=6.65, n=62). Posttreatment levels (M=20.23, S.D.=4.65, n=56) were significantly higher than pretreatment levels (P = .03) but still significantly lower than premorbid levels (Pb.001). Only two patients dropped out before the end of treatment; harms were not reported. The authors state limitations including retrospective bias of patient and significant-other reports and that the study was uncontrolled.
- Chronic Fatigue Syndrome: An Evaluation of a Community Based Management Programme for Adolescents and their Families.2006 · no comparison group · 10 with outcome data
- Post-COVID-19 ME/CFS: a case report of the treatment and recovery of a 17-year-old high-school student2026 · case report · 1 in the study
Summary
This case report describes one 17-year-old girl with post-COVID-19 ME/CFS, referred to the author’s department for severe fatigue that developed after SARS-CoV-2 infection. She had been unable to attend school. No comparison group was treated. The author applied a multifaceted treatment approach including midodrine, ibudilast, and the traditional Japanese herbal medicines hochuekkito and tokishakuyakusan, together with instruction on eating habits and supplements, physical activities, managing cognitive fatigue, environmental adjustment, therapeutic interoceptive awareness, adjustment of disrupted diurnal sleep-wake rhythms, conditioning exercise, instructions for safe recovery, and nurturing self-efficacy. The interventions were introduced progressively, tailored to the patient’s phase of recovery; treatment duration was not otherwise reported. Follow-up was approximately one year after her initial consultation. The report states that approximately one year after her initial consultation, the patient made a full recovery, entered university, and is now enjoying university life; she had been unable to attend school but was ultimately able to attend university. Harms and withdrawals were not reported. Limitations were not reported.
- Feasibility of Using a Commercially Available Smartwatch to Advance Outcomes for Patient With Post-Acute Sequelae of COVID-19 (PASC): Case Report2025 · case report · 1 in the study
Summary
This retrospective case report explored whether smartwatch use can augment rehabilitation of a patient with Post-Acute Sequelae of COVID-19 (PASC) including fatigue, post-exertional malaise, brain fog, weakness, and limited ability to complete IADLs and work/life roles. One adult completed a 15-week post-COVID outpatient program (11 visits each for physical, occupational, and speech therapies) at an outpatient physical rehabilitation hospital. A Garmin Venu SQ2 watch was provided at the second visit to monitor daily steps, heart rate, sleep, and stress. Treatment included pacing, graded endurance and strength training, cognitive therapy, and diaphragmatic breathing, with smartwatch data integrated to guide exercise intensity, stress management, and sleep hygiene. There was no comparison group. Between the first and last therapy weeks, average daily Steps were 8,667 vs. 7,419, average daily Stress 32.1 vs. 32.3, Sleep Duration 6.6 vs. 7.2 hours, and Resting Heart Rate 60.2 vs. 57.7 bpm. Between admission and discharge, 6MWT distance was 401 vs. 571 m, STS repetitions 10 vs. 16, dominant arm Grip Strength 36 vs. 56 lbs; RPE decreased (6MWT 7 vs. 2; STS 5 vs. 3), dyspnea decreased (5 vs 2; STS 5 vs. 3), and DePaul PEM frequency was 2.0 vs. 0.4 and severity 2.2 vs. 0.6. No harms or withdrawals were reported. The authors state no limitations.
- Treatment of Post-COVID and Chronic Fatigue Syndrome with a Proprioception Based Treatment2025 · case report · 9 in the study · 6 with outcome data
Summary
This case series describes nine patients with severe Post-COVID syndrome accompanied by chronic fatigue syndrome who underwent a structured, multimodal inpatient program emphasizing sophisticated pacing, with a median treatment duration of 116 days. The program also included psychotherapeutic interventions, cognitive training, physician-supervised biofeedback, music therapy, physiotherapy, and Functional Relaxation, with individualized medication and supplementation. There was no comparison group; outcomes were compared before and after treatment. Health-49 and ICD-10-based symptom rating (ISR) were collected at admission and discharge, but patient-reported outcome measures were obtainable for only six patients. Median HRQoL scores improved across all Health-49 subdomains except social strain; somatoform complaints decreased from 2.50 to 1.43. ISR total score decreased from 1.06 to 0.55, and the anxiety syndrome domain decreased from 1.38 to 0.38. Activity improved from 4.00 to 2.92 and self-efficacy from 2.80 to 1.50. Social strain changed from 1.50 to 1.62. Four patients remained wheelchair-dependent at discharge. Side effects were not reported. The authors state that the findings are limited by sample size and that formal inferential analysis is precluded.
- Multimodal Telerehabilitation in Post COVID-19 Condition Recovery: A Series of 12 Cases.2025 · case report · 12 in the study
Summary
This prospective case series asked whether a 12-week multimodal telerehabilitation program could help adults with Post COVID-19 Condition. Twelve patients from three health centers in Aragón, Spain (9 female and 3 male; average age 51 years), received home-based asynchronous telerehabilitation. The program combined therapeutic education, pulmonary rehabilitation, and physical rehabilitation (aerobic training and strengthening). There was no comparison group; outcomes were compared before and after treatment. Fatigue was the primary outcome. After 12 weeks, the text reports a significant reduction in Fatigue Severity Scale score, from 6.41 to 4.85 (d = 1.088). It reports statistically significant improvements in 6MWT (p < 0.001, d = 1.488), 30″ STST (p < 0.001, d = 1.127), 30″ ACT (p < 0.001, d = 1.422), MIP (p = 0.003; d = 1.1.03), and MEP (p = 0.031; d = 1.337). For quality of life and perceived dyspnea, the results text notes clinical improvements but also no significant changes, while the discussion states no improvements in quality of life and perception of dyspnea. After the intervention, the text reports no correlation between dyspnea groups and MIP (p = 0.887, η2 = 0.002) or MEP (p = 0.131, η2 = 0.120), and a correlation between 6MWT distance and perceived fatigue (p = 0.012; η2 = 0.505). The text does not report harms or withdrawals for harms; it defines dropout as adherence below 90% or medication change, without counts. The authors state limitations including a small sample and no long-term follow-up.
- Physical therapy management of an individual with post-COVID fatigue considering emotional health in an outpatient setting: A case report.2024 · case report · 1 in the study
Summary
This case report described outpatient physical therapy management for post-COVID fatigue, with emphasis on patient education and emotional health. The patient was one 50-year-old woman, ten-weeks post-COVID syndrome, whose fatigue with ordinary activities impeded return to work. She received physical therapy management including patient education, supporting emotional health, aerobic training, strengthening exercises, breathing exercises, and a home exercise program over 20 biweekly sessions. There was no comparison group. Outcomes reported at discharge included exercise capacity, six-minute walk test distance (6MWD), muscle strength, dyspnea, UCSD Shortness of Breath Questionnaire (SOBQ), depression, Patient Health Questionnaire (PHQ-9), anxiety with activity, confidence to resume activities, and return to work safely. Baseline 6MWD was 79.5 m and discharge 6MWD was 335 m; SOBQ was 72/120 at baseline and 34/120 at discharge; PHQ-9 was 6/27 at baseline and 1/27 at discharge. The abstract reports improvements in exercise capacity, muscle strength, dyspnea, and depression beyond the MCID/MID values. At discharge, the patient had no anxiety with activity and reported confidence to resume activities, allowing return to work safely. Harms and withdrawals were not reported. The abstract does not state limitations.
- [Pacing in a 59-year-old female patient with post-Covid syndrome - a model for self-directed rehabilitation].2024 · case report · 1 in the study
Summary
This case report concerns one 59-year-old woman with post-COVID syndrome after a corona infection. She is described as previously healthy and active, with pronounced physical and cognitive fatigue; the abstract says inpatient rehabilitation gave no relief and that a pension was necessary. The treatment described is a pacing system with documentation of symptoms and classification into severity grades; no duration is reported. There is no comparison group, no randomisation and no crossover. The text mentions the fatigue scale for motor and cognition FSMC for assessing the extent of fatigue, but no scores are reported. The only treatment result recorded is that the pacing system enabled the patient access to her physical performance and to her emotional reactions; no direction of change, follow-up, analysed number or statistics are reported. The abstract reports no side effects, no harms and no withdrawals. The authors conclude that the patient needs patience for the healing course. No limitations are stated.
- The successful rehabilitation of a 75-year-old female with debilitating long COVID: A case report.2022 · case report · 1 in the study
Summary
This case report followed one 75-year-old woman with long COVID after COVID-19 with acute respiratory failure and extensive pulmonary fibrosis, who came to a rehabilitation clinic after two weeks of self-health management with residual symptoms and physical limitations. She received an outpatient rehabilitative intervention for 8 weeks, scheduled 50 min/twice a week, consisting of respiratory muscle training, chest expansion, resisted diaphragmatic training, aerobic cycle endurance training, resistance training, plus daily incentive spirometer training and lip breathing training; there was no comparison group. Assessments were reported before rehabilitation (Day 45) and after rehabilitation (Day 108), with some within-rehabilitation values. The paper reports that after 6 sessions her oxygen supply was discontinued during exercise, and at completion she could walk alone, go up and down one stair, and perform activities of daily life without oxygen supplementation and other help. Table 1 shows MBS 4 to 0, mMRC 4 to 1, CAT 35 to 17, BI 60 to 100, PCFS 4 to 1, FSS 6 to 3, and EQ-5D-5L VAS 40 to 70; PSQI rose from 8 to 16. Harms recorded were sleep quality worsening (PSQI 8 to 16) and severe sleep problems persisting. The paper did not report withdrawals for harms.
- Cardiopulmonary rehabilitation in post-COVID-19 patients: case series.2021 · case report · 4 in the study
Summary
This case series enrolled four post-COVID-19 patients with varying severity and no comparison group; it was approved by a São Paulo research ethics committee. The authors aimed to present their experience with a three-month cardiopulmonary rehabilitation program. Participants received aerobic exercise (3 times/week, 30 minutes; at 60% and 80% of HR reserve and Borg 4 to 6 with SpO2 ≥ 90%), resistance exercise (60% MR, all muscle groups, 3 times/week, 3 series of 10 repetitions), and, for the fourth case, inspiratory training with POWERbreathe at 30% maximal inspiratory pressure. Outcomes included the 6-Minute Walk Test, peripheral muscle strength, handgrip, double product, and Borg scale-associated dyspnea. The 6-Minute Walk Test covered distance increased by 16%, 49%, 67%, and 94% for cases 1 to 4, respectively; double product was reduced by 42%, 27%, 8%, and 34% for cases 1 to 4, respectively. Peripheral muscle strength increased ranging from 20% to six times baseline values. Borg scale-associated dyspnea variables were reduced for all cases. For case 1, minimal SpO2 was 95 at baseline and 94 at 3 months. Reported harms included desaturation in two cases, dyspnea during the workout in all patients, wrist tendinopathy and late left humerus fracture in cases two and three, and right lower limb edema with right iliac vein thrombosis in the fourth case. The authors state limitations include lack of pulmonary function and inspiratory muscle strength assessment, cardiopulmonary and ergometric testing, quality of life questionnaires, or assessment of functional capacity by other means in all cases.
- Physical Therapy Management of an Individual With Post-COVID Syndrome: A Case Report.2021 · case report · 1 in the study
Summary
This case report described a 37-year-old woman with post–COVID syndrome after mild COVID-19 who did not require supplemental oxygen or hospitalization; she received outpatient physical therapy in a pulmonary rehabilitation clinic. There was no comparison group. She participated in biweekly physical therapist sessions for 8 weeks (16 sessions) including aerobic training, strength training, diaphragmatic breathing techniques, mindfulness training, education, and a home exercise plan. Outcome testing occurred 120 days after initial diagnosis. The 6-minute walk distance was 312 meters at baseline and 511 meters at follow-up, an increase of 199 meters, equating to 80% of her age-predicted distance. Metabolic equivalent for task levels increased with variability. Muscle strength, muscle power, physical function, and exercise capacity improved. Quality of life and PTSD scores did not improve; all IES-R subcomponents increased, and health-related quality of life scores were the same or worse. Cognitive functioning appeared slightly improved or unchanged, with TUG-cog difference 34% at initial examination and 21% at follow-up. The patient returned to cycling and swimming. No adverse events were reported, but she had worsening headaches, dyspnea, and fatigue, exhaustion lasting 2-3 days, a transient drop to 88% SpO2, and one missed session due to gastrointestinal symptoms. The authors state additional research is required.
- Pervasive refusal syndrome.2012 · case report · 1 in the study
- Promising outcomes of an adolescent chronic fatigue syndrome inpatient programme.2009 · case report · 16 with outcome data
Summary
Sixteen adolescents with chronic fatigue syndrome who completed a 4-week inpatient programme at the Austin Hospital, Melbourne, were analysed. All received a supervised graded exercise programme prescribed daily by an exercise physiologist, alongside approximately 45 min of hydrotherapy each day, psychological/psychiatric support and, from the second week, recreation and leisure therapy. There was no control group; outcomes were compared before and after the programme, with reassessment on the second last day. The programme reported an 18% improvement in volitional time to fatigue and a 17% improvement in peak oxygen uptake; MET values improved by 19% and predicted maximal oxygen uptake was 15% higher. Push-ups increased by 70%. On questionnaires, the SF-36 physical component score increased by 25%, fatigue severity improved by 13%, and depression index improved by 42%; the mental component score also improved. Harms and withdrawals were not reported. The authors state the study is limited by the small sample size and lack of a control group.
- Management of chronic fatigue syndrome: case study.1996 · case report · 2 in the study
- Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndrome.2024 · how it is prescribed, safety only · 200 with outcome data
Summary
This single-cohort retrospective study with a follow-up survey investigated symptomatic treatment use and patient-reported improvement in post-COVID syndrome. It included 200 patients attending the post-COVID center of the University Hospital of Erlangen between December 2022 and July 2023, with symptoms persisting at least three months after SARS-CoV-2 infection; vaccine-related symptom onset was excluded. Baseline records captured symptomatic therapies from three months post-infection until presentation. A follow-up questionnaire was completed by 165 patients (response rate 82.5%), a mean 6.3 months (SD = 2.2) after initial consultation. Treatment duration was not reported. There was no control group; patients rated improvement within the same cohort for each therapy they used, using 0 = no improvement to 3 = very strong improvement. Among therapy users, strong to very strong improvement was reported by 12 of 38 for beta-blockers, 8 of 27 for antibiotics, 5 of 15 for plasmapheresis, and 8 of 73 for outpatient psychotherapy. Vitamins and nutritional supplements were rated 9 of 135. No between-group comparison was reported. Harms, side effects, worsening and withdrawals were not reported. The authors state that the study gives initial insights into utilization and patient-reported symptom improvement.
- The Effectiveness of Non-Pharmacological Interventions in Treating Adolescents and Young Adults with Neuropsychiatric Symptoms of Long COVID: A Systematic Review and Meta-Analysis.2026 · systematic review
Summary
This systematic review and meta-analysis examined non-pharmacological interventions for neuropsychiatric symptoms of long COVID in adolescents and young adults aged 13–25 years. The review included seven studies; the recorded sample sizes were 17, 16, 208, 124, 22, 239, and 36 participants. Interventions included forest bathing, TTM, a neuropsychological rehabilitation program, a multidisciplinary post-COVID rehabilitation program, micro-choice based concentrated group rehabilitation, and EECP. Durations varied, and the review reported that most studies lacked a comparison group. Outcomes included mental health, anxiety, depression, fatigue, QoL, cognitive function, headaches, and insomnia. In the meta-analysis, the pooled mental health result was statistically significant (SMD 0.64, 95% CI 0.0012 to 1.2692, p<0.0497). Pooled results for fatigue (SMD 1.74, 95% CI −0.9416 to 4.4262, p=0.1307), QoL (SMD −1.34, 95% CI −5.2620 to 2.5784, p=0.2787), and cognitive function (SMD 1.05, 95% CI −2.1961 to 4.2934, p=0.2989) were not statistically significant. Individual studies reported improvements in several outcomes; Chokpaisam et al reported no statistically significant change in emotional well-being (78.35 ± 17.44 vs 81.18 ± 17.99, p=0.336), and Kvale et al reported no statistically significant difference in anxiety and depression (27.3% vs 38.2%, p=0.210). No harms or withdrawals were recorded. The authors stated limitations including cohort designs without comparison groups, no age-based subgroup analyses, small sample sizes, and heterogeneity.
- Rehabilitation in long COVID: a systematic review and meta-analysis.2026 · systematic review
Summary
This systematic review and meta-analysis asked whether rehabilitation programmes help adults with long COVID. It included 12 studies with 1403 participants. The interventions combined structured exercise with an educational component and were compared with usual care or control groups. Outcomes included exercise capacity, quality of life, pulmonary function, dyspnoea, anxiety, depression and fatigue. In the short term, exercise capacity on the 6-min walk test improved with a mean difference of 102.34 m (95% CI 44.48 to 160.21 m; p<0.0001) in four RCTs. Dyspnoea on the mMRC improved in the RCT subgroup with a mean difference of −1.44 (95% CI −2.72 to −0.16). Anxiety on HADS-A reduced with a mean difference of −1.64 (95% CI −3.02 to −0.26; p=0.02). Fatigue showed no statistical difference (MD 7.96, 95% CI −2.11 to 18.02), and FEV1 showed no difference (SMD=0.11; 95% CI −0.12 to 0.34; p=0.33). Quality of life on EQ-5D-5L showed no significant difference (MD 0.07; 95% CI −0.09 to 0.22). Long-term HRQoL and dyspnoea showed no significant effects (SMD −0.74; 95% CI −2.54 to 1.06 and SMD −0.56; 95% CI −1.72 to 0.60). Long-term functional capacity showed a significant effect (SMD 0.88; 95% CI 0.56 to 1.19; p<0.0001). Worsening or stopping was not reported. None of the included studies systematically monitored or documented post-exertional malaise, and adverse events were generally under-reported.
- Effectiveness of physical, psychological, and alternative interventions for post-COVID-19 condition: a systematic review.2026 · systematic review
Summary
This systematic review asked whether supervised physical, psychological and alternative non-pharmacological treatments help adults with post-COVID-19 condition. It included 27 randomized trials with 1,998 participants; trials were supervised and face-to-face and compared interventions with usual care, placebo/sham or active comparators. Interventions included cardiopulmonary rehabilitation, multimodal and unimodal exercise, CBT and lifestyle programmes, neuromodulation, oxygen therapies, acupuncture and balneotherapy. Intervention durations varied. The review reported that cardiopulmonary rehabilitation and multimodal exercise consistently improved cardiorespiratory fitness and walking capacity; CBT and lifestyle adjustments significantly reduced fatigue and subjective concentration complaints. Examples recorded: in 114 participants, CBT lowered CIS-fatigue by a between-group mean difference of −8.8 points (95% CI −11.9 to −5.8); in 70 participants, active HD-tDCS plus rehabilitation lowered MFIS total fatigue by a between-group difference of −14.03 points (95% CI −20.28 to −7.78). Findings for neuromodulation, complementary and oxygen therapies were heterogeneous, often showing no benefit over placebo. For example, HBOT did not produce significantly greater improvements than sham on any primary or secondary outcome. Side effects and withdrawals were not reported in the recorded data. The authors state that the evidence does not support definitive conclusions about the effectiveness of any intervention category.
- Cognitive Interventions and Rehabilitation to Address Long-COVID Symptoms: A Systematic Review.2026 · systematic review
Summary
This systematic review examined cognitive interventions and rehabilitation for adults with long COVID symptoms. It included 19 articles identified from MEDLINE, CINAHL, PsycINFO, Cochrane Trials, and Scopus, with a search date of July 25, 2023. The review summarized cognitive training, CBT, neurostimulation, combined neurostimulation and cognitive training, and multicomponent rehabilitation programs. Included studies had different designs; the review itself had no comparison group. In a 100-participant randomized trial, an amygdala and insula retraining program was reported to decrease fatigue and increase energy versus control. A 114-participant randomized trial reported CBT reduced fatigue versus care as usual and favored CBT on secondary measures. A 73-participant pre-post study reported higher cognitive scores in all assessed domains after computerized cognitive training. A 64-participant pre-post program reported 42.8% complete recovery and 68% varying improvement in cognitive function, plus significant improvement on the Barthel Index. A 33-participant program reported improved mood, self-efficacy, and participation but no significant fatigue improvement. A 12-participant program reported that all 12 gained insight and 11 reported increased work-life coping. One case report reported short-term memory decreased 15% to 22%. Stopping and side effects were not reported.
- Effectiveness of Non-Pharmacological Interventions for Fatigue in Long COVID: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026 · systematic review
Summary
This systematic review and meta-analysis included 13 RCTs with 1276 participants with long COVID. It compared non-pharmacological interventions—exercise training, cognitive behavioural therapy, non-invasive neuromodulation, and nutritional supplementation—with control conditions. Fatigue severity was assessed with validated instruments. The review reported that exercise training was the only modality associated with a statistically significant reduction in fatigue. For CBT, non-invasive neuromodulation, and nutritional supplementation, the review did not observe a statistically significant pooled effect. The difference in effects between intervention modalities was not statistically significant (p = 0.286). Harms were reported in several trials: two participants discontinued the exercise intervention (transient worsening of fatigue), and 2 participants of the training groups stopped (worsening of their symptoms in response to the intervention). In one trial there were eight AEs (four PEM, two musculoskeletal issues, one nausea and one atypical chest pain) and one unrelated SAE. In another, eight of the sixteen patients receiving active tDCS and nine of the seventeen assigned to sham tDCS experienced mild to moderate side effects such as burning or tingling. The review notes that overall certainty is low to moderate, with substantial between-study heterogeneity and limited RCTs for non-exercise interventions.
- Exercise effectiveness on fatigue in Long-COVID: systematic review and meta-analysis.2026 · systematic review
Summary
This systematic review and meta-analysis examined exercise for fatigue in adults with Long COVID (symptoms ≥3 months). The authors searched 7 databases in July 2025 and included 14 randomized controlled trials. Exercise groups were compared with usual care. In pooled analyses, the exercise group increased grip strength by 3.86 kg (MD 3.86 kg, 95% CI 2.23-5.50; P < .00001), respiratory muscle strength by 15.54 cmH2O (MD 15.54 cmH2O, 95% CI 8.73-22.34; P < .00001), and 6-minute walk distance by 93.57 m (MD 93.57 m, 95% CI 60.34-126.80; P < .00001). Sit-to-stand repetitions increased (SMD 1.43, 95% CI 0.40-2.46; P = .006) and sit-to-walk speed decreased by 1.23 s (SMD −1.23, 95% CI −2.11 to −0.34; P = .007). The exercise group reduced dyspnea incidence (RR 0.33, 95% CI 0.19-0.56; P < .0001), dyspnea severity (SMD −0.89, 95% CI −1.52 to −0.27; P = .005), fatigue incidence (RR 0.45, 95% CI 0.28-0.74; P = .002), and fatigue severity (SMD −0.59, 95% CI −0.96 to −0.21; P = .002). Subgroup analyses for fatigue severity found multimodal exercise reduced fatigue severity (SMD −0.45, 95% CI −0.85 to −0.06; P = .03), whereas single-modality exercise did not (SMD −0.84, 95% CI −1.71 to 0.03; P = .06). Attrition rates ranged from 0% to 30.38%; no adverse events were reported in the included studies, but most trials provided limited information regarding PEM monitoring and adverse event ascertainment. The authors describe the certainty of evidence as moderate to very low.
- Return to work with long COVID: a rapid review of support and challenges.2025 · systematic review
Summary
This rapid review examined support for return to work in people with long COVID. Searches were completed in June 2024 across major databases including MEDLINE, Embase, PsycINFO, evidence-based medicine reviews, Web of Science and Google Scholar, and twenty-five studies were included. The review covered non-workplace-based support and workplace-based support. Non-workplace support included a telerehabilitation programme using pacing strategies and occupational therapy, pacing strategies, and a home exercise plan with moderate and intense activities. Workplace support included adjusted work arrangements, flexible hours, working from home, task changes, emotional support, financial support, and vocational integration programmes. The review reported that the telerehabilitation programme reduced the number of participants on medical leave by week eight and increased the number returning to full-time work. Patients who adhered more strictly to pacing strategies had higher recovery rates, defined as ability to return to work. A three-month home exercise plan showed no change in work ability from baseline, and the authors noted no significant WAI improvement following a home exercise plan. The review also described organisational barriers such as lack of understanding of long COVID symptoms, insufficient workplace guidance, and educational gaps among managers, and facilitators such as recognition and validation of long COVID and eligibility for disability benefits. The authors state that the search was limited to English language.
- Effectiveness of physiotherapy modalities on persisting dyspnoea in long COVID: A systematic review and meta-analysis.2025 · systematic review
Summary
This systematic review and meta-analysis asked whether physiotherapy treatments reduce persisting dyspnoea in long COVID. The reviewers searched MEDLINE, PEDro, WOS, Scopus, VHL and the Cochrane Library for studies published between September 1st, 2019 and July 2nd, 2023; the protocol was registered as CRD42023427464. They included comparative trials of adults with persistent breathlessness following COVID-19, regardless of initial severity, in whom physiotherapy was implemented as treatment for dyspnoea. 19 studies including 1292 adults fulfilled the inclusion criteria. Treatments were grouped as high-intensity rehabilitation, low-to-moderate intensity rehabilitation, respiratory muscle training, and other/passive techniques; dyspnoea was assessed with dyspnoea-specific, functional, or health-related quality-of-life scales. The authors report that physiotherapy and especially pulmonary rehabilitation may help alleviate respiratory symptoms. They state that high-intensity rehabilitation shows particularly more promising results than low-to-moderate rehabilitation or respiratory muscle training, whereas results for low-to-moderate intensity and respiratory muscle training groups were non-significant. For low-level laser therapy, the review states it seems to have significantly reduced dyspnoea and markers of inflammation in people with long-covid. The recorded data include no side-effect, worsening, or withdrawal counts. The authors state limitations including heterogeneity of interventions and controls, risk of bias from open or assessor-only blind studies, and short-term follow-up.
- Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials.2025 · systematic review
Summary
This meta-analysis pooled 51 RCTs with 4026 participants with Long COVID, searching PubMed, Cochrane Library, Embase, Web of Science, SPORTDiscus (EBSCO), CINAHL (EBSCO), and Rehabilitation & Sports medicine source (EBSCO) to July 20, 2025. Trials compared exercise training, respiratory muscle training, telerehabilitation, tDCS, olfactory training, steroid sprays, or PEA-LUT with no intervention, standard primary care, or placebo; follow-up ranged from 14 to 180 days. Outcomes included cardiopulmonary function, exercise capacity, fatigue, dyspnea, and olfactory recovery. Exercise training showed significant better 6MWT (MD 83.20; 95% CI 52.04–114.37) and 30sSTS (MD 3.05; 95% CI 1.96–4.13), but no significant difference for HADS-depression, HADS-anxiety, SF-12-PCS, FVC (% predicted), FEV1, VE/VO2, VE, RER, or FEV1/FVC. Respiratory muscle training showed significant better 6MWT (MD 89.54; 95% CI 9.86–169.23) and MIP (cm H2O) (MD 19.69; 95% CI 10.14–29.24), with no significant difference for FVC, FEV1, MFIS, HADS, or MEP. Telerehabilitation showed significant better 6MWT (MD 34.14; 95% CI 2.54–65.74), 30sSTS (MD 1.41; 95% CI 0.67–2.15), and FSS (MD −1.59; 95% CI −2.64 to −0.53). tDCS showed significant lower MFIS-physical (MD −2.29; 95% CI −4.36 to −0.22). Olfactory training and steroid sprays showed no significant differences; PEA-LUT showed significant higher TDI Score (MD 4.66; 95% CI 2.16–7.15). No side-effect or withdrawal counts were reported; the authors noted exercise may pose a risk of symptom exacerbation in post-exertional malaise. They reported high risk of bias in 33 studies and high heterogeneity.
- Applicability and adaptation of cognitive behavior therapy for long COVID neuropsychiatric symptoms: a review with insights from ME/CFS.2025 · systematic review
Summary
This narrative synthesis examined cognitive behavior therapy (CBT) for long COVID and ME/CFS. The authors state it is a narrative synthesis rather than a formal systematic review. A focused ClinicalTrials.gov search covering trials registered between May 2022 and October 2024 identified 189 potentially relevant trials, with 10 meeting final inclusion criteria. The paper did not give a treatment, duration, or follow-up for its own study; it summarized named studies. In the ReCOVer trial, CBT was reported to reduce severe fatigue compared with usual care (mean difference −8.5 points on the Chalder Fatigue Scale; 95% CI −12.3 to −4.7; p < 0.001). A living systematic review reported moderate-certainty evidence that CBT reduces fatigue (mean difference −8.4, 95% CI −13.11 to −3.69) and improves concentration (mean difference −5.2, 95% CI −7.97 to −2.43) in long COVID. In ME/CFS, one systematic review reported a fatigue reduction versus controls (g = −0.52, 95% CI −0.69 to −0.35); an individual patient data meta-analysis reported a fatigue-severity benefit (β = −11.46, 95% CI −15.13 to −7.79, p < 0.001) and no indication that patients meeting different case definitions or reporting post-exertional malaise benefited less. A brief outpatient program with cognitive-behavioral elements reported improved physical function (difference 9.2; 95% CI 4.3–14.2; p < 0.001); a concentrated group rehabilitation program reported 99% completion. The review also cited that 74.8% reported symptom exacerbation following physical activity, 21.0% mixed effects, and 28.7% no worsening.
- Post-Acute COVID-19 Syndrome (PACS) and Exercise Interventions: A Systematic Review of Randomized Controlled Trials.2025 · systematic review
Summary
This systematic review asked whether exercise interventions affect health-related quality of life and functional fitness in adults with Post-Acute COVID-19 Syndrome. It searched databases and clinical registers up to July 2025 and included 20 randomized controlled trials. Exercise programmes varied: aerobic training, resistance or concurrent training, breathing exercises, strength-based exercises, pilates, yoga disciplines and telerehabilitation; one study used continuous aerobic training at 50% of workload. Durations included a 2-week protocol and an 8-week protocol. Comparators included usual care, waitlist, no intervention, general guidance, another exercise setting or another exercise delivery. Outcomes were HRQoL and functional fitness. Some trials reported significant HRQoL improvements (Refs. [30,39,46]) and positive SF-12 physical and mental components (Refs. [27,29,35]). Ref. [32] found no significant quality-of-life change between supervision by a general or specialized physiotherapist, though the SF-12 physical component changed. Ref. [33] found virtual reality was not superior to traditional methods. Ref. [31]’s 2-week breathing- and strength-based protocol and Ref. [41]’s 8-week breathing, pilates and yoga protocol were described for respiratory function. Overall dropout rates were below 37%; treatment-attributed harms were not reported. The authors state limits include heterogeneity of protocols and non-comparable frequency, duration, and modality.
- Psychotherapy in patients with long/post-COVID - A systematic review on the feasibility, acceptability, safety, and efficacy of available and emerging interventions.2025 · systematic review
Summary
This systematic review asked whether psychotherapy for long/post-COVID has been studied and what is known about feasibility, acceptability, safety, and efficacy. It searched PubMed, PsycInfo, and Web of Science on February 8, 2024 and included 12 studies of people with long/post-COVID; reported sample sizes in the recorded data include 16, 30, 33, 44, 51, 57 per group, 63, 64, 123, and 224. Treatments were psychotherapy, mostly CBT-based, often delivered within multimodal rehabilitation; one RCT compared CBT for post-COVID fatigue with care as usual. The recorded data do not state treatment durations. Outcomes included fatigue, pain, dyspnea, anxiety, depression, quality of life, cognitive symptoms, and physical functioning. Many pre-post improvements were reported. In the RCT, between-group differences favored CBT for fatigue, physical functioning, somatic symptoms, social functioning, and concentration problems at T1 and T2 (Cohen’s d=0.74 at post-treatment; Cohen’s d = 0.65 at six-month follow-up). Some findings were not significant: Hasting et al. reported no significant improvement in fatigue or sleepiness; Huth et al. reported no significant improvement in somatic symptom distress, depression, anxiety, or psychobehavioral features; Hayden et al. found no significant improvement in pain or anxiety at 6-month follow-up. García-Molina et al. reported poorer performance at 6-month follow-up in the intervention group. Harms included adverse events in Huth et al. (85.4%; severe 29.3%) and Kuut et al. (8 during CBT; 20 during care as usual; no serious adverse events); Compagno et al. reported no adverse cardiovascular events or clinical complications, and Fontana et al. reported no adverse events. Dropouts included 20.3% in Huth et al., 13 % in Kuut et al., twelve in Páez et al., 3 in Hayden et al., and two in Hasting et al.
- Identifying Factors That Might Affect Outcomes of Exercise-Based Therapies in Long-COVID.2024 · systematic review
Summary
This systematic review examined exercise-based therapies for people with Long-COVID; it included 39 studies. The search was performed from 13 February 2024 to 27 February 2024 in Pubmed, PEDro, BioMed Central, EBSCOhost, ProQuest and the ZBSport. Treatments included supervised exercise training and programs combining physical training with respiratory training, pacing or physiotherapy; some combined programs lasted >5 weeks with three individualized sessions per week. The review reports no comparison group. Outcomes covered Long-COVID symptoms, quality of life, physical fitness and pulmonary parameters. In one named study (Binetti et al.), a 3-month protocol showed no significant improvements in Long-COVID symptoms or physical fitness. Adverse events were documented in 16 studies: no adverse events were identified in 12/16 studies, and 4/16 studies reported adverse events related to the intervention. One study recorded 6–9% adverse events and 2–5% serious adverse events in the intervention and usual care groups; 21 serious adverse events and 19 admissions to hospital or prolongation of admission were reported, and one serious adverse event (syncope with vomiting 24 h after training) was possibly related to the intervention. Intervention-related adverse events included unilateral knee pain, severe anxiety before the session and headache. In a pacing study, four patients were unable to comply with guidance. There were no cases of exacerbation of symptoms after exercise during weekly monitoring. The authors state that comparison was difficult because the same parameters were examined using a wide variety of measurement methods.
- Systematic review of interventions for mental health, cognition and psychological well-being in long COVID.2024 · systematic review
Summary
This systematic review aimed to identify and synthesise publicly available research testing treatments for mental health, cognition and psychological well-being in long COVID. It included 33 documents representing 31 studies and 2477 participants recruited across four continents. The studies covered 7 psychosocial, 5 pharmaceutical, 3 natural supplement, 9 neurocognitive, 2 physical rehabilitation and 5 integrated intervention studies; 11 were RCTs, 2 non-randomised controlled trials, 10 uncontrolled trials, 7 case studies or series and 1 qualitative study. Some controlled trials reported significant group×time interactions: vortioxetine for depression and health-related QoL but not cognition; hyperbaric oxygen for total cognition and psychological distress only; high-definition transcranial direct current stimulation for cognitive and psychosocial fatigue, anxiety and QoL; and a programme combining non-invasive cognitive stimulation and guided mindfulness for mental fatigue, anxiety, depression, mood disturbance and several cognitive domains. Other trials reported no significant group×time interaction, including an adaptogen formulation and the ReCOVERY app. Many uncontrolled studies reported significant prepost improvements, but the authors state these cannot be definitively associated with treatment without a control group. Counts of people who worsened or stopped and side-effect counts were not reported in the recorded data; the authors note many studies did not report adverse events.
- Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review.2024 · systematic review
Summary
This qualitative systematic review asked which treatments have been studied for cognitive impairment after COVID-19. The search covered PubMed, Scopus, and ProQuest up to December 31, 2023, and included 29 studies of post-COVID cognitive impairment; samples ranged from single patients to larger groups. Treatments included cognitive remediation, multidisciplinary rehabilitation, noninvasive brain stimulation, hyperbaric oxygen, pharmacological and nutraceutical agents, neurofeedback, photobiomodulation, and meditation. Comparisons, where reported, included control, sham, placebo, or usual-care groups. Cognitive functioning was assessed with standardized tests, test batteries, or structured interviews. Findings varied. A randomized sham-controlled HBOT trial in 37 subjects reported significant improvements in global cognitive functioning, attention, and executive functions versus control. A famotidine RCT reported significantly improved global cognition in the treatment group (N = 25). A donepezil RCT found no differences between N = 15 and N = 10 in memory after 4 and 12 weeks. A tDCS randomized sham-controlled trial in 23 subjects found no significant effects on executive functioning and processing speed after eight tDCS sessions. A remote multidisciplinary RCT found no significant differences between N = 52 and N = 48. A multidisciplinary study in 80 subjects found no significant improvements in memory and attention at discharge. Other studies reported improvements in smaller or uncontrolled samples. No worsening, stopping, or side effects were reported in the recorded data. The authors state limitations including heterogeneity, lack of long-term follow-up, and under-characterization of samples.
- Interventions for the management of long covid (post-covid condition): living systematic review.2024 · systematic review
Summary
This living systematic review assessed drug and non-drug interventions for long covid in adults. It included 24 unique trials with 3695 patients, predominantly from the Americas or Europe. One trial (n=114) compared an online CBT programme called “fit after covid” with usual care; moderate certainty evidence suggested CBT probably reduces fatigue (mean difference −8.4, 95% CI −13.11 to −3.69) and probably improves concentration (mean difference −5.2, −7.97 to −2.43). One trial (n=585) compared combined physical and mental health rehabilitation with one session of online advice and support; moderate certainty evidence suggested it probably increases recovery or important improvement (161 more per 1000 patients, 95% CI 61 more to 292 more), improves quality of life (mean difference 0.04, 95% CI 0.00 to 0.08), and reduces depression (mean difference −1.50, −2.41 to −0.59), with little or no effect on physical and cognitive function or anxiety. Intermittent aerobic exercise 3-5 times weekly for 4-6 weeks probably improves physical function compared with continuous exercise (mean difference 3.8, 95% CI 1.12 to 6.48; n=110). Vortioxetine for eight weeks did not improve cognitive function; coenzyme Q10 500 mg/day for six weeks probably did not improve quality of life (n=119); SIM01 might alleviate fatigue (200 more per 1000 patients, 95% CI 94 more to 336 more; n=463) but probably did not improve quality of life. No instances of post-exertional malaise were reported in the rehabilitation trial; effects on serious adverse events were very uncertain.
- Effectiveness of Rehabilitation Interventions on Adults With COVID-19 and Post-COVID-19 Condition. A Systematic Review With Meta-analysis.2024 · systematic review
Summary
This systematic review with meta-analysis asked whether rehabilitation interventions help adults with COVID-19 or post COVID-19 condition (PCC). It included 40 studies with 2445 participants; patients were adults hospitalized in any setting or discharged at home, with any COVID-19 severity or PCC. Interventions included pulmonary rehabilitation, self-activities, qigong exercise and acupressure rehabilitation program (QARP), yoga and naturopathy, Mandala coloring, cognitive motor training, and FES-cycling. Comparisons were usual care or no intervention. Pooled analyses compared pulmonary rehabilitation with usual care in post COVID-19 patients: exercise capacity favored pulmonary rehabilitation (MD 65.06, 95% CI 42.87 to 87.25; 2 studies, 184 participants); FEV1 favored pulmonary rehabilitation (MD 0.16, 95% CI 0.05 to 0.28; 2 studies, 179 participants); FEV1/FVC favored pulmonary rehabilitation (MD 0.05, 95% CI 0.01 to 0.09; 2 studies, 174 participants); FVC showed no effect (MD 0.19, 95% CI -0.03 to 0.42; 2 studies, 179 participants). Self-activities plus usual care compared with usual care showed an anxiety effect (MD -12.03, 95% CI -21.16 to -2.90; 2 studies, 207 participants). Narrative findings said QARP and “twist and raise” walking technique seem to reduce dyspnea and weakness; yoga and naturopathy, Mandala coloring, and respiratory exercise seem to reduce anxiety and depression; cognitive motor training seems to improve cognitive function; FES-cycling seems useful for erect position restoration and walking capacity. Li 2022 reported no serious adverse events; another study reported headache and dizziness events but no significant difference between groups. Worsening or stopping was not reported. The authors state very uncertain evidence and very low certainty.
- ‘Pacing’ for management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review and meta-analysis2024 · systematic review
Summary
This systematic review and meta-analysis asked whether pacing affects symptoms in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Six electronic databases and grey-literature websites were searched up to 16/11/2023, yielding 5 included studies. Pacing was compared with specialist medical care in the PACE trial; other included designs were uncontrolled or case series. Outcomes were physical function, pain, and fatigue. For physical function (k = 4), the pooled SMD was 0.15 (95% CI = −0.39, 0.68, p = 0.5951). For pain (k = 4), the pooled SMD was −0.11 (95% CI = −0.32, 0.10, p = 0.3090); Bourke et al. [29] observed no change to pain (SMD = −0.06), and Nijs et al. [32] (n = 7) resulted in an SMD of 0.01. For fatigue (k = 4), the pooled SMD was −1.09 (95% CI = −2.38, 0.21, p = 0.0998); the PACE trial reported a positive effect of pacing compared to the control group for fatigue, with n = 159 and n = 160 in the pacing and specialist medical care [SMC] control group respectively. Side effects and withdrawals were not reported. The authors state insufficient evidence to conclude a positive effect for physical function, pain, and fatigue, although pacing may reduce fatigue.
- Intervention modalities for brain fog caused by long-COVID: systematic review of the literature.2024 · systematic review
Summary
This systematic review examined interventions for brain fog caused by long-COVID in adults with proven symptoms. It included 17 studies, including a case report of 1 patient and a cohort of 208. Interventions were rehabilitation (cognitive training, telerehabilitation, mindfulness-based programs), noninvasive brain stimulation (transcranial magnetic, direct current, alternating current stimulation, photobiomodulation), hyperbaric oxygen therapy, and PEA-LUT. Treatment duration varied; PEA-LUT was assessed three months after treatment. Some studies compared an intervention with control or treatment as usual, while others reported before-and-after changes. Outcomes included MoCA, MMSE, WAIS4, BNIS, NeuroTrax, CANTAB, TAP/AVLT, CAB, PEBL, and PDQ-D-5. Noninvasive brain stimulation studies all showed improvement in cognitive ability. Hyperbaric oxygen studies showed improvements in cognitive tests and brain perfusion. PEA-LUT improved PRMQ and MoCA scores in treated patients; in one trial mental clouding fell in groups 1 and 3 but not group 2. Rehabilitation results were mixed, with some studies reporting enhancement and others no significant improvement. Adverse effects were mild: scalp pain in 4 out of 23 patients after stimulation; after hyperbaric oxygen, barotrauma n=4, ear pain n=1, palpitations n=3, headache n=1, fever n=1. Rehabilitation and pharmacological treatment had no adverse effects. The authors state limitations include a limited number of studies and high heterogeneity.
- Effects of rehabilitation interventions for old adults with long COVID: A systematic review and meta-analysis of randomised controlled trials.2024 · systematic review
Summary
This systematic review and meta-analysis examined rehabilitation interventions for old adults with long COVID. It searched PubMed, EMBASE, Web of Science, Scopus, and Cochrane Library databases to 15 November 2023 and included 11 RCTs involving 832 participants (64.37 ± 7.94 years; 52.2% were men) with a mean/median age of 60 or older. Rehabilitation interventions included exercise training and respiratory rehabilitation; duration was not reported. They were compared with control groups (usual/standard care/placebo). Outcomes included 6 MWT, 30 seconds STS, HGS, FEV1/FVC, fatigue, quality of life, independence in activities of daily living, depression, and anxiety. Compared with controls, the review reported improvement in 6 MWT (MD = 15.77 m, 95% CI = 5.40, 26.13, P < 0.01), 30 seconds STS (MD = 4.11 n, 95% CI = 2.46, 5.76, P < 0.001), fatigue (SMD = −0.66, 95% CI = −1.13, −0.19, P < 0.01), independence in activities of daily living (SMD = 0.31, 95% CI = 0.13, 0.48, P < 0.001), depression (SMD = −0.89, 95% CI = −1.76, −0.02, P < 0.05), anxiety (SMD = −0.81, 95% CI = −1.58, −0.05, P < 0.05), and all SF-36 quality-of-life domains. HGS was not significant (MD = 1.67 kg, 95% CI = −0.84, 4.18, P > 0.05), and FEV1/FVC was not significant (MD = 3.45%, 95% CI = −1.43%, 8.33%, P > 0.05). Side effects and withdrawals were not reported.
- Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19 Condition: A Systematic Review and Meta-Analysis.2023 · systematic review
Summary
This systematic review with bayesian meta-analysis searched MEDLINE, Scopus, CINAHL, and the Clinical Trials Registry from January 2020 until February 2023 and included 14 trials (1244 patients; 45% female participants; median [IQR] age, 50 [47 to 56] years) with post–COVID-19 condition. It examined respiratory training and exercise-based rehabilitation interventions against placebo, usual care, waiting list, or control. The median follow-up for the primary outcome was 6 (5.5-7.0) weeks. For functional exercise capacity (6-minute walking test; 7 trials, 389 participants), the pooled SMD was −0.56 (95% CrI, −0.87 to −0.22). For lower limb muscle function (4 trials, 371 participants), the SMD was −0.77 (95% CrI, −1.94 to 0.44), with uncertain magnitude and direction. Dyspnea (8 trials, 573 participants) had SMD −1.00 (95% CrI, −1.94 to −0.10). FEV1 (6 trials, 363 participants) showed no difference: SMD −0.16 (95% CrI, −0.42 to 0.11); FVC showed no difference: SMD −0.13 (95% CrI, −0.38 to 0.12). Overall quality of life (5 trials, 366 participants) had SMD −0.41 (95% CrI, −0.73 to −0.06). Adverse events: OR 1.68 (95% CrI, 0.32 to 9.94); Five trials gave no adverse-event information, four trials (5 records) reported no related adverse events, and adverse events were reported in 5 trials. Fatigue evidence was limited and could not be synthesized. Worsening or stopping was not reported.
- Effects of cardiorespiratory rehabilitation program on submaximal exercise in patients with long-COVID-19 conditions: a systematic review of randomized controlled trials and recommendations for future studies.2023 · systematic review
Summary
This systematic review examined whether cardiorespiratory rehabilitation programs affect submaximal exercise performance, specifically the walk-test outcome, in people with long COVID-19. The review included six randomized controlled trials in Long-COVID-19 patients; it had no comparison group of its own and enrolled no participants. The authors describe cardiorespiratory rehabilitation programs as promising interventions to enhance exercise capacity in this population. The authors state that findings from the included randomized controlled trials provide evidence supporting CRRPs in improving submaximal exercise performance in LC19Ps. They conclude that CRRPs show promise in ameliorating submaximal exercise performance among LC19Ps. The text provided does not report side effects, or counts of people who worsened or stopped. The authors state that future research is needed to determine optimal CRRPs, including duration, intensity, and specific intervention components, and that the long-term sustainability and durability of improvements associated with CRRPs warrant further exploration. They also state that future studies should prioritize patient-centric outcomes and address potential implementation barriers.
- Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms after COVID-19: a systematic review.2023 · systematic review
Summary
This systematic review asked whether rehabilitation treatments applicable in ambulatory care help adults with persisting symptoms after COVID-19. Searches on 9 May 2022 identified 45,479 records, and 38 studies comprising 2,790 participants were included. Interventions included physical training, breathing exercises, nutritional supplements, olfactory training, multidisciplinary treatment, and other treatments such as hyperbaric oxygen therapy; treatment duration was not reported. Comparisons varied, including low- versus high-intensity training in 76 men and advanced versus classical olfactory training in 80 patients. Outcomes included fatigue, dyspnoea, pain, physical capacity, pulmonary function, sensory function, quality of life, return to activities, functional capacity, and adverse events. Physical training and breathing exercises may reduce fatigue, dyspnoea, and chest pain and may improve physical capacity and quality of life, with very weak evidence; improvement was not demonstrated for muscle pain or return to work. Low-intensity training increased handgrip strength and quality of life compared with high-intensity training. Advanced olfactory training was not superior to classical training. Hyperbaric oxygen therapy can have beneficial effects on fatigue in one cohort of 10 patients. Side effects with olfactory training occurred in 18 out of 80 participants. Reported adverse events included hospitalisations, dizziness, symptom exacerbation such as fatigue, headache in one participant, and post-exertional malaise after exercise.
- A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome.2022 · systematic review
Summary
This systematic review asked how adults with chronic fatigue syndrome fare after CBT or GET. It included 15 publications comprising 1990 participants from the UK, the Netherlands, the USA, and New Zealand. Treatments were compared with control conditions such as relaxation, medical care, and wait-list. Outcomes included fatigue, physical functioning, global improvement, and global worsening at post-treatment and follow-up. Treatment duration varied across trials and is not summarised here. Pooled analyses reported more improvement with CBT than control: 23% (95% CI 16–31) more participants improved in fatigue, 14% (95% CI 4–23) more in physical functioning, and 20% (95% CI 11–29) more rated themselves as improved; 8% (95% CI 1–14) fewer reported global worsening. For GET, 23% (95% CI 15–31) more improved in physical functioning and 26% (95% CI 19–32) more reported global improvement; 10% (95% CI 4–16) fewer reported global worsening. Individual studies reported worsening: 21% seriously deteriorated with self-help GET in Clark et al., 9% with CBT and 6% with GET in White et al., and 7% deteriorated and attributed this to treatment with CBT in Sharpe et al. Whether worsening was followed by stopping treatment is not reported. The authors state limitations include clinical heterogeneity, reliance on self-report, and possible limited generalisability to severe CFS.
- What treatments work for anxiety and depression in children and adolescents with chronic fatigue syndrome? An updated systematic review.2022 · systematic review
Summary
This systematic review updated searches from 2015 to 2020 in Cochrane Library, Medline, Embase and PsycINFO for studies of children and adolescents with CFS/ME and validated measures of depression and/or anxiety. Combined with previous reviews, 16 studies and 965 participants were included; follow-up ranged from immediately post-treatment to 21 years. Treatments included CBT, the Lightning Process, valacyclovir, pacing, gammaglobulin, placebo, and inpatient or specialist care programmes. An RCT compared Lightning Process plus specialist medical care with specialist medical care alone; the review reports adjusted mean differences in depression and anxiety scores at 6 and 12 months, for example depression −1.5 (−3.5 to 0.5, 0.1) at 6 months and −1.8 (−3.4 to −0.1, 0.04) at 12 months. An observational cohort of routine specialist care measured depression and anxiety at baseline but not post-treatment. CBT-type interventions had most evidence for improving comorbid anxiety and/or depressive symptoms, but delivery and modality varied. A trial reported a deterioration in school attendance in the pacing arm. The review reports insufficient evidence to draw conclusions, and no study specifically targeted depression or anxiety. The authors state the evidence is poor and insufficient for meta-analysis.
- A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Covid?2021 · systematic review
Summary
This mixed-methods systematic review asked whether post-viral fatigue interventions offer lessons for long Covid. Online databases were searched in October 2020, and 40 papers were selected. The included fatigue interventions involved 25 studies in CFS/ME, nine in fibromyalgia and eight in unexplained fatigue. Treatments varied widely and were compared with controls, typically usual care or waiting lists; fatigue severity was the main outcome. Intervention duration varied and is not quantified in the recorded data. The review reported mean differences for several interventions. The largest mean difference was for the Three Principles/Innate Health programme (MD -39.0, 95% CI -51.8 to -26.2, SMD = 1.670). Group-based CBT also showed reductions (MD -27.5, 95% CI -33.7 to -21.3, SMD = 1.170; MD -23.7, 95% CI -29.2 to -18.2, SMD = 2.266). Smaller mean differences were reported for GET (MD -11.5, 95% CI -17.6 to -5.4, SMD = 0.524) and self-regulation based physical activity (MD -9.9, 95% CI -16.3 to -3.4, SMD = 0.513). TENS (MD -6.0, 95% CI -16.9 to 4.9, SMD = 0.239), Tai Ji Quan (MD -0.4, 95% CI -9.6 to 8.9, SMD = 0.023) and supportive listening (MD 1.06, 95% CI -1.4 to 3.6, SMD = -0.111) showed little or no benefit. Doxycycline mean differences were positive (MD 6.3, 95% CI 3.7 to 8.8, SMD = -0.752; MD 8.75, 95% CI 6.36 to 11.14, SMD = -1.120). No side effects, withdrawals or worsening were reported in the recorded data.
- Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.2021 · systematic review
Summary
This systematic review examined the cost-effectiveness of interventions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). It included 10 economic evaluations based on randomised controlled trials; searches covered MEDLINE (1946–2020) and EMBASE (1974–2020). The included evaluations examined CBT, GET, counselling, specialist medical care, adaptive pacing, guided support groups, fatigue self-management, treatment as usual, pragmatic rehabilitation, supportive listening and the lightning process, alone or with other care. Study sizes ranged from 100 to 640 participants. Outcomes were costs and health effects such as QALYs or fatigue scores. In the largest trial, CBT had a 59.5% likelihood of being cost-effective versus GET (34.8%), specialist medical care (5.5%) and adaptive pacing (0.2%) at £30,000 per QALY. One trial reported CBT was dominated by counselling for cost per improved fatigue score. GET versus CBT had an incremental cost of £193 and incremental effect of 0.71. GET was more cost-effective than usual care plus self-help booklet above £987 for a clinically significant fatigue improvement. For the lightning process plus specialist medical care, incremental cost was £390 and incremental effect 0.095 QALYs, with £1508 incremental net monetary benefit. Side effects and withdrawals were not reported.
- Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review.2018 · systematic review
Summary
This systematic review asked whether interventions for medically unexplained symptoms (MUS) or functional somatic syndromes (FSS), including fibromyalgia, irritable bowel syndrome and chronic fatigue syndrome, are cost-effective. The search covered PubMed, PsycINFO, NHS-EED and the CEA registry to 15 June 2018 and included 39 full economic evaluations in adult patients. Interventions varied: group CBT, individual CBT, graded exercise therapy, adaptive pacing therapy, multidisciplinary rehabilitation, counselling, educational and pharmacological treatments. Comparators included usual care, waiting lists, other physical or psychological treatment and other drugs. Outcomes were incremental costs, incremental effects and ICERs, using QALYs or clinical scales. Results differed by study: in CFS, CBT and GET dominated specialist medical care on average, with ICERs of €24,475 and €31,456 per QALY; APT had an ICER of €73,576 per QALY and SMC was preferred over APT for all outcomes. MRT appeared not cost-effective compared with CBT. In fatigue, graded exercise had an ICER of €1,377 per unit of clinically significant improvement on the Chalder Fatigue Scale, and counselling was dominated by usual care plus a self-help booklet. No side-effect or withdrawal counts were recorded. The authors state language restrictions and limited comparability; they describe heterogeneity across the included studies.
- Treatment for paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) and comorbid depression: a systematic review.2016 · systematic review
Summary
This systematic review asked which treatments for depression are effective in children and young people with CFS/ME, and whether comorbid depression affects outcome. MEDLINE, EMBASE, PsycInfo and the Cochrane library were searched in February 2015; 9 studies met the inclusion criteria. No study specifically tested a treatment for paediatric CFS/ME with depression, and no study stratified outcome by depression severity. Included studies examined CBT-based rehabilitation (up to 15 hourly sessions; n=23), telephone CBT guided self-help (6 fortnightly 30-minute sessions; n=63, 52 at follow-up), 4-week multicomponent inpatient programmes (n=39, 19 at follow-up; n=16; RCT n=22 comparing aerobic and resistance training), and valacyclovir (n=15, 14 at follow-up; treatment 3 to 60 months, mean 27.9 months). Depression and fatigue were measured. There was no overall comparison group; the included RCT compared aerobic with resistance training. Chalder et al reported depression significantly improved; Denborough et al reported mean BDI was 21 pretreatment and 15 post-treatment and improvement maintained at 6-month follow-up; Gordon and Lubitz reported significant improvement in BDI and Fatigue Severity scores; both RCT arms improved in BDI; Lloyd et al reported improvements in depression at 6 months; Henderson et al reported depression symptoms decreased in depressed and non-depressed patients and all patients reported at least 80% self-rated improvement. Kawatani et al found no significant improvement in fatigue at 6-month follow-up; mood was not reassessed. Reported concerns included that SSRIs can increase suicidality and that exercise could exacerbate symptoms in patients with CFS/ME; Denborough et al reported internalising problems escalated above preadmission levels.
- Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.2013 · systematic review
Summary
This systematic review searched CINAHL, PsycINFO and Medline to May 2012, with a limited update in October 2012, for studies of interventions in children and adolescents with CFS/ME. It included 24 articles based on 21 studies, with variable designs and quality. In Wright (2005), 13 participants were randomized to a structured tailored incremental rehabilitation program or pacing; the review reports improvements in activity and school attendance with the program immediately after treatment compared with pacing. Viner (2004) reported 43% of the treatment group had complete resolution of CFS/ME compared with 4.5% with supportive care. Lim (2002) reported that before an inpatient program 94% attended school less than half-time, and 78% attended full-time or with occasional absences only at follow-up. Szyndler (2003) reported problem improvement or resolution in 31% by clinician rating and 86% by family rating. Van Geelen (2010) reported 52% nearly complete improvement and 48% no improvement. For harms, Rowe (1997) reported adverse effects common, and Nijhof (2012) reported no serious adverse events. The authors state that methodological inadequacies and inconsistent approaches limit interpretation.
- Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.2006 · systematic review
Summary
This updated systematic review asked whether any intervention is effective for treatment, management or rehabilitation of adults and children with CFS/ME. The authors searched eleven electronic databases and included 70 studies, of which 59 were RCTs; comparisons were between treatment and control groups. Interventions included CBT, GET, rehabilitation, immunological and pharmacological treatments, supplements and complementary therapies. Outcomes covered physical, psychological, laboratory/physiological and quality-of-life measures. CBT and GET appeared to reduce symptoms and improve function based on RCTs. In a CBT trial (n=69), physical functioning, fatigue and symptoms favoured CBT (P<0.003) and school attendance favoured treatment (P=0.04). Another CBT trial (n=65) found no significant difference for fatigue, anxiety and depression, or disability. In GET trials, CGI and fatigue favoured treatment (n=49; P<0.03), and fatigue and depression/anxiety were significantly better (n=61; P=0.027). One GET trial reported withdrawal of one patient in each group because of worsening symptoms; eleven patients withdrew because of adverse events in a GET with or without fluoxetine trial. Galantamine (n=434) showed no significant differences; 130 patients withdrew, 389 reported adverse events and 88 withdrew. Acetyl-L-carnitine and propionyl-L-carnitine (n=90) improved general fatigue in PLC (P=0.004) and combined group (P<0.001), and mental fatigue in ALC group (P=0.015); 8 patients withdrew due to side effects. Staphylococcus toxoid (n=98) had 13 treatment-group and 7 placebo-group patients with side effects. Hydrocortisone/fludrocortisone (n=80) found no significant differences.
- Resveratrol for Post-COVID-19 Cognitive Dysfunction: From Molecular Basis to Clinical Translation.2026 · review
Summary
This paper is a focused narrative review, not a clinical trial. The authors searched PubMed, Scopus and Web of Science through to May 2026 for evidence on whether resveratrol could treat post-COVID-19 cognitive dysfunction, described as brain fog. No participants were enrolled or treated in this work, and the authors state that "no randomized trial has tested its cognitive benefit in the intended population." The review describes other studies, including a 52-week randomized placebo-controlled trial in 119 participants with mild-to-moderate Alzheimer's disease, where dosing escalated from 500 mg once daily to 1000 mg twice daily, resveratrol and its metabolites were measurable in plasma and CSF, and nausea, diarrhea and weight loss were the most frequent adverse events. In acute COVID-19, a phase 2 outpatient trial in 100 evaluable participants reported hospitalization in 2% and 6%, emergency-department visits in 8% and 14%, and pneumonia in 8% and 16%, with "No clinically significant adverse event was attributed to resveratrol." A 24-month crossover trial in 125 postmenopausal women reported a 33% improvement in overall cognitive performance compared to placebo. The authors state that the review was not designed as a systematic review, that no formal meta-analysis, duplicate independent screening, or standardized risk-of-bias assessment was performed, and that the approach may therefore be subject to selection bias and may not capture all relevant studies.
- Mapping the occupational therapy process in response to COVID-19 and long COVID: A scoping review.2026 · review
Summary
This scoping review asked what occupational therapy process was reported for people with COVID or long COVID; no ME/CFS was mentioned. Three databases were searched for papers published 2020–2023 in English, Portuguese or Spanish. From 455 texts, 25 studies were selected, spanning children to older adults and settings from intensive care to community and telehealth; inpatient hospital units were most frequent. The review mapped evaluation, intervention and outcomes. Standardised assessments covered occupational history, activity limitations, body functions, cognition and emotional regulation; interventions were educational, compensatory, restorative or acquisitional. Findings were reported study by study; intervention duration was not reported. Jung et al. reported time-use occupational therapy was greater than control for occupational balance, QoL and mental health, p < 0.001. Rodrigues et al. reported experimental and control groups both had less fatigue and anxiety; the experimental group also had more well-being and less shortness of breath, ES small to medium. Trzmiel et al. and Zasadzka et al. reported both groups improved significantly but no difference between groups. Pre–post and cohort reports included less depression with online CBT; less dyspnoea and more QoL/endurance with telerehabilitation; 75% had more function; 86% were discharged from hospital; and 56 of 122 (46%) were fully rehabilitated. Case studies reported better ADL, mobility, strength, problem-solving, sleep, fatigue management or return to work; a case study reported no difference in leisure. No harms were recorded.
- Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities.2026 · review
Summary
This narrative review used pragmatic methods and searches up to January 2025 to map candidate treatments for long COVID that clinicians and people with lived experience prioritised. No participant total for the review itself was reported. Evidence was summarised across intervention groups. A moderate-quality RCT of 155 participants found no significant improvement with Paxlovid. In a non-randomised controlled trial of fexofenadine plus famotidine, 14 patients were in the treatment group and 13 in the control group; 29% of treated patients had complete resolution of long COVID symptoms, and all treated patients showed significant improvement in fatigue, brain fog, abdominal disorders, and increased heart rate compared with controls. A single case report found eight out of 12 reported improved cognitive abilities with guanfacine plus N-acetylcysteine; four patients discontinued therapy, two for unspecified reasons and two due to hypotension and/or dizziness. A pilot RCT of 13 participants found active taVNS (n = 8) improved fatigue, mood, and cognitive symptoms compared with sham (n = 5), with no serious adverse events observed. A small RCT found no significant differences with 700 mg leronlimab. Two RCTs did not report any benefit from CoQ10. A case study of 4 participants reported symptom improvements up to 6 months after nicotine patches 7.5 mg per day for 7 days. Five RCTs reported multicomponent interventions improved quality of life and dyspnoea, with no strong evidence for other symptoms; 16 RCTs examined exercise training.
- Digital Interventions Addressing Cognitive and Psychological Symptoms in Long COVID: Scoping Review of Multicomponent Approaches.2026 · review
Summary
This scoping review examined digital interventions for cognitive and psychological symptoms in people with long COVID. It included 25 (2.82%) records identified through a database search between December 2024 and February 2025. The records covered telehealth or telerehabilitation, virtual reality, mobile health apps, online psychological therapies, game-based cognitive training, neuromodulation (transcranial direct current stimulation), and multicomponent programs. No comparison was required for inclusion; comparators were reported when present. Outcomes concerned attention, memory, executive function, depression, anxiety, fatigue, and well-being. Reported effects were mixed. Telehealth or telerehabilitation records were summarized as improvements in quality of life, mental health (anxiety and depression), and self-efficacy, with mixed effects on cognition. Virtual reality records were summarized as enhanced emotional well-being and physical functioning, inconsistent effects on cognition, and some usability issues; some users reported side effects such as dizziness and headaches. Mobile health app records were summarized as gains in attention, mood, and self-reported recovery. Online psychological therapy records were summarized as decreased anxiety, posttraumatic stress disorder, and depression and high feasibility and acceptability. Game-based cognitive training was summarized as improved processing speed and task-switching and no sustained improvement in attention. Neuromodulation was summarized as enhanced cognition, mood, and energy levels in a small-scale pilot study. Multicomponent programs were summarized as broad improvements across mental health, cognitive symptoms, and physical activity. The authors state limitations including small sample sizes, lack of control groups, heterogeneity in outcomes and intervention protocols, and short follow-up durations, plus underrepresentation of older adults and underserved populations.
- Assessment and management of post-COVID-19 pulmonary complications: a rapid review.2026 · review
Summary
This rapid review assessed evidence on management and treatment of pulmonary complications in post-COVID-19 condition (PCC). It included 73 unique records from published and grey literature; these comprised guidance documents, secondary studies and primary research studies. Included primary studies involved adults with PCC and pulmonary complications, with individual study sizes that included 28 and 871 participants. Interventions included IHHT plus standard rehabilitation, nirmatrelvir plus ritonavir, hyperbaric oxygen, systemic corticosteroids, and multicomponent exercise rehabilitation. Comparisons included standard rehabilitation, placebo plus ritonavir, sham treatment, nonsteroid care, and usual care or control. Outcomes included 6MWT distance, Borg and PROMIS dyspnoea, RAND-36 physical function, FEV1, FVC, FVC % pred, resting oxygen requirement and adverse events. Doehner 2024 reported a significant between-group difference in 6MWT distance favouring IHHT plus rehabilitation (p<0.001). Geng 2024 found no between-group difference in PROMIS dyspnoea (p>0.05). Kjellberg 2025 found no difference in RAND-36 physical function (p=0.277) or 6MWT distance (p=0.62) with hyperbaric oxygen versus sham. Ntiamoah 2024 reported significant improvements in FEV1, FVC and FVC % pred in the steroid group only. Torres 2024 reported FVC % pred improved from 52±0.17% to 60±0.20% (p=0.019) and resting oxygen requirement reduced (p=0.005), with no significant change in 6MWT distance (p=0.50). Seo 2025 reported diarrhoea in 80% of patients with nintedanib; Ora 2023 reported no adverse events with sodium pyruvate nasal spray. The authors state study quality and risk of bias were heterogeneous and findings should be interpreted with caution.
- Role of Occupational Therapy for Persons Experiencing Long COVID: A Rapid Review.2026 · review
Summary
This rapid review examined the role of occupational therapy for adults and older adults with long COVID across the healthcare continuum. It included Twenty-one articles. The review reports no comparison group and was not randomised. Reviewed occupational therapy interventions were mainly delivered in rehabilitation settings and included retraining in activities of daily living, cognitive rehabilitation, physical and breathing exercises, patient education, return-to-work planning, and psychosocial support. One included trial randomised 64 participants to two groups (n = 32 in each group) and reported that a telerehabilitation exercise program resulted in greater improvements on perceived physical exertion at rest and after physical activity. In another included study, post-course participants reported 53.9% improved health state, 7.9% no change, 10.5% worse health state, and 22.4% mixed change. In a telerehabilitation cohort of 34 enrolled, 30 completed; 63% still experienced post-exertional malaise, only four participants were able to work full-time, and fatigue and health-related quality of life did not statistically or clinically meaningfully improve. An energy management study of 17 participants found the SF36 mental component showed no significant changes. The authors state limitations including potential to miss articles, most studies from North American and European countries, and that most studies were pilot, feasibility, and case studies that lacked power and were heterogeneous.
- Return-to-work for people living with long COVID: A scoping review of interventions and recommendations.2025 · review
Summary
This scoping review asked which interventions may support return-to-work (RTW) or work ability in people living with Long COVID. The authors searched five electronic databases and grey literature up to January 3, 2025, and included 19 intervention studies and 12 clinical practice guidelines; study designs included cohort, quasi-experimental, observational, interventional, RCT and case-report designs. No comparison group was analysed. Interventions included multimodal and interdisciplinary work-focused rehabilitation, psychoeducation, pacing, breathing strategies, cognitive rehabilitation and workplace RTW planning, plus enhanced external counterpulsation, CICT and pulsed electromagnetic field therapy. Reported durations included a 3-day concentrated program, a 36-hour CICT intervention, and follow-up at six months and one-year. Findings varied: some studies reported improvement in workability, sick leave, fatigue, functional status, cognitive function or RTW; others reported no RTW improvement (Derksen et al. 2023), no significant overall RTW enhancement with physical conditioning (Hasenoehrl et al. 2023), 72% still unable to RTW after rehabilitation (Muller et al. 2023), and a 2% RTW improvement with a psychotherapy-based inpatient program (Kupferschmitt et al. 2023). The review states that graded exercise is contraindicated for people with PEM and that interventions ignoring PEM risk worsening fatigue.
- Rehabilitation interventions and outcomes for post-COVID condition: a scoping review.2025 · review
Summary
This scoping review asked which rehabilitation interventions and outcome measures are used for post-COVID-19 condition (PCC). It searched CINAHL, EMBASE, MEDLINE, PsychINFO, CENTRAL and Scopus from inception until 22 January 2024 and included 74 studies of adults or children with PCC. It did not test one treatment against a comparison group; it mapped intervention components and outcomes across the included studies. Most interventions combined education, exercise and therapies and were multidimensional; durations varied. Outcomes covered fatigue, postexertional malaise, health-related function and quality of life, mental health, cognitive function and memory, dyspnoea, muscle strength and aerobic endurance, and balance, gait and coordination. The review did not report a pooled treatment effect. For harms, 26 of the 74 included studies reported adverse events; of these, 7 reported intervention-induced adverse events. The most common intervention-related adverse events were dizziness (2 studies) and postexertional symptom exacerbation (2 studies); two studies reported respiratory reinfection. The Limitations section states that 48 of the 74 included studies did not report adverse events and that, of the 21 studies that did report, only 7 reported an occurrence. The authors call for improved reporting on intervention adherence and for comprehensive, multifaceted rehabilitation interventions that address the full spectrum of PCC manifestations.
- A Comprehensive Scoping Review on Diet and Nutrition in Relation to Long COVID-19 Symptoms and Recovery.2025 · review
Summary
This scoping review synthesized 50 studies (27 intervention and 23 observational) in adults with long COVID-19, identified through database and manual searches. The review itself had no comparison group and no meta-analysis. Included studies examined vitamin D, multinutrient/nutraceutical formulations, amino acids and metabolic support, creatine, oxaloacetate, nitric-oxide boosters, gut microbiota-targeted therapies, and diet/lifestyle programs; comparisons included placebo, controls, or another formulation. Examples reported: in 80 people with post-COVID-19 syndrome, weekly vitamin D improved fatigue (p = 0.024), anxiety (p = 0.011), and cognitive function (p = 0.012), with no effects on depression, sleep quality, or inflammatory markers. A single 200,000 IU vitamin D3 dose in 144 hospitalized patients showed no benefit on persistent symptoms or quality of life. Magnesium plus vitamin D improved depression (73.2% vs 34.5% remission, p = 0.006). PIRV-F20 in 44 long COVID-19 patients improved six-minute walking distance (+40 m vs +10 m, p = 0.02) but not strength or symptoms. Noni in 188 post-COVID-19 patients reduced fatigue (61.5% vs 24.3%), cognitive symptoms (59.4% vs 21.6%), and joint pain (66.2% vs 33.8%). SIM01 in 463 individuals alleviated core symptoms (all p < 0.01). Beetroot juice in 31 patients showed no significant between-group differences. Side effects and withdrawals were not reported in the recorded data. The authors state no formal quality appraisal was performed and causal inferences cannot be made.
- Interventions for Long COVID: A Narrative Review.2025 · review
Summary
This narrative review synthesized evidence from 97 studies (n=8260, 103 publications) on interventions for common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues. The review included randomized and non-randomized studies and compared medications, rehabilitation, behavioral and mind-body programs, supplements, complementary treatments, and COVID-19 vaccination with placebo, usual care, no treatment, or other active comparators. For vortioxetine versus placebo, one RCT (n = 141) reported a significant reduction in depression symptoms (adjMD of −1.52; 95% CI −2.85 to −0.19) and improvement in quality of life (WHO-5, adjMD of 2.36; 95% CI 0.77 to 3.94), with mixed cognitive results. An RCT of “Fit after COVID” CBT (n=114) reported improvement in fatigue (CIS-fatigue: MD −8.8; 95% CI −11.9 to −5.8), cognitive impairment (CIS-concentration: MD −5.1; 95% CI −6.9 to −3.4), and physical function (SF-36-Physical Health: MD 7.1; 95% CI 2.9 to 11.3). Hyperbaric oxygen therapy (n=73) improved fatigue (SF-36 energy subscale, 18.2 vs 6.0, p=0.029) and sleep quality (PSQI, 8.1 vs 9.2, p=0.042) versus sham. Transcranial direct current stimulation (n=47) reduced physical fatigue (MFIS-Physical: p=0.034) but not overall fatigue (MFIS-Total: p=0.184). A COVID-19 vaccine study (n=453) found no statistically significant difference in fatigue, depression, or sleep quality. Adverse events included treatment-related reactions with vortioxetine (26.8% vs. 22.1%), non-serious adverse events with AXA1125 (RR 2.62, 95% CI 1.00 to 6.89), and similar adverse event rates with SIM01 (10% vs. 11%; p=0.63).
- Pharmacologic and Nonpharmacologic Treatment of Long COVID: A Meta-narrative Review2025 · review
Summary
This meta-narrative review evaluated pharmacologic and nonpharmacologic treatments for long COVID, defined as persistent symptoms 4 weeks or longer after acute COVID-19. The authors searched English-language articles from November 2019 through December 2023 and included 51 studies. Most included studies reported nonpharmacologic treatments, with fatigue the most prevalent symptom. Interventions described included therapeutic exercise, nutritional supplements, oxygen-ozone autohemotherapy, rehabilitation, molecular hydrogen therapy, hyperbaric oxygen, epipharyngeal abrasive therapy, Qingjin Yiqi granules, pomegranate juice with sumac, remdesivir, antibody-based therapies, and intranasal corticosteroids. Findings varied by study: some reported improvements in fatigue, dyspnea, cognitive symptoms, chest pain, immunodeficiency, or olfactory dysfunction. The review also reported no significant reduction in number or severity of long COVID–related symptoms with high-dose CoQ-10 compared with placebo; no significant difference in symptoms and mortality risks between nirmatrelvir/ritonavir and no treatment groups; smell score differences not statistically significant with corticosteroid nasal irrigation; and no effect of olfactory training on olfactory test scores. In Pehlivan et al., 6 cases were dropped for several reasons. The authors state the evidence is limited and of low quality.
- Post-Acute Sequelae of SARS-CoV-2 Infections: Exercise Limitation and Rehabilitation.2024 · review
Summary
This review considered studies of exercise limitation and rehabilitation in post-COVID/long COVID and ME/CFS; the literature search used PubMed, Google Scholar, and Embase and excluded preprints and case reports. In Bouteleux et al. (2021), rehabilitation in 39 patients with COVID-19 infection and persistent dyspnea was followed by significant improvement in dyspnea but no change in fatigue; 6-minute walk distance increased, hyperventilation syndrome frequency decreased, and quality of life improved, while anxiety and depression persisted. Colas et al. (2023) compared 38 patients in each group in a 4-week exercise rehabilitation program; each group had increases in VO2 at anaerobic threshold, peak VO2, and hand grip force, COVID-19 patients had larger increases in peak VO2 than patients with coronary disease, and autonomic variables did not significantly change in any group. Hausswirth et al. (2023), a randomized controlled trial with 34 patients with long COVID (17 intervention, 17 control), reported that a neuro-meditation program improved responses on all questionnaires in the intervention group. Pouliopoulou et al. (2023) included 14 trials with 1244 patients: seven trials with 389 participants reported improved functional exercise capacity based on 6-minute walk tests, with an increase of 35.8 ± 6.6 meters; eight trials with 573 participants reported significant changes in dyspnea; five trials with 366 participants reported significant improvement in quality of life; FEV1 or FVC showed no significant changes. The review stated that routine rehabilitation can cause significant post-exertional malaise and contribute to chronic fatigue in patients with moderate to severe ME/CFS.
- Cardiovascular abnormalities of long-COVID syndrome: Pathogenic basis and potential strategy for treatment and rehabilitation.2024 · review
Summary
This review summarized cardiac symptoms and management of long-COVID syndrome; it reports no own cohort size or study location. For exercise-based rehabilitation, the review cites a meta-analysis on 14 randomized clinical trials involving 1 244 patients with long-COVID, reporting that a standardized rehabilitation intervention was associated with improved functional exercise capacity. It also describes an 8-week supervised home-based respiratory muscle training program, after which patients had improved quality of life measured, forced spirometry measurements, improved respiratory muscle function, and improved lower limb muscle strength. The review states that guided exercise training may also counteract long-COVID symptoms with improvement in cardiopulmonary fitness, functional status, and quality of life, and that recumbent or semi-recumbent exercises such as rowing and cycling are recommended. It notes postexertional malaise (PEM) is present in 30% of patients with long-COVID and that PEM is characterized by worsening symptoms after physical activity that could last for days to weeks. The review states there is still no evidence-based guideline available for the management of cardiovascular complications of long-COVID.
- Reporting of pre-existing multiple long-term conditions in physical rehabilitation for long COVID: a scoping review.2024 · review
Summary
This scoping review asked how studies of physical rehabilitation for adults living with long COVID report pre-existing multiple long-term conditions (MLTCs). The authors searched databases from 1 January 2020 to 11 July 2023 and included 50 articles. The review did not test a treatment or compare groups; it mapped reporting. The authors state there is limited and inconsistent reporting of the presence of MLTCs in studies of physical rehabilitation for adults with long COVID. No treatment effects, side effects, or withdrawals are reported for this review. The authors note as a limitation that MLTCs were considered a “single entity,” which they say is important because MLTCs are heterogeneous and this has implications for tailoring physical rehabilitation interventions.
- Effects of transcranial direct current stimulation on COVID-19 neurological symptoms: a mini-review2023 · review
Summary
This mini-review searched MEDLINE via PubMed and Cochrane databases for long COVID and non-invasive brain stimulation and included two case-report articles on tDCS. The cases were a 58-yearold man and two referred female participants with long COVID and cognitive symptoms. Gómez et al. (2021) described daily tDCS; after the final session, his HARS, HDRS, and MFIS scores showed a clinically significant decline from the initial session, and he reported feeling better, worrying less, and improvements in anxiety symptoms and cognitive and physical functioning. Eilam-Stock et al. (2021) described a remotely supervised tDCS protocol paired with physical exercise, online adaptive computerized cognitive training, and guided mindfulness meditation; both participants reported improvement across physical, cognitive, emotional, and functional domains. The review states no control groups were used, the studies had methodological differences, and the sample size is insufficient to draw definitive conclusions. Side effects and withdrawals were not reported. The authors conclude that more data are needed on efficacy and optimal implementation and that randomized trials compared with sham stimulation might help.
- Exercise Training in Non-Hospitalized Patients with Post-COVID-19 Syndrome-A Narrative Review.2023 · review
Summary
This narrative review summarized seven studies of exercise interventions in adults with post-COVID-19 syndrome (PCS), identified through MEDLINE and Scopus. Interventions included exercise training, pulmonary rehabilitation, digital physiotherapy, and blended community-based rehabilitation; reported program lengths included 6 weeks and 4 weeks. Some trials compared exercise with self-management rehabilitation recommendations or inspiratory muscle training. Outcomes included VO2max/VO2peak, maximal workload, 6MWT, SPPB, DASI, SF-12, EQ-5D-5L, and PCFS. Estimated VO2max increased by 2.1 mL/kg/min in EX and by 2.9 mL/kg/min in CT and 2.5 mL/kg/min in CTRM, with no changes in the control groups. VO2peak improved by 2.4 mL/kg/min; maximal workload by 21.8 W after 6 weeks of pulmonary rehabilitation; 6MWT by 68.9 m and 57.6 m; SPPB by +1.22 points after 4 weeks of digital physiotherapy. DASI and EQ-5D-5L increased. SF-12 physical domain showed a group effect from 35.7 to 47.8, while CT, CTRM, and RM showed pre–post increases without between-group differences; mental health increased in CTRM only from 39.5 to 44.8. PCFS < 2 changed from 3 to 14 with CT. No adverse events were reported. Dropouts were n = 6, n = 4, n = 1, and n = 3 in named studies; reasons included adherence problems, personal issues, injury and sickness, SARS-CoV-2 reinfection and fear of reinfection. Authors state no risk-of-bias and quality assessment was performed; they assume high risk of bias and low quality; heterogeneity was broad.
- Digital Interventions for Treating Post-COVID or Long-COVID Symptoms: Scoping Review.2023 · review
Summary
This scoping review asked what evidence-based digital interventions exist to help manage physical and mental health in people with post-COVID/long-COVID symptoms. The search took place between May and July 2022 in Proquest, Ebsco, PubMed, PubPsych, and Scopus, and 8 original studies matched inclusion criteria. The studies included adults from Ireland, the United Kingdom, Chile, Greece, China, and Austria; samples were 27 (21 for analyses), 150 (115 completed), 11, 10 (8 at all measurement points), 149 (76 pre-post measurements), 35 (22 completed), 120 (105), and 7. Interventions included online breathing/vocal sessions, telerehabilitation exercise programs, a 7-week online rehabilitation course, a fatigue app, and online peer-support groups. Most studies had no control group; one randomized controlled trial compared intervention with control. Outcomes included breathlessness, fatigue, physical capacity, quality of life, anxiety/depression, and patient experience. Some studies reported improvements in breathlessness, physical capacity, fatigue, pain, anxiety, and some quality-of-life domains; the randomized trial reported 6-min walking distance increases of 17.1 m in the control group and 80.2 m in the intervention group, and 90.4% versus 61.7% dyspnea free without long-term effects. Other outcomes did not improve, including bowel, bladder, concentration, short-term memory, unpleasant dreams, balance, gait speed, and some mental-health domains. Dropouts ranged from 0%-20% in pretest studies to 23%, 37%, 13%, and 49% in other studies. Negative emotions and uncertainty about peer advice were reported.
- Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.2021 · review
Summary
This narrative review asked how long COVID is characterised and what treatments might apply, noting limited literature on pathophysiology, risk factors and treatment. It searched PubMed, with the last search on 5th February 2021 and a brief update on 15th April 2021; no review-level numbers enrolled, started or analysed are reported. The reviewed studies concerned discharged COVID-19 patients with on-going symptoms, elderly COVID-19 survivors, and COVID-19 survivors with palpitations or tachycardia. A personalized multidisciplinary rehabilitation approach involving breathing, mobilisation and psychological interventions was reported in 23 discharged patients; lung function and physical capacity improved, but most participants' lung function did not heal completely and persistent neurological symptoms remained. A case series of seven discharged patients reported combined breathing and light exercise rehabilitation healed and improved fatigue symptoms in five and two cases, respectively. One RCT of 72 elderly survivors reported that a 6-week rehabilitation program involving breathing, stretching and home exercises improved lung function, exercise capacity, quality of life and anxiety, but not depression. A small study of 24 survivors with palpitations or tachycardia reported ivabradine relieved racing heart rate compared with carvedilol. An international survey found 85.9% of participants with long COVID experienced symptom relapse after mental or physical activities. The review also states GET and CBT may pose potential harm in some instances and rehabilitation may not be suitable for critical COVID-19 survivors with severe pulmonary or cardiac damage. The authors call for future research on repurposed drugs.
- Long Covid — Pathophysiology and Treatment2021 · review
Summary
This review examined long COVID pathophysiology and treatment. It did not conduct a primary study, so the number enrolled and analysed in this paper is not reported; the setting is not reported. The review discusses rehabilitation and other interventions. It reports a study by Daynes of 30 patients with long COVID given a six weeks rehabilitation programme with two supervised sessions per week; patients' aerobic capacity improved and no serious adverse events were recorded. It also cites a study [35] of CFS patients undergoing a physical activity programme based on aerobic physical activity, in which a Fifty one percent dropout rate was noted due to post-exertional malaise (PEM). A yet not peer-reviewed small study [37] suggested that AstraZeneca and Pfizer-BioNTech vaccines were related with overall improvements in symptoms in long COVID patients. The review states there is no proven treatment for long COVID. It notes no clear data on the natural course of COVID 19 and pathophysiology mechanism leading to long COVID. It also states that physical exercise programme in ME/CFS might be deleterious to some patients.
- Patients' experiences and effects of non-pharmacological treatment for myalgic encephalomyelitis/chronic fatigue syndrome - a scoping mixed methods review.2020 · review
Summary
This scoping mixed methods review asked what non-pharmacological treatments for ME/CFS do and what patients find important. It identified 16 papers from European studies, searching January 2009 to January 2019 and updating to 18 March 2020. Effect studies examined CBT, activity pacing and multidisciplinary rehabilitation including CBT and GET; qualitative studies examined CBT, GET self-help, self-management education, multimodal specialist care and the Lightening Process. CBT findings included reduced fatigue: Janse et al. reported 43% in iCBT groups reached normal fatigue vs 15% in waiting-list controls; Nijhof et al. reported school attendance 84% vs 51%, and 75% vs 16% reached full attendance at 6 months; Tummers et al. reported 33% vs 9% with clinically reduced fatigue in one study. Activity pacing and rehabilitation effects were inconsistent; Nunez et al. found worse SF-36 pain scores after 1 year in the rehabilitation group. Pinxsterhuis et al. found no group difference in physical functioning after 6 or 12 months. Janse et al. reported no serious adverse events; Cheshire et al. reported some felt worse with GET. The authors state CBT relieved fatigue but long-term effects need more investigation, and activity-pacing and rehabilitation studies are scarce with inconsistent effects.
- Management of chronic fatigue syndrome/myalgic encephalomyelitis in a pediatric population: A scoping review.2020 · review
Summary
This scoping review examined peer-reviewed research on managing chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in a pediatric population aged under 18 years. The authors searched electronic databases and included 29 peer-reviewed research articles; no new participants were enrolled. The review grouped findings under nutrition/dietary components, exercise therapy, psychosocial factors, and multifaceted treatment. Included studies evaluated CBT with biofeedback, the Lightning Process plus standard medical care, aerobic graded exercise versus progressive resistance training, graded activity/exercise with family sessions, dietary changes, pacing versus STAIRway to Health, and other programs. Outcomes included fatigue severity, school attendance, physical function, anxiety and depression, quality of life, and global health. The review reports that included studies found lower fatigue severity and higher school attendance with CBT plus biofeedback, improvement with Lightning Process plus standard medical care, and no significant difference between aerobic graded exercise and progressive resistance training for physical capacity and QOL, while fatigue and depressive symptoms improved only in the aerobic group. No harms, side effects, worsening or withdrawals were reported in the recorded data. The authors state a lack of research in younger children and insufficient evidence for dietary modifications or supplements in prepubescent children.
- Child and adolescent chronic fatigue syndrome/myalgic encephalomyelitis: where are we now?2019 · review
Summary
This review examined recent evidence on CFS/ME in children and young people, including impact, treatment and prognosis. It reported no enrolment, follow-up or treatment-duration figures for its own study and did not set out a search date or number of included studies. The review described PACE, an adult randomized controlled trial, as comparing SMC alone with SMC plus APT, CBT or GET; PACE demonstrated that CBT and GET added to SMC performed better as outpatient treatments than APT added to SMC or SMC alone. GETSET, an adult self-help graded exercise trial, reported that guided self-help added to SMC had a moderate effect on fatigue but less effect on physical functioning for those waiting for clinic therapy. In children and young people, five systematic randomized controlled trials demonstrated benefit from CBT treatment, while there was little evidence for GET. Burgess et al. reported improved physical functioning and social adjustment after a home-based, family-focused rehabilitative approach for severely affected housebound adolescents, but no substantial improvements in fatigue in all participants. Crawley et al. reported the Lightning Process plus SMC compared with SMC in mildly and moderately affected adolescents. A large online CBT trial was described as in progress. GETSET identified no serious adverse reactions in self-help GET in adults with CFS/ME. No withdrawal data were reported. The authors stated that current evidence is hampered by different diagnostic criteria, the heterogeneous nature of the condition, and limited number of small studies; they also stated that the evidence base in CYP is more limited.
- Cognitive behavioural therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective. Re-analysis of a Cochrane review.2019 · review
Summary
This paper is a re-analysis of the Cochrane review of cognitive behavioural therapy (CBT) for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); no new participants were recruited. It examined seven randomised controlled trials of CBT for CFS with 820 participants, plus additional studies. In the included trials, CBT was compared with relaxation, counselling, no treatment, waiting list, or other controls. Outcomes included fatigue, physical functioning, 6-minute walk test, step test, work/employment status, quality of life, and dropouts/missing data. The authors report that CBT only leads to a small, short-lived subjective improvement of fatigue in 14 per cent of patients, not matched by objective improvement; they state that seven patients need to be treated for one to report this improvement. Quality-of-life scores did not improve. Most studies in the Cochrane review failed to report safety or adverse reactions; patient evidence suggests adverse outcomes in 20 per cent of cases, and after treatment in NHS CFS clinics 26.8 per cent reported deterioration. Dropouts and missing data were high in several trials. The authors conclude that CBT should be downgraded to adjunct support-level therapy rather than a treatment for ME/CFS. They state that flaws in the review and trials created a bias in favour of the intervention.
- Multidisciplinary rehabilitation treatment is not effective for myalgic encephalomyelitis/chronic fatigue syndrome: A review of the FatiGo trial.2018 · review
Summary
This review re-analysed the FatiGo trial, a multicentre randomized controlled trial involving 122 patients with CFS/ME. FatiGo compared multidisciplinary rehabilitation treatment (MRT) with cognitive behaviour therapy (CBT). Outcomes were assessed at 26 and 52 weeks. The review reports mean CIS fatigue scores at 52 weeks of 33.8 after MRT and 40.1 after CBT, with MRT improving by 5.7 compared with CBT. SF-36 physical component scores were 40.2 and 36.7; the trial reported no significant difference in quality of life between groups. Objective activity improved by 5.8 per cent with MRT and 6.5 per cent with CBT at 52 weeks. At 52 weeks, CBT improved by 2.5 per cent compared with 26 weeks while MRT deteriorated by 3.5 per cent; MRT had a 0.7% objective negative effect compared with CBT, and improvement rates were not significantly higher (p-values 0.10 and 0.85). Dropout was 14.8 per cent (18/122); activity monitor results were unavailable for 34.4 per cent (42/122). Side effects were not reported. The review states FatiGo was unblinded, used subjective primary outcomes, had no placebo control, and ignored its only objective outcome.
- Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.2017 · review
Summary
This comprehensive review examines benefits and harms of treatments for CFS/ME and makes recommendations. It reports no single enrolled or analysed total. Among the included studies, a phase II rintatolimod trial had 92 patients and a phase III trial had 234 patients; a rituximab RCT had 30 patients, with sustained overall improvement in 67% of CFS/ME patients versus 13% of controls. The PACE trial had 640 patients; a recovery paper reported 22% recovered in the CBT and GET groups, compared with 8% in the APT group and 7% in the SMC-only group. A survey of 828 Norwegian CFS subjects reported pacing useful in 96%, and 79% of patients with experience of graded training considered it worsened their health. CoQ10 plus NADH was studied in 80 patients, with maximum heart rate p=0.022. The review also describes harms: three patients administered acyclovir withdrew due to reversible renal failure, and two out of 13 participants developed neutropenia. The authors state no firm conclusions can be drawn because the few RCTs were small-scale, with a high risk of bias, and used different case definitions; nutritional studies were very limited, mostly small and without long-term follow-up.
- Chronic fatigue syndrome: la bête noire of the Belgian health care system.2009 · review
Summary
This paper is a REVIEW & CASE REPORT concerning Chronic Fatigue Syndrome. It reports no enrolled or analysed participant numbers for its own study and presents no treatment trial of its own. It discusses Belgian CFS Reference Centers using CBT/GET. For the Belgian National Health Care System (2006), it states that treatment with CBT/GET at those CFS Centers is not effective, that the employment rate was even decreased after the “rehabilitation” program, that cardiopulmonary capacity was not significantly ameliorated, that there are only modest effects in some, but not all, self-rated symptoms, and that there are virtually no patients who had recovered from ME/CFS. It reports patient inquiries in which CBT/GET had no significant impact (15–30%), the condition further deteriorated (approx. 40–60%), CBT/GET was successful only in a very small group (15–35%), and the “success rate” was not much higher than standard care alone or a self-chosen therapy (20–30%). Case report 1.3 states that fatigue, fibromyalgia and gastrointestinal symptoms increased during CBT. The paper also cites Lerner et al. 2007 for valacyclovir for six months showing significant efficacy, Maes et al. 2009b for CoQ10 reversing symptoms, and Maes et al. 2007a for complete recovery with IVIg and specific NAIOSs. Adverse effects listed in Twisk and Maes, 2009 include increased inflammation, incremental dysregulation of the immune system, a further rise in O&NS, decrements in muscle strength, intensification of muscle and joint pain, increase of neurological impairments, additional ion channel anomalies, and decrement of an already reduced stress response. The paper states that the CBT/GET program is potentially harmful to patients with ME/CFS.
- Chronic fatigue syndrome: is there a role for occupational therapy?2004 · review
Summary
This composite review examines chronic fatigue syndrome (CFS) and occupational therapy treatment strategies. It reports no single enrolled sample or comparison group; it describes occupational therapy programs and related studies. Programs used CBT, GET and pacing, or energy conservation. In Cox & Findley (1994), twenty-eight subjects met the 1988 definition for CFS; results indicated a 57% improvement in perceived level of activity six months after discharge, and the authors noted a lack of controls. Cox & Findley (1998) studied 109 subjects; 82% perceived an increase of functional ability, and a poorer prognosis for recovery was noted in patients reporting symptoms for more than five years. A survey of 72 patients included 32 patients diagnosed with CFS alone; gradual improvement in activity levels was perceived over three years at six-month intervals, with three patients returning to work. In Essame et al. (1998), nineteen patients received a multi-disciplinary program, which produced an improvement in 89% of patients in eight weeks; after a one-year follow-up of fourteen patients, all had maintained or improved their median scores and only two patients had not improved or were worse by discharge. Packer et al. (1995) studied two groups of 16 participants and reported a decrease in fatigue severity and impact over six weeks. The review noted high withdrawal rates among problems in the literature, without attributing them to a treatment. The authors state that the studies are limited in number and research methods.
- Chronic fatigue syndrome: traditional and community-based approaches to rehabilitation.2004 · review
Summary
This narrative review summarised and critically reviewed existing studies of psychological and psychosocial rehabilitation for chronic fatigue syndrome (CFS), searching Medline, PSYCHINFO, CINAHAL, ERIC and the Science Citation Index. Reviewed treatments included CBT with graded activity, graded exercise, activity pacing, supportive counselling, multidisciplinary inpatient and community-based programmes. Sharpe et al. 1996 reported 73% CBT achieved satisfactory outcome vs. 27% usual care, 73% vs. 23% improved function by >10 points, and 63% vs. 20% improved work status. Fulcher & White 1997 reported 51% in the exercise group improved vs. 27% of controls. Wearden et al. 1998 reported exercise improved fatigue and functional work capacity at 12 and 26 weeks; fluoxetine improved depression at 12 weeks, not sustained at 26 weeks. Powell et al. 2001 reported all three intervention groups improved more than controls at one-year follow-up. Ridsdale et al. 2001 found no differences between CBT and counselling at 3 and 6 months; 53% of the original sample were fatigue cases at 6 months. Marlin et al. 1998 reported 61% returned to gainful employment, 27% functioned at a level equivalent to employment, and 12% remained on disability. Dropout rates included 42% in exercise + fluoxetine, 38% CBT in Prins et al. 2001, and 36% cognitive therapy in Ridsdale et al. 2001. The authors state current evidence for complete and enduring benefit of any single approach remains relatively weak, and many studies are limited by absence of a placebo control group, high dropout rates and selection bias.
- Psychological treatment of patients with chronic toxic encephalopathy: lessons from studies of chronic fatigue and whiplash.2003 · review
Summary
This review asked whether psychological treatment or cognitive rehabilitation helps patients with chronic toxic encephalopathy (CTE), using comparable evidence from chronic fatigue syndrome (CFS) and chronic whiplash-associated disorder (WAD). PubMed and PsychLIT were searched from inception to June 2000. Of 34 selected studies, 24 evaluated CFS, 5 WAD, and 5 CTE. Treatments included CBT, CBT plus graded exercise or graded activity, cognitive rehabilitation, relaxation, group therapy and other programs; comparisons included support groups, natural course, relaxation, counseling, controls and untreated patients. Outcomes included fatigue severity, functional impairment, quality of life, physical functioning, symptoms, work status, neuropsychological measures and satisfaction. In CFS, one quality A trial reported CBT was more effective than guided support groups or natural course for fatigue severity and functional impairment; other trials reported no significant differences between CBT and relaxation, CBT and counseling, or three brief treatment conditions. CTE cognitive rehabilitation studies were quality C and gave inconsistent results. Recorded harms were high dropout in a CFS trial, 33% dropout in another, refusal of therapy, and an increase of symptoms at 6-months’ follow-up after a CTE program. The authors state few treatment studies and no randomized controlled trials for WAD or CTE.